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 Technological advancement and globalization have led to the spread of foods to 
countries where the food does not yet have a documented history of consumption, in 
other words, novel foods. Novel foods also encompass truly novel foods, foods that have 
been processed in a novel manner, and novel means of exposure. With novel foods comes 
the potential of food allergens that pose an uncharacterized risk to those with food 
allergies. Food allergies are an increasingly important facet of public health. Therefore, a 
deeper understanding of novel foods as well as methods to evaluate consumers’ potential 
risk is necessary. Literature reviews and experimental evaluations leveraging liquid 
chromatography-electrospray ionization-mass spectrometry were used to explore the risks 
posed by novel sources of food allergens. Subject sources of allergens included Acheta 
domesticus, the house cricket, Tenebrio molitor, the yellow mealworm; extensively 
thermally processed walnut hulls and peanuts, as well as smoke from the wood of tree nut 
trees, and vapor from E-cigarette liquids. Novel methodologies to interpret complex mass 
spectrometry data were developed, allowing resultant information to be used in the 
assessment of allergenic risk. The methodologies developed in this research expand upon 
the utility of mass spectrometry to evaluate potentially allergenic proteins from poorly 
 
  
characterized sources. Broader characterization of the hazards and risks posed by food 
allergens permits stakeholders to be more adequately informed regarding the risks they 












Copyright 2021, Lee K. Palmer
v 
ACKNOWLEDGMENTS 
Thanks to everyone who believed in Dr. Lee.
vi 
PREFACE 
This doctoral dissertation is organized into eight chapters providing an overview of the 
analysis of novel sources of food allergens using mass spectrometry and the application 
of risk assessment methodologies to evaluate the risks posed to consumers.  
 
Some of the content included in Chapter 1, section 1.7 is expected to be included in a 
manuscript under the lead of Justin Marsh (J. T. Marsh, S. J. Koppelman, L. K. Palmer, 
P. E. Johnson, “Determination of major allergen levels, isoforms, and hydroxyproline 
modifications among peanut market types by mass spectrometry,” (in preparation for 
submission to a refereed journal)). 
 
Some of the content in included in Chapter 2 is expected to be included in a manuscript 
under the lead of Lee Palmer (L. K. Palmer, B. Oppert, L. C. Perkin, M. Lorenzen, A. T. 
Dossey, P. E. Johnson, “Predicted allergens and quantitative proteomics from life stages 
of the house cricket, Acheta domesticus,” (in preparation for submission to a refereed 
journal)). 
 
Chapter 4 has been published in LWT (L. K. Palmer, J. T. Marsh, J. L. Baumert, P. E. 
Johnson, LWT 132, 109903 (2020)). 
 
The abstract of Chapter 5 has been submitted for publication in Allergy (L. K. Palmer, P. 
E. Johnson, “Detection of Food Allergen-Derived Peptides from Extractive-Based E-
Cigarette Liquids,” (submitted for publication in Allergy, January 2021)). 
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Overall aims of the Dissertation Research 
1. Explore novel foods, foods processed in novel ways, and novel means of exposure 
as novel sources of food allergens; 
2. Develop methodologies for incorporating mass spectrometry into allergen risk 
assessment; 
3. Evaluate how conventional risk assessment methodologies can be leveraged to 
determine the qualitative and quantitative allergic risks posed by novel sources of 
food allergens. 
 
Structure of the dissertation 
 In Chapter 1, the literature regarding the relationship between food allergy and 
novel foods is explored. 
 Chapters 2 and 3 introduce insects as a seldom consumed food in the Western 
Hemisphere and explores Acheta domesticus, the house cricket, and Tenebrio molitor, the 
yellow mealworm. Developmental stages of A. domesticus are evaluated for differences 
in potential risk posed to consumers and a pair of genetically modified T. molitor are 
compared with the wildtype to determine the effects of genetic modification on levels of 
predicted allergens. 
 Chapter 4 explored extensively thermally processed peanuts to evaluate if any 
remnants of proteins can persist and if they have the capacity to theoretically cause 
reactions in peanut allergic consumers. 
 Chapter 5 evaluated the presence of food allergen residues in E-cigarette liquids 
resulting in risk assessments in terms of both food allergens and respiratory allergens. 
viii 
 Chapters 6 and 7 are literature-based risk assessments evaluating the use of 
extensively thermally processed walnut hulls for water purification and the potential risks 
associated with the use of tree nut wood to smoke foods. 
 Finally, Chapter 8 presents a discussion of the findings including limitations, 
necessary assumptions, and future directions. 
 
ix 
TABLE OF CONTENTS 
LIST OF FIGURES .................................................................................................... xvii 
LIST OF TABLES ........................................................................................................ xx 
CHAPTER 1: UNDERPINNING THE RELATIONSHIP BETWEEN FOOD 
ALLERGIES AND NOVEL FOODS ..............................................................................1 
1.1 Introduction ............................................................................................................1 
1.2 Novel foods ............................................................................................................1 
1.2.1 The niche for novel foods ................................................................................1 
1.2.2 Brief novel food regulations of selected countries and trade blocs ....................4 
1.3 Food allergy ......................................................................................................... 17 
1.3.1 Overview ....................................................................................................... 17 
1.3.2 Mechanisms of IgE-mediated hypersensitivity ............................................... 21 
1.3.3 Diagnosing food allergy ................................................................................. 23 
1.3.4 Prevalence and impact of food allergies ......................................................... 26 
1.3.5 Properties and characteristics of allergenic food proteins ............................... 28 
1.3.6 Food processing and food allergens................................................................ 30 
1.3.7 Novel sources of food allergens ..................................................................... 32 
1.4 Quantitative methodologies for the detection of food allergens ............................. 32 
1.4.1 Polymerase chain reaction .............................................................................. 33 
1.4.2 Enzyme-link immunosorbent assays .............................................................. 35 
x 
1.4.3 Mass spectrometry ......................................................................................... 36 
1.5 Risk analysis and food allergens ........................................................................... 39 
1.5.1 Risk assessment ............................................................................................. 40 
1.5.2 Risk management........................................................................................... 44 
1.5.3 Risk communication ...................................................................................... 45 
1.6 Allergic risks of consuming insects ...................................................................... 46 
1.6.1 Background ................................................................................................... 46 
1.6.2 Crickets ......................................................................................................... 46 
1.6.3 Mealworm ..................................................................................................... 50 
1.6.4 Allergens of edible insects and related species ............................................... 51 
1.6.5 Allergen classes of concern ............................................................................ 55 
1.6.6 Allergen Carryover from Feed ....................................................................... 59 
1.6.7 Summary ....................................................................................................... 60 
1.7 Peanut food allergy and the effects of thermal processing ..................................... 61 
1.7.1 Background ................................................................................................... 61 
1.7.2 Peanut allergy ................................................................................................ 62 
1.7.3 Effects of thermal processing on peanut allergenicity ..................................... 69 
1.7.4 Summary ....................................................................................................... 71 
1.8 Allergic risks of exposure to food allergens by inhalation ..................................... 71 
1.8.1 Background ................................................................................................... 71 
xi 
1.8.2 Defenses, barriers, and transport of allergens ................................................. 72 
1.8.3 Inhalation of food allergens ............................................................................ 75 
1.8.4 Insights into routes of exposure from biopharmaceuticals .............................. 75 
1.8.5 Summary ....................................................................................................... 77 
1.9 Concluding remarks ............................................................................................. 77 
CHAPTER 2: PREDICTED ALLERGENS AND QUANTITATIVE PROTEOMICS 
FROM LIFE STAGES OF THE HOUSE CRICKET, ACHETA DOMESTICUS ............ 79 
2.1 Abstract ................................................................................................................ 79 
2.2 Introduction .......................................................................................................... 80 
2.3 Methods and Materials ......................................................................................... 81 
2.3.1 Chemicals and samples .................................................................................. 81 
2.3.2 Extraction and SDS-PAGE ............................................................................ 82 
2.3.3 Mass Spectrometry ........................................................................................ 83 
2.3.4 Data Analysis................................................................................................. 85 
2.4 Results ................................................................................................................. 88 
2.4.1 Characteristics of samples and cricket life stages ........................................... 88 
2.4.2 Proteomic shifts across life stages .................................................................. 88 
2.4.3 Proteome annotation and gene ontology enrichment ....................................... 91 
2.4.4 Predicted allergens across life stages .............................................................. 93 
2.5 Discussion ............................................................................................................ 97 
xii 
CHAPTER 3: PROTEOMIC EVALUATION OF YELLOW MEALWORM, 
TENEBRIO MOLITOR, WITH EXPERIMENTAL GENETIC MODIFICATIONS ... 101 
3.1 Abstract .............................................................................................................. 101 
3.2 Introduction ........................................................................................................ 102 
3.3 Methods and Materials ....................................................................................... 103 
3.3.1 Samples and Chemicals ............................................................................... 103 
3.3.2 Sample preparation and protein extraction ................................................... 104 
3.3.3 Mass Spectrometry ...................................................................................... 104 
3.3.4 Data Analysis............................................................................................... 106 
3.4 Results ............................................................................................................... 109 
3.4.1 Proteomics of T. molitor samples ................................................................. 109 
3.4.2 Proteome annotation and gene ontology enrichment ..................................... 112 
3.4.3 Predicted allergens of T. molitor .................................................................. 114 
3.5 Discussion .......................................................................................................... 118 
CHAPTER 4: PERSISTENCE OF PEANUT ALLERGEN-DERIVED PEPTIDES 
THROUGHOUT EXCESSIVE DRY THERMAL PROCESSING .............................. 121 
4.1 Abstract .............................................................................................................. 121 
4.2 Introduction ........................................................................................................ 122 
4.3 Materials and methods ........................................................................................ 123 
4.3.1 Chemicals .................................................................................................... 123 
xiii 
4.3.2 Thermal Processing...................................................................................... 124 
4.3.3 Protein Extraction ........................................................................................ 124 
4.3.4 Mass Spectrometry and data analysis ........................................................... 125 
4.3.5 SDS-PAGE, sera, and immunoblotting ........................................................ 127 
4.4 Results ............................................................................................................... 128 
4.4.1 Observable Properties of Thermally Processed Peanuts ................................ 128 
4.4.2 Mass Spectrometry ...................................................................................... 129 
4.4.3 Antibody Binding to Thermally Processed Peanut ........................................ 133 
4.5 Discussion .......................................................................................................... 135 
CHAPTER 5: DETECTION OF FOOD ALLERGEN-DERIVED PEPTIDES FROM 
EXTRACTIVE-BASED E-CIGARETTE LIQUIDS .................................................... 139 
5.1 Abstract .............................................................................................................. 139 
5.2 Introduction ........................................................................................................ 140 
5.3 Methods and Materials ....................................................................................... 142 
5.3.1 Samples and Chemicals ............................................................................... 142 
5.3.2 Sample preparation ...................................................................................... 143 
5.3.3 SDS-PAGE .................................................................................................. 143 
5.3.4 Mass Spectrometry ...................................................................................... 143 
5.3.5 Risk assessment ........................................................................................... 145 
5.4. Results .............................................................................................................. 146 
xiv 
5.4.1 Visualization of present proteins .................................................................. 146 
5.4.2 Assessment of Data Sets and Peptide Assignments ...................................... 150 
5.4.3 Identification of proteins present in E-cigarette liquids ................................. 152 
5.4.4 Quantification of proteins and evaluation of the risk of eliciting allergic 
reactions ............................................................................................................... 152 
5.5 Discussion .......................................................................................................... 153 
CHAPTER 6: LITERATURE-BASED RISK ASSESSMENT OF ACTIVATED 
CARBON MADE FROM WALNUT HULLS FOR USE IN WATER PURIFICATION 
SYSTEMS ................................................................................................................... 157 
6.1 Summary ............................................................................................................ 157 
6.2 Background ........................................................................................................ 157 
6.3 Activated Carbon Processing .............................................................................. 158 
6.4 Allergenic Hazards of Walnut Hulls ................................................................... 159 
6.5 Effects of Thermal Processing on Allergens ....................................................... 160 
6.6 Allergen Labeling of Activated Carbon Derived from Walnut Hulls ................... 161 
6.7 Chemical Hazards of Walnut Hulls ..................................................................... 162 
6.8 Conclusions ........................................................................................................ 163 
CHAPTER 7: LITERATURE-BASED RISK ASSESSMENT OF ALLERGENS IN 
SMOKE DERIVED FROM TREE NUT WOOD ........................................................ 164 
7.1 Summary ............................................................................................................ 164 
xv 
7.2 Background ........................................................................................................ 164 
7.3 Wood, Trees, and Logging ................................................................................. 165 
7.4 Industrial Smoke Production, Processing, and Usage .......................................... 166 
7.5 Smoke as a Medium for Allergen Transport ....................................................... 169 
7.6 Effects of Thermal Processing on Allergens ....................................................... 171 
7.7 Allergen Labelling of Products Produced in Part with Smoke from Tree Nut Wood
 ................................................................................................................................ 173 
7.8 Conclusions on the risks associated with Smoke derived from Tree Nut Wood ... 173 
CHAPTER 8: SUMMARY AND CONCLUSIONS ON NOVEL SOURCES OF FOOD 
ALLERGENS ............................................................................................................. 174 
REFERENCES ............................................................................................................ 177 
APPENDIX A SUPPLEMENTARY FIGURES AND TABLES FROM CHAPTER 2: 
PREDICTED ALLERGENS AND QUANTITIATIVE PROTEOMICS FROM LIFE 
STAGES OF THE HOUSE CRICKET, ACHETA DOMESTICUS ............................... 204 
APPENDIX B ANNOTATIONS OF QUANTIFIED PROTEINS FROM ACHETA 
DOMESTICUS (XLSX, 380 KB) ................................................................................ 213 
APPENDIX C SUPPLEMENTARY FIGURES AND TABLES FROM CHAPTER 3: 
PROTEOMIC EVALUATION OF YELLOW MEALWORM, TENEBRIO MOLITOR, 
WITH EXPERIMENTAL GENETIC MODIFICATIONS ........................................... 214 
APPENDIX D ANNOTATIONS OF QUANTIFIED PROTEINS FROM TENEBRIO 
MOLITOR (XLSX, 337 KB) ....................................................................................... 227 
xvi 
APPENDIX E SUPPLEMENTARY FIGURES AND TABLES FROM CHAPTER 4: 
PERSISTENCE OF PEANUT ALLERGEN-DERIVED PEPTIDES THROUGHOUT 
EXCESSIVE DRY THERMAL PROCESSING .......................................................... 228 
APPENDIX F COMPLETE PEPTIDE LIST FOR ROASTED PEANUTS (XLSX, 4853 
KB) ............................................................................................................................. 235 
APPENDIX G SUPPLEMENTARY FIGURES AND TABLES FROM CHAPTER 5: 
DETECTION OF FOOD ALLERGEN-DERIVED PEPTIDES FROM EXTRACTIVE-
BASED E-CIGARETTE LIQUIDS ............................................................................. 236 
xvii 
LIST OF FIGURES 
Figure 1.1. Examples of novel foods and processes involving by-product or waste 
valorization. .....................................................................................................................2 
Figure 1.2 Mechanism of cellular activation in response to allergenic insult and 
subsequent recognition by IgE. ...................................................................................... 21 
Figure 1.3 The constituent parts and sub-parts of an iteratively applied risk analysis. ..... 40 
Figure 2.1 Heatmaps and Pearson correlation matrices of all proteins and robust proteins
 ...................................................................................................................................... 91 
Figure 2.2 GO enrichment of life stages ......................................................................... 93 
Figure 2.3 S-curves of quantifiable proteins and predicted allergens per life stage ......... 94 
Figure 2.4 Venn diagram of protein assignments and annotations .................................. 95 
Figure 2.5 Robust and variable predicted allergen heatmap and characteristics of 
predicted allergens across life stages .............................................................................. 96 
Figure 3.1 Heatmaps of all proteins and robustly identified proteins ............................ 111 
Figure 3.2 GO enrichment of samples against all proteins or robustly identified proteins
 .................................................................................................................................... 113 
Figure 3.3 S-curves of quantifiable proteins ................................................................. 115 
Figure 3.4 Venn diagram of protein assignments and annotations ................................ 116 
Figure 3.5 Selected predicted allergen heatmap and characteristics of predicted allergens 
across life stages .......................................................................................................... 117 
Figure 4.2 SDS-PAGE and immunoblots ..................................................................... 134 
xviii 
Figure 4.3 Dot blots ..................................................................................................... 135 
Figure 5.1 SDS-PAGE gel of E-liquids ........................................................................ 150 
Appendix A Figure 2.1.1 A. domesticus life stages ....................................................... 204 
Appendix A Figure 2.1.2 SDS-PAGE of extracts from A. domesticus life stages .......... 206 
Appendix A Figure 2.1.3 Spectra of peptides with posttranslational modifications and 
relevant unmodified forms ........................................................................................... 207 
Appendix A Figure 2.1.4 Phylogeny of the origin species of allergen predictions ........ 209 
Appendix C Figure 3.1.1 Alignments and sequence coverage for arginine kinase and 
tropomyosins ............................................................................................................... 217 
Appendix C Figure 3.1.2 Spectra of peptides with posttranslational modifications and 
relevant unmodified forms ........................................................................................... 219 
Appendix C Figure 3.1.3 Phylogeny of the origin species of allergen predictions ......... 221 
Appendix C Figure 3.1.4 Alignment of T. molitor identified tropomyosins with known 
allergenic tropomyosins ............................................................................................... 225 
Appendix C Figure 3.1.5 Identity matrix of alignment of T. moltior tropomyosins with 
known allergenic tropomyosins ................................................................................... 226 
Appendix E Figure 4.1.1 Peanut kernel halves over thermal processing ....................... 230 
Appendix E Figure 4.1.2 Extracts of peanuts heated at 176 °C and 260 °C ................... 231 
Appendix E Figure 4.1.3 Extracts of peanuts heated at 176 °C and 260 °C ................... 232 
Appendix E Figure 4.1.4 Peanut allergenic profile for peanuts heated at 176 °C ........... 232 
xix 
Appendix E Figure 4.1.5 Persistence of peanut allergen peptides at 176 °C .................. 233 
Appendix E Figure 4.1.6 Negative control immunoblots .............................................. 234 
Appendix G Figure 5.1.1 Annotated Peptide spectra .................................................... 242 
 
xx 
LIST OF TABLES 
Table 1.1 Symptoms by system associated with IgE-mediated reactions to food. ........... 19 
Table 1.2 Pros and cons of quantitative methodologies to detect food allergens. ............ 33 
Table 1.3 Major and minor allergens of peanut .............................................................. 63 
Table 2.1 Life stage quantification characteristics .......................................................... 89 
Table 3.1 Sample quantification characteristics ............................................................ 110 
Table 4.1 MS quantification and summary of peanut allergens after roasting at 176 °C 130 
Table 4.2 Maximum length of contiguous peptides of peanut allergens after roasting for 
176 °C ......................................................................................................................... 132 
Table 5.1 Literature values and assumptions used in food allergen risk assessment of E-
liquids ......................................................................................................................... 147 
Table 5.2 Literature values and assumptions used in respiratory allergen risk assessment 
of E-liquids .................................................................................................................. 148 
Table 5.3 E-liquid properties and volumes analyzed by SDS-PAGE and Mass 
Spectrometry ............................................................................................................... 149 
Table 5.4 Protein quantification using mass spectrometry ............................................ 153 
Appendix A Table 2.1.1 Life stage replicate characteristics ......................................... 205 
Appendix A Table 2.1.2 Mass spectrometry multi-round search metadata.................... 206 
Appendix A Table 2.1.3 Peptide posttranslational modification characteristics ............ 208 
xxi 
Appendix A Table 2.1.4 Enriched Gene Ontology (GO) terms for the top 10% most  
abundant proteins per life stage .................................................................................... 210 
Appendix C Table 3.1.1 Tribolium castaneum tropomyosin-2 exon structure utilized to 
manually curate T. molitor protein sequences............................................................... 214 
Appendix C Table 3.1.2 T. molitor tropomyosin-2 exon nucleotide sequences ............. 215 
Appendix C Table 3.1.3 Mass spectrometry multi-round search metadata .................... 218 
Appendix C Table 3.1.4 Peptide posttranslational modification characteristics ............ 220 
Appendix C Table 3.1.5 Enriched Gene Ontology (GO) terms of the top 10% most 
abundant proteins per sample against all proteins ......................................................... 221 
Appendix C Table 3.1.6 Enriched Gene Ontology (GO) terms of the top 10% most 
abundant proteins per sample against robust proteins ................................................... 223 
Appendix E Table 4.1.1 Posttranslational modifications added to PTM search ............. 228 
Appendix E Table 4.1.2 Lists of peptides used for quantification of peanut allergens ... 229 
Appendix G Table 5.1.1 Comprehensive peptide identifications .................................. 237 
Appendix G Table 5.1.2 Normalized sample wise peptide presence and quantity ......... 238 
Appendix G Table 5.1.3 Comprehensive protein identifications ................................... 243 
1 
CHAPTER 1: UNDERPINNING THE RELATIONSHIP BETWEEN FOOD 
ALLERGIES AND NOVEL FOODS 
 
1.1 Introduction 
 Technological advancement and globalization have led to the spread of food to 
countries that do not have a history of safe consumption of that food, in other words 
novel foods. As novel foods, novel techniques to process foods, and novel means to 
consume foods continue to develop, so do the sources of potential food allergens. Food 
allergies are becoming an increasingly important facet of public health around the world. 
To protect the health of consumers a deeper understanding of both novel foods and the 
risk posed is needed. The following will review food allergy and detection of food 
allergens, novel foods and regulatory definitions, and the principles of food allergen risk 
analysis with considerations to novel sources of food allergens. 
 
1.2 Novel foods 
1.2.1 The niche for novel foods 
 A novel food can be broadly defined as a food without a significant history of 
consumption or produced by a method that had not been previously applied to food, 
which is subjective at the level of the individual, culture, and governmental regulatory 
agencies. For example, for many in the Western Hemisphere, insects are considered a 
novel food but elsewhere, such as Thailand, they represent a common nutrient source. 
Novel foods are diverse including examples such as cell-based meat [14], mycoprotein 




 Novel processing technologies are also being researched and utilized such as cold 
atmospheric plasma, oscillating magnetic fields, high-pressure processing, pulsed electric 
fields, pulsed light, irradiation, and ultrasound, where much of the industry is focused on 
maintaining sensory qualities but held back by costs and a current dearth of research into 
the application of these technologies as applied to food [19]. Novel foods and ingredients 
may also be produced through the application of traditional processing techniques to 
foods that had not previously been processed in that manner, such as with protein 
isolates. Genetic modification of crops and organisms can generate novel variants of 
crops with improved nutritional quality as in golden rice engineered to produce β-
carotene (provitamin A) and tackle vitamin A deficiencies, iron biofortified rice to 
 




increase the iron content and combat anemia, and quality protein maize to improve the 
amino acid profile of corn via a higher production of essential amino acids [20]. 
 The world population is projected as just under 10 billion people in 2050 [21], 
and feeding the population requires adequate food and protein. Despite farmers producing 
approximately 4600 kcal per person, or double what is needed, malnutrition remains a 
persistent threat [22]. The global spread of the Western diet, characterized by a diet rich 
in animal proteins, refined fats, sugars, and processed foods, has driven further animal 
rearing and has been viewed as a significant confounder in a path toward sustainably 
feeding the future population [23, 24]. Proponents suggest novel foods as a means to 
alleviate unsustainable consumption of animal protein requiring profound inputs of land, 
fresh water, and energy but also excessive environmental impacts such as generation of 
greenhouse gasses, deforestation, loss of biodiversity, and degraded water supplies 
through runoff of excess fertilizer and pesticides [23, 25]. Novel processing technologies 
then can be implemented for improved efficiency of current food systems by reducing 
food waste, where approximately one-third of food produced for human consumption is 
lost or wasted throughout the supply chain [25]. 
 Comparisons to conventional animal rearing have been performed using insects as 
an alternative animal protein source. Insects broadly have a greater food conversion ratio, 
require less land to rear, require minimal water, and produce fewer greenhouse emissions 
than conventional livestock [26]. In terms of energy, mealworms have been investigated 
in the Netherlands in a year-round climate-controlled facility and found to require less 
energy than beef but equivalent to pork [27], but this could be improved by growing the 
mealworms in a more suitable climate. Although insects have been touted for their ability 
4 
to thrive on waste and by-products, crickets reared on an industrial scale do require at 
least an organic side-stream of processed relatively high-quality feed to thrive and 
preferably the current feed given to poultry [28]. Insects as a novel food demonstrate 
considerable improvements in sustainability compared to conventional livestock but are 
more appropriately understood as competition rather than wholly usurping the position of 
conventional livestock. 
 As sustainable novel foods are but a competitor within the marketplace, ensuring 
that novel foods are supported from both the consumer and producer sides is critical. 
Producers need to be appropriately compensated for practicing sustainable farming 
practices that support the environment [23]. Simultaneously, consumers need to be 
appropriately guided to overcome neophobia through the persistence of the novel food in 
the market but also labeling of food packages [29, 30]. Careful presentation of novel 
foods is key, as evidenced by long-used processing technologies such as irradiation, 
which is commonly regarded as a novel processing technology despite its use for 
decades. Further, irradiated products when presented as ‘treated with ionization’ are 
regarded less negatively as compared to ‘treated with irradiation’, likely through 
associations of irradiation with inferior goods and nuclear power. Presentation of labels is 
in part based on the producer’s interests but heavily driven by pertinent regulations 
demanded by regulatory agencies. 
 
1.2.2 Brief novel food regulations of selected countries and trade blocs 
 Although which foods are categorized as novel can vary by individual and 
cultural standards, a key unifying factor is the guidance provided by regulatory agencies 
5 
and government mandates. Regulations regarding what constitutes a novel food 
commonly identifies a lack of a documented history of safe use within the purview of 
each regulatory agency, with considerations given for safe use in other countries. Foods 
deemed novel undergo risk assessments to determine if significant harm will come from 
consumption of the novel food. Differences among regulations are often in the form of 
differences of explicitly stated means that a food may be novel such as if a genetically 
modified organism is also a novel food.  
 
1.2.2.1 Australia and New Zealand 
 The statutory authority on food safety for both Australia and New Zealand is the 
Food Standards Australia New Zealand (FSANZ) and is responsible for the development 
and administration of the Australia New Zealand Food Standards Code [31]. As of 13 
April, 2017, Standard 1.5.1 – Novel foods establishes that novel foods are non-traditional 
and thereby require safety assessments specific to adverse effects, composition, 
processing, source, consumption patterns [32]. Categories of non-traditional foods are 
given as plants or animals and components thereof, plant or animal extracts, herbs and 
extracts thereof, dietary macro-components, single chemical entities, microorganisms and 
probiotics, and foods produced from new sources or by a process not previously applied 
to food [32]. Further, the standard clarifies that a non-traditional food stipulates any of a 
food, food-derived substance, other component of food, as well as any other substance 
without a history of human consumption in Australia or New Zealand is non-traditional 
and therefore a novel food.  
6 
 Retail sale of novel foods or foods with a novel ingredient may be sold if listed in 
section S25-2 and stipulated conditions of use are complied with 
(https://www.legislation.gov.au/Details/F2017C00413) [32]. Enquiries of the novelty of a 
particular food or food ingredient are handled by the Advisory Committee on Novel 
Foods and make recommendations to FSANZ pertaining to if it is a non-traditional food, 
if an assessment of public health and safety should be required given intended levels and 
use, and if the enquirer ought make an application to request the Food Standards Code be 
amended by FSANZ to undertake an assessment of public health and safety [33]. FSANZ 
also compilate a record of views formed on a larger body of foods and food ingredients to 
clearly present a summary of if each were identified by FSANZ as a traditional food, 
novel food, the justification of the view, and comments which may include safety 
concerns, labeling requirements, and pertinent sections of the Food Standards that may 
apply [32, 34]. 
 
1.2.2.2 Brazil 
 In Brazil, the statutory authority on food safety is the National Agency of Sanitary 
Surveillance (ANVISA) whose purpose is to protect the health of the population via 
sanitary control of food and pharmaceuticals [31]. Regulations for novel foods include 
Resolution No. 16, of April 30, 1999 (Resolução nº 16, de 30 de abril de 1999) and 
Resolution No. 17, of April 30, 1999 (Resolução nº 17, de 30 de abril de 1999) [35, 36], 
which established the mandatory registration procedures for novel foods and ingredients 
and the guidelines for safety assessments of novel foods and ingredients, respectively. 
ANVISA has since released a guidance document the Food and Ingredient Safety 
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Evidence Guide (Guia para Comprovação da Segurança de Alimentos e Ingredientes) 
[37]. Novel foods were defined as foods or food ingredients for human consumption 
without a history of consumption in Brazil or foods containing currently consumed 
ingredients but at much greater levels than currently observed excluding food additives, 
manufacturing aids, food provided as capsules, pills, tablets, or similar; and foods with 
novel ingredients given an exemption [31, 37, 38]. The registrant must include 
information pertaining to identity, scientific evaluations of safety, and comprehensive 
literature regarding the food or ingredient. Novel foods then undergo a safety and risk 
assessment on a case-by-case basis by the Techno-scientific Advisory Committee on 
Functional Food and Novel Foods (CTCAF).  
 As of July 2020, regulatory discussion has identified that the current regulations 
are highly subjective regarding what constitutes a safe history of use and clarity is 
required into the legal definition of novel foods and ingredients as well as the 
transparency into the safety assessments of novel foods and ingredients [38]. The 
proposed definition of a novel food would include foods and ingredients from vegetables, 
animals, minerals, microorganisms, fungi, algae, or synthetics without a history of safe 
consumption in Brazil as food and further specifies that novel foods and ingredients 
include but are not limited to: derivative products without a history of safe use, new or 
intentionally modified molecules, cell cultures or tissues thereof, those produced with a 
process not yet applied to food, products with an altered nutritional profile, 
nanomaterials, nutrient sources, bioactive substances, and substances only authorized for 
use in dietary substances if they were to be added to food. 
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1.2.2.3 Canada  
 The regulatory authority regarding novel foods in Canada is the Food Directorate 
of Health Canada and is responsible for assessments of novel food safety [31]. Novel 
foods are regulated as described by Division 28 of Part B of the Food and Drug 
Regulations [39], where B.28.001 stipulates that a novel food is a substance or 
microorganism without a history of safe use as food, or manufactured by a process not 
previously applied to that particular food and additionally causes the food to undergo a 
major change (i.e. places the food outside the accepted limits of natural variations for that 
food with regard to composition, structure, nutritional quality, physiological effects, 
alters the manner of how it is metabolized, or affects the microbiological safety, chemical 
safety, or safe use of the food), and lastly the food is derived from a plant, animal, or 
microorganism that has been genetically modified resulting in new characteristics, 
removed characteristics, or characteristics are outside of natural variation. The use of the 
term “substance” is not defined, although a novelty determination may be requested to 
clarify that a particular substance is either novel or non-novel 
(https://www.canada.ca/en/health-canada/services/food-nutrition/genetically-modified-
foods-other-novel-foods/requesting-novelty-determination.html). 
 Novel foods require pre-market authorization for either sale or advertisement 
predicated on notification of Health Canada [31]. Petitioners provide pertinent 
information regarding the safety of the novel food such as history of use, dietary 
exposure, detail of production, and considerations of nutrition, toxicology, allergy, 
chemistry, and microbiology. The Food Directorate encourages consultations during 
development of novel foods to determine which data are necessary to demonstrate safety. 
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The Food Directorate has released guidelines on the safety assessment of novel foods 
[40], as well as a document providing transparency and insight into the Food 
Directorate’s management process for novel foods [41]. The Food Directorate maintains 
a list of approved novel foods and genetically modified organisms with completed safety 
assessments and found to be safe for human consumption 
(https://www.canada.ca/en/health-canada/services/food-nutrition/genetically-modified-
foods-other-novel-foods/approved-products.html). Further, The Food Directorate also 




1.2.2.4 China  
 The most current statutory authority overseeing inquiries on novel foods and 
ingredients is the National Health Commission (NHC), which superseded the National 
Health and Family Planning Commission (NHFPC) as of March 2018 [42]. The most 
current novel food regulations are the Administrative Measure of Safety Evaluation of 
Novel Food Ingredients as of 2013, which established that novel food ingredients are 
those without a history of dietary use in China including animals, plants, microorganisms, 
components from any of animals, plants, or microorganisms; components whose original 
structure has been altered, and other newly developed foods. A history of dietary use was 
established as more than 30 years. Novel food ingredients cannot be introduced to the 
market without approval and safety evaluation from the NHC. Considerations are 
provided to novel food ingredients that have substantial equivalence to foods or prior 
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approved novel food ingredients not limited to genus, species, source, biological 
characteristics, composition, edible parts, and level of use.  
 The NHC evaluates the safety of novel food ingredients and provides 
recommendations with the assessment [42]. The assessment includes conclusions 
pertaining to the safety, technical need, and social impact. If approved by the NHC, the 
novel food ingredient may be used in general goods as well as health functional foods. 
Notably, new genetically modified organisms, ingredients for the exclusive use for health 
functional foods, or food additives are outside of the scope of the provisions of these 
evaluations. Announcements and interpretations for novel food ingredients are posted on 
the NHC website (http://www.nhc.gov.cn/sps/s2909/new_list.shtml).  
 
1.2.2.5 Eurasian Customs Union (EACU) 
 The Eurasian Economic Union (EACU) formed as of 1 January 2015 and 
currently comprises of Armenia, Belarus, Kazakhstan, Kyrgyzstan, and the Russian 
Federation to represent a single market [43]. Across the EACU, the regulations for novel 
foods are the Technical Regulations of the Customs Union TR CU 021/2011 [44]. Within 
the EACU, novel foods are defined as food products including additives or flavorings 
without a history of consumption by humans within the customs territory such as a new 
or modified molecular structure, microorganisms or isolates thereof, microscopic fungi or 
algae, plants, isolates of animals, genetically modified organisms, nanomaterials, or 
nanotechnology products (Article 4). Classes specifically excluded from this definition 
include food products obtained by traditional methods, are currently in circulation, and 
are by virtue of experience safe. Food ingredients are not specifically identified as falling 
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within this regulation nor are new production processes unless they specifically modify 
molecular structures [45].  
 Novel food products are subject to state registration as it is being produced within 
the EACU or before importing into the EACU [43], where state registration is carried 
about by a nationally authorized body dependent which nation the application is being 
filed [43, 45]. Registration requires information regarding scientific procedures to 
confirm the novel food product is safe for humans and information regarding its effects 
on humans to establish no adverse effects. After successful registration, the novel product 
is no longer novel and not subject to registration by other applicants, although each must 
conform to the initial registration. Registered applications and documents are available to 
the public (http://eec.eaeunion.org/).  
 
1.2.2.6 European Union (EU) 
 The European Union (EU) comprises of 27 member states and with  
Norway, Iceland, and Lichtenstein comprise the European Economic Area (EEA). The 
European Commission (EC), the executive branch of the EU, acts as the regulatory 
authority regarding novel foods with the European Food Safety Authority (EFSA) acting 
as the advisory scientific body [31]. In 2015, the EC established the current definitions of 
novel foods per Regulation (EU) 2015/2283 that applies across the EEA [46]. Using 15 
May 1997 as a reference date, novel foods were defined as any food not used for 
significant human consumption within the Union and is any of: a food with a new or 
intentionally modified molecular structure, food consisting of or isolated from 
microorganisms, fungi, algae, minerals, plants, animals, or nanomaterials; are from a 
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production process not yet used for food production in the Union and resulting in 
significant changes to the composition or structure of the food, nutritional value, 
metabolism, or level of undesirable substances; vitamins, minerals or other substances 
produced with a process not yet used for food production in the Union, or foods used 
exclusively in food supplements with intent to use in foods other than supplements. 
Novel foods were specifically segregated from genetically modified foods, enzymes, 
additives, flavorings, or extraction solvents. 
 Novel foods require pre-market approval predicated on an evaluated lack of risk 
to human health, its intended use is not misleading, and if substituted for current foods its 
substitution would not be a detriment to human health [46]. Further, those producing 
novel foods are compelled to verify the novelty of their food by consulting the country 
where they plan to place the novel food. The administrative and scientific requirements 
for novel food applications were established per Regulation (EU) 2017/2469 [47]. The 
applicant provides a technical dossier including their own safety assessment data, 
including biological or toxicological assessments, as well as their proposed conclusion 
from their provided data to enable the EC to consult EFSA for an opinion on the overall 
risk assessment of the novel food and highlighting uncertainties and limitations of the 
evaluation. The EC catalogues lists of novelty determinations 
(https://ec.europa.eu/food/safety/novel_food/catalogue/search/public/index.cfm#) as well 





 Novel foods in India are under the supervision of the Food Safety and Standards 
authority of India (FSSAI) [48]. Novel foods are currently regulated according to the 
Food Safety and Standards Regulations, 2016 stipulating that a novel food may not have 
a history of human consumption, may have any ingredient that may not have a history of 
human consumption, or made from a new technology and process resulting in significant 
changes in the structure to alter nutrition, metabolism, or undesirable substances [49]. 
Individual classes or types of novel foods are not specified within this regulation. 
 The pre-market approval process has been explained in the Food Safety and 
Standards Regulations, 2017 [50]. As per guidance, novel foods may not be 
manufactured or imported without prior approval, where the application includes 
information on the source, function and intended use, scientific analyses, regulatory 
status in other countries, and documents on risk and toxicological assessments. 
Regulation, 2017 gives more insight into what constitutes a novel food, which includes 
novel foods and ingredients, foods processed with novel technology, additives, 
processing aids and enzymes, as well as foods consisting of or isolated from 
microorganisms, bacteria, yeast, fungi, or algae.  
 
1.2.2.8 Japan  
 In Japan, the primary statutory authority regarding food sanitation is the Ministry 
of Health, Labor, and Welfare (MHLW) [31, 51]. Under the Food Sanitation Act, there is 
no segregated definition of a novel food or ingredients nor delineated procedures for 
approval (Article 4, Food Sanitation Act). Rather, the Food Sanitation Act has provisions 
to prohibit sale of foods that have not been generally served for human consumption and 
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have not demonstrated a lack of risk to human health, have been served for human 
consumption but served in an extraordinarily manner, or where serious damage to human 
health has been attributed (Article 7, Food Sanitation Act). In each case, the MHLW is 
advised by the Pharmaceutical Affairs and Food Sanitation Council (PAFSC). 
Genetically modified organisms are separately assessed by the Food Safety Commission 
(FSC) but is also responsible for risk assessment of food hazards. 
 
1.2.2.9 Saudi Arabia 
 As of the end of 2019, Saudi Arabia’s Saudi Food and Drug Authority (SFDA) 
has proposed a set of draft requirements to regulate novel foods [52]. The draft 
regulations pertain to microorganisms, fungi, algae, minerals, plants, animals, cell 
cultures or tissues, and nanomaterials as well as foods with new or modified molecular 
structures, foods derived from new production processes, and foods that are traditionally 
consumed from other countries. The regulation would require pertinent information such 
as the scientific basis for safety under intended use or in the case of traditional foods from 
elsewhere would require information about history of safe use. The SFDA would take the 
information provided into consideration as well as the similarity to foods that are 
understood as safe. 
 
1.2.2.10 Singapore 
 The Singapore Food Agency (SFA) is investigating a framework for novel foods 
and had presented its proposed regulatory framework for comments [53]. The proposed 
framework seeks to clearly define and gird the scope of novel foods, establish safety 
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criteria, and application processes. The proposed definition is that a novel food is one not 
used for human consumption in Singapore or outside of Singapore for more than 20 years 
and is from an unconventional source or prepared by an unconventional process. 
Examples provided include foods isolated from or produced from plants or animals or 
their parts; isolated or produced from microorganisms, fungi, algae; food with new 
chemical structures not previously found in food whether such food is synthesized from 
raw materials or manufactured from a process not conventionally used in food 
production; food derived from biologically synthesized substances such as genetically 
modified organisms, tissue culture, cell culture, or cloning; foods consisting of 
intentionally engineered nanomaterials. Therefore, foods with a history of safe use are not 
novel foods, where the history is to be considered based on length of consumption and 
use, extent of use, quantity used, purpose and context of use, evidence of lack of adverse 
health effects. Delineated examples of novel foods include plant parts without a history of 
safe use, insects without a history of safe use, animals without a history of safe use, 
isolates from insects, refined extracts from animal products, newly identified 
microorganisms without a history of safe use, substances synthesized using food-grade 
raw materials (e.g. enzymatically modified ingredients), cell-based meat, engineered 
nanomaterials (particle size < 100 nm). 
 
1.2.2.11 United States of America (USA) 
 The regulatory authority overseeing food additives in the United States (USA) is 
the United States Food and Drug Administration (USFDA) [31]. Under current law, there 
is no delineated definition of novel foods or ingredients; however, any substance 
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reasonably expected to become a component of food is a food additive and subject to pre-
market approval by the USFDA, unless that component is generally recognized as safe 
(GRAS) or meets an exclusion from the definition of food additive according to section 
201(s) of the Federal Food, Drug, and Cosmetic Act. Food additives approved either by 
USFDA pre-market approval or GRAS is evaluated under the conditions of its intended 
use and the use of a food additive above that which was approved would require 
reevaluation [31, 54].  
 Substances that have not been documented as GRAS or USFDA approved, listed, 
or excluded require USFDA pre-market approval using a food additive petition [54]. The 
technical elements necessary include chemical composition, proposed use, levels of use, 
data regarded intended effects, quantified detection levels, estimated exposure levels, 
safety reports, proposed tolerances of production, and environmental impact information. 
The USFDA provides various guidance documents for identifying pertinent regulations 
as well as recommendations for chemical, toxicological, microbial, and environmental 
testing, evaluations, and assessments (https://www.fda.gov/food/food-ingredients-
packaging/food-additives-petitions).  
 An alternative to a food additive petition is GRAS status, which can be 
determined either through demonstrated food use in the USA prior to 1958 or by 
scientific procedures accompanied by a general recognition of safety based on the views 
of qualified experts [54]. It is becoming more uncommon for food additives to be 
approved by a history of use prior to 1958, and therefore GRAS by scientific procedures 
is the principal means to attain GRAS. The data required for GRAS is like that of a food 
additive petition such as technical safety evidence for intended use but also a 
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demonstration of safety using evidence that is generally known (i.e. publicly available 
information). A key difference is GRAS does not have to be filed with the USFDA and 
providing a notification of GRAS is voluntary and so some companies convene a panel of 
experts as a GRAS panel to evaluate a self-affirmation of GRAS while others document 
the self-affirmation without a GRAS panel. Despite the voluntary notification scheme, 
the USFDA is interested in GRAS notifications of foods that may pose a risk to the US 
population. If the petitioner decides to notify the USFDA of its GRAS determination, the 
USFDA responds to GRAS notifications either with acceptance without questions, 
rejection for insufficient data or unclear safety, or stop by request of the inquirer. The 
USFDA maintains lists of GRAS notifications 
(https://www.cfsanappsexternal.fda.gov/scripts/fdcc/?set=GRASNotices), food additives 




1.3 Food allergy 
1.3.1 Overview 
 Allergic disease encompasses a broad spectrum of disorders characterized by 
abnormal immune responses. Atopic diseases, in other words diseases with a genetic 
predisposition toward development of allergic disease, encompass asthma, allergic 
rhinitis, hay fever, atopic dermatitis, and food allergy, although the relationships between 
these diseases and their immune response have not been fully clarified [55]. Those with 
atopic diseases are commonly predisposed to greater production of immunoglobulin E 
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(IgE) antibodies, but many people with elevated levels of total and allergen specific IgE 
do not present with atopic disease. Some present with one specific atopic disease whereas 
others co-express several. Atopic diseases are often categorized umbrella terms such as 
asthma or allergic rhinitis but it is more appropriate that each be understood as a 
collection of diseases merely grouped by the phenotype of the disease [56].  
 Causative agents in Immunoglobulin E (IgE)-mediated hypersensitivity reactions 
that can first sensitize an individual to prime the immune system and secondly elicit a 
reaction and develop symptoms are broad. Such agents include outdoor allergens (grass 
and tree pollen) [57], indoor allergens (house dust mites, pets, cockroaches) [58], insects 
stings and/or bites [59], as well as food [60], where the only difference among these is the 
source of the allergen. Food allergy is an abnormal immunological response to foods or 
their components [60], typically a naturally present protein and are differentiated into 
antibody-mediated immediate hypersensitivity reactions, cell-mediated delayed 
hypersensitivity reactions, and mixed antibody-cell mediated conditions. IgE-mediated 
hypersensitivity reactions account for most food allergic reactions [61]. Other food 
sensitivities and intolerances may not be immune mediated. Food intolerances are 
metabolic food disorders that become evident upon consumption of certain foods (lactose 
intolerance), and food sensitivities are idiosyncratic reactions to specific food 
components occurring through unknown mechanisms (sulfite-induced asthma) [60].
 Symptoms of IgE-mediated food allergy are diverse where symptoms include 
pruritis (itching) and numbness and objective symptoms include hives, eczema, swelling, 
wheezing, chest tightness, chest pain, nasal congestion, trouble breathing, abdominal 
pain, diarrhea, nausea, vomiting, constriction of the airways, drops in blood pressure, and 
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anaphylaxis (Table 1.1) [62]. Symptoms can be evident within minutes and can last for 
several hours. In some cases, symptoms can appear hours after ingestion as in the case of 
alpha-gal syndrome, a delayed syndrome related to red meat ingestion due to 
sensitization through tick bites [60, 61]. The severity of reactions is understood to follow 
a dose-response relationship [62], although this is complicated by factors such as the 
allergen itself, individual host factors, and interventions to control the reaction [63]. 
 
 A risk factor for development of food allergies was once thought to be early 
exposure to the offending allergen, but early exposure was found to be a protective factor 
rather than a risk factor according to the Learning Early about Peanut Allergy (LEAP) 
trial [64]. Environmental factors also impact the development of allergies as protective 
Table 1.1 Symptoms by system associated with IgE-mediated reactions to food. 









• Conjunctival erythema 








• Laryngeal edema 





• Abdominal cramps 
• Angioedema of tongue, 
lip, or pharynx 
• Emesis 
• Nausea 
• Oral pruritus 
Cardiovascular 
• Bradycardia 











effects have been ascribed to farm exposure, breastfeeding, and exposure to other 
children; particularly older siblings, but risk factors include air pollution and pet 
ownership [65]. Genetics are a major factor as studies on twins has shown significant 
heritability of phenotypes of allergic disease, specifically a higher correlation of 
heritability has been shown for monozygotic twins (sharing 100% of genes) than 
dizygotic twins (sharing 50% of genes) [66]. A broad array of genes has been identified 
where specific gene variants have been associated with greater susceptibility to various 
allergic diseases. A key example is the gene for filaggrin (FLA), which has been 
associated with asthma, atopic dermatitis, and food allergy as the product filaggrin is a 
major component of the protein-lipid envelope of the epidermis and thereby important for 
establishment and maintenance of the epidermal barrier. Meta-analysis has shown that 
there is a strong dose-dependent association between atopic dermatitis, food sensitization, 
and food allergy as well as evidence that atopic dermatitis precedes food sensitization and 
food allergy [67].  
 There is currently no cure for food allergies. Therefore, management of food 
allergies from a consumer perspective is often required and demands careful reading of 
food package labels in addition to dietary choices [68]. Nonetheless, relying on package 
labels can leave patients at risk of accidental exposure due to cross-contamination with 
allergenic foods or incorrect labeling [62]. To reduce the burden of food allergies, 
immunotherapies have been explored to increase the tolerance of allergic individuals 
toward their offending allergens such as oral (direct consumption), sublingual (held under 
the tongue), and epicutaneous (dermally applied patch) immunotherapies [69]. 
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1.3.2 Mechanisms of IgE-mediated hypersensitivity 
During sensitization, the immune response is driven by differentiation of naïve T cells 
into TH2 cells as well as class switching of naïve mature B cells from production of non-
IgE antibodies to IgE production (Figure 1.2) [70]. 
Differentiation of T cells occurs as antigen presenting cells (including but not limited to 
dendritic cells) present an antigen-derived peptide to the T cell along with appropriate co-
stimulating molecules to result in activation. Upon activation, the TH2 cells secrete 
cytokines [Interleukin (IL)-4, IL-13], which encourage continued TH2 differentiation, 
proliferation, as well as B-cell IgE class switching and production. Activated CD4 T-cells 
along with activated B-cells can result in B-cell differentiation into antibody-secreting 
 
Figure 1.2 Mechanism of cellular activation in response to allergenic insult and 
subsequent recognition by IgE.  
 
Adapted from [4]. 
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plasma cells and memory cells, which persist and respond to future insults with IgE 
production long after sensitization. Produced IgE can strongly bind to the surface of mast 
cell and basophil FcɛRI to prime them for activation. During sensitization, there is no 
active immune response and therefore no symptoms. 
 Subsequent antigenic insults result in antigens binding to IgE and subsequent 
cross-linking of FcɛRI resulting in both activation and degranulation of mast cells and 
basophils [70]. The granules release potent mediators to produce local, tissue, and 
systemic responses, which are responsible for the symptoms associated with immediate 
hypersensitivity reactions [60]. Released histamine from the granules can elicit 
inflammation, pruritis, and vasoconstriction of blood vessels of the gastrointestinal and 
respiratory tracts. Other released molecules include lipid mediators, leukotrienes, and 
prostaglandins, where leukotrienes are related to symptoms that develop slowly as in late-
phase asthmatic reactions.  
 Exposure to food proteins do not typically result in the development of allergic 
disease nor the formation of IgE antibodies. Even in atopic individuals exposure to food 
proteins in the gastrointestinal tract promotes oral tolerance through the formation of 
protein-specific IgG, IgM, and/or IgA antibodies [60]. Other mechanisms of tolerance 
include clonal anergy, apoptosis of antigen specific T cells, active immune suppression, 
and bystander suppression. Regulatory T cells (Tregs) are involved in controlling the 
response of the immune system by inhibiting T cell proliferation and differentiation 
through the cytokines IL-10 and TGF-β [70, 71], which act as a key component of oral 
tolerance and maintain healthy immune responses to allergens [72]. 
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 Other types of reactions are also meaningful as in IgG mediated hypersensitivity 
reactions caused by IgG binding to cell surfaces resulting in cell death (penicillin 
allergy), immune complex mediated reactions resulting from the formation and 
deposition of antigen-antibody aggregates (serum sickness), and delayed hypersensitivity 
reactions incorporating CD8 and TH1 cells and pathways (mosquito bites) [70]. Celiac 
disease is a non-IgE mediated hypersensitivity triggered by gluten proteins in various 
grains, predominantly wheat. Celiac is characterized by IgG and IgA responses to gluten 
after the effects of endogenous transglutaminase has deamidated gluten and “produced” 
the necessary antigen in the form a gluten-transglutaminase complexes. Resultant T cell 
activation and subsequent proinflammatory response is coupled with an autoantibody 
response causing damage to the small bowel and atrophy of the villi leading to long term 
damage and nutrient uptake deficiencies [73]. 
 
1.3.3 Diagnosing food allergy 
 Diagnosis of food allergies begins with the clinical history of the patient. 
Information such as the food consumed, how the food was prepared, symptoms 
experienced, severity of symptoms, and the interval between consumption and onset of 
symptoms are all incorporated to determine the likelihood of food allergy [74]. Further, 
background regarding atopy, current food allergies, current medications (e.g. 
antihistamines), and diet can refine the diagnosis and identify if any food sensitivities are 
present, if the manifestation is a food allergy, and if offending foods can be singled-out 
[75]. Clinical histories substantiating a possible food allergy are complimented with skin-
prick testing, serum IgE testing, and food challenges [76].  
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 Skin prick tests act as a relatively quick and cheap method to establish allergic 
sensitization. The test is performed by puncturing the skin with food extract, puncturing 
the suspect food and then the skin, or through intradermal injection and compared against 
negative (e.g. saline solution) and positive (e.g. histamine) controls [77]. A positive 
reaction is evaluated in terms of the resultant wheal and the size measured, where a wheal 
diameter greater than 3 mm is considered positive. Skin prick results must be analyzed 
carefully as wheal sizes vary according to age, site used for testing, skin prick technique 
used, and the antigen used for the test whether fresh or commercial [78]. Skin prick tests 
can have negative predictive values up to 95% but this varies greatly depending on the 
food tested and the type of extract used as commercially produced plant extracts can 
result in sensitivities of as low as 20% [74]. Positive skin prick tests only confirm the 
presence of allergic sensitization as opposed to allergic disease, although positive results 
coupled with a compelling clinical history are strongly incriminating [77]. 
 Evaluation of allergen-specific IgE acts as an alternative and compliment to skin 
prick testing, but is more costly, time-consuming, and similarly does not discriminate 
allergic disease and allergic sensitization [74]. Methods to measure allergen-specific IgE 
include fluorescent enzyme immunoassays such as ImmunoCAP and Immuno Solid-
phase Allergen Chip (ISAC). These tests are performed in a laboratory setting where 
serum is applied to immobilized antigens and detected by anti-IgE antibodies with 
fluorescent tags where greater fluorescence indicates more bound IgE. These tests are 
semi-quantitative, and so are not perfectly comparable across different methodologies, 
but are used to determine predictive values of allergic disease as increasing 
concentrations of measured IgE are correlated with greater likelihood of allergic disease 
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[79]. When measured specific-IgE are greater than or equal to 95% of the predictive 
value then food allergy is likely, whereas if levels are less than or equal to 50% of the 
predictive value then oral challenge may be carried out to exclude food allergy [78]. 
These tests can be further leveraged for component-resolved diagnostic testing to identify 
individual proteins binding a patient’s serum IgE and establish patterns among foods with 
homologous proteins.  
 When clinical history and diagnostic tests are unclear, food challenges can be 
performed to assess clinical reactivity. Food challenges can be performed as a double-
blind placebo-controlled food challenge (DBPCFC) or open food challenge (OFC). Food 
challenges can be expensive and necessitate a highly controlled environment and so are 
not performed without careful consideration of alternative means of diagnosis. Open food 
challenges are subject to observer bias and psychogenic factors resulting in a greater 
false-positive rate but are more practical in clinical settings [74, 78]. Double-blind 
challenges are the preferred diagnostic method, but the suspect allergen must be 
appropriately masked in a vehicle food to be indistinguishable from a placebo, which can 
be difficult in the case of easily detected allergenic foods such as apple or shrimp. In 
either method, the food should be given in a tiered manner given timed intervals and 
beginning with very low doses to determine the threshold dose resulting in symptoms. 
The food challenge ends upon either completion of the challenge without symptoms or 
discontinued upon development of symptoms and the patient treated immediately. In 
some cases, food challenges can result in anaphylaxis, underscoring that food challenges 
should be conducted by trained professionals in appropriate settings [79]. Negative 
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results allow the patient to introduce the challenged food into their diet, but positive 
results indicate that avoidance is necessary. 
 
1.3.4 Prevalence and impact of food allergies 
 In 1995, the FAO-WHO Expert Consultation on Food Allergies of 1995 identified 
eight major food and groups associated with over 90% of food allergies: gluten 
containing grains, crustaceans, eggs, fish, peanuts, soybeans, milk, and tree nuts [80]. In 
1999, the list was included in the Codex Alimentarius and later adopted by many 
countries as the basis for their laws regarding labeling of allergenic foods. There are 
differences in prevalence of individual food allergens as in celery allergy in Europe, 
sesame allergy in Israel, and buckwheat allergy in Japan [60], which is commonly 
reflected in differences among countries food allergen labeling laws. 
 Recent surveys have determined that the estimated total prevalence of convincing 
food allergy in the U.S. is at least 10.8% given that of those surveyed 19% self-reported a 
food allergy [81], which underscores the importance of clinical diagnosis and the proper 
education of those at risk. However, the disparity among self-reported and clinically 
confirmed food allergy identifies a problem that the true prevalence of food allergy is not 
accurately known. Large epidemiologic studies incorporating studies of questionnaires 
and surveys may not be accurate to the true prevalence of food allergy [56]. Considerable 
heterogeneity is present among studies of food allergy prevalence due to differences 
among how studies may incorporate likely, but unconfirmed, food allergy as opposed to 
prevalence of clinically or objectively confirmed food allergy. Among well designed 
studies, variability of questionnaires, IgE testing, skin prick testing material, and oral 
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challenge material can cause the prevalence of food allergy to vary considerably across 
studies [82]. 
 Identifying those at risk is difficult as in the case of children born in East Asia or 
Africa but raised in the West being at greater risk of developing food allergy compared to 
Caucasian counterparts [83]. Many factors impact the prevalence of recorded food allergy 
including geography, diet, age, race, and ethnicity [75]. The prevalence of food allergy is 
generally regarded as increasing although uncertainty exists due mostly to lack of clinical 
confirmation of food allergy (i.e. food challenges) in favor of skin prick tests, IgE-based 
biomarkers, or a lack of any clinical evaluation [84].  
 Food allergies impose great social cost on those affected and while food allergy 
has been historically understood as a pediatric disease a great and increasing proportion 
of adults are affected [85]. The annual economic cost of food allergies has been estimated 
at above $4,000 per child including costs of hospitalizations, clinician visits, and 
medications. Those of lower socioeconomic status are most affected as they have a 
greater propensity to spend more on hospitalizations and emergency room visits. In 
addition to out-of-pocket costs, lost opportunity costs impose a great burden on those 
with food allergy via lost wages to take themselves or others to the hospital as well as 
potentially restricted career choices to take care of children with food allergies [86]. For 
those self-reporting food allergies, some of these costs could also be undertaken and 
thereby impose a burden even without the presence of disease. 
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1.3.5 Properties and characteristics of allergenic food proteins 
 Formal nomenclature of allergens is performed by the International Union of 
Immunological Societies (IUIS) as the IUIS Allergen Nomenclature Sub-Committee 
under the purview of the World Health Organization (WHO) [87]. The nomenclature of 
allergenic proteins is based on Linnaean binomial nomenclature identifying the genus and 
species of all organisms. The base format includes the abbreviated genus name, 
abbreviated species name, allergen number, and a four-digit number representing the 
isoallergen and variant numbers (e.g. Ara h 10.0102; Arachis hypogaea 10th allergen, 
isoallergen 1, variant 2). Allergen numbers were initially assigned in order of discovery 
but has since been assigned to organize allergenic proteins by similarity for clarity. 
Isoallergens are those from the same species representing similar function with a shared 
sequence identity of >67% and variants are those with a shared sequence identity of 
>90% [87]. 
 Epitopes are specific chemical groups in an antigen that determine the specificity 
of an antigen [88]. Epitopes are the basic structural unit of both B and T cell receptors 
and antibodies and can be divided into either B or T cell epitopes according to which 
cells they bind and divided further into linear or conformational epitopes. Linear epitopes 
are made of sequentially contiguous amino acids as compared to conformational epitopes, 
which are composed of amino acids representing a spatially close region formed due to 
protein folding. Cross-linking of FcεRI requires two antibody molecules to bind to the 
same allergen. Epitopes adhered to antibodies or either T cell or B cell receptors are held 
by a binding pocket allowed by the receptor’s amino acid side chains and by non-
covalent interactions with the epitope [70]. Although the receptors are highly specific for 
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their antigen, binding is predominantly determined by anchor resides to determine the 
principal specificity of the binding pocket. 
 Cross-reactivity is recognition of multiple antigens by antibodies with a single 
specificity [89], in that antibodies produced against a specific protein may bind to related 
sequences and structures of the same or similar organisms. Cross-reactivity permits 
reactivity without initial exposure to the exact same epitopes, rather only highly similar 
epitopes. Factors affecting cross-reactivity include common proteins, epitopes, and folds 
[88]. In allergy, cross-reactivity results in a broader array of antigens that can result in 
allergic reactions, and thereby is advantageous for protection against pathogens but not in 
the case of dietary proteins [89]. Families of cross-reactive allergenic proteins have been 
identified plants including profilins, prolamins, cupins, and Bet v 1-like proteins but also 
animals including parvalbumins, tropomyosins, and arginine kinases [88, 90]. Cross-
reactivity also leads to some odd couplings and disparities when focusing on foods rather 
than the cross-reactive allergens as those with cow’s milk allergy are highly likely to be 
reactive to goat’s milk but seldom reactive to horse’s milk or another example of the 
relatively common cross-reactivity of those with latex allergy reacting to any of kiwi, 
banana, or avocado [91]. Cross-reactivity also bridges the gap between aero-allergens and 
food allergens as in pollen-food syndromes between, for example birch-apple syndrome 
through homology of birch Bet v 1 and apple Mal d 1 [92].  
 To determine if a particular protein has the capacity to elicit reactions, proteins 
can be evaluated to determine the plausibility of their allergenicity. Decision trees and 
weight-of-evidence approaches have been adapted from evaluations of proteins derived 
from biotechnology to aid in the process of evaluating potentially allergenic proteins 
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[93]. Individual proteins can be evaluated on the basis if there are other allergenic 
proteins known from the organism, if the protein is homologous to other known 
allergens, if sera with known reactivity have IgE that can bind the protein, enzyme 
digestibility assays (e.g. pepsin, trypsin, chymotrypsin), and animal models (e.g. BALB/c 
mice). Knowledge about the properties of the protein in question can also be informative 
as allergens tend to have similar properties such as maintenance of protein folds (calcium 
binding, lipid binding, and disulfide bonding leading to heat resistance), maintenance of 
primary sequence (resistance to proteolysis), repeated epitopes (repeating primary 
structures, multimeric quaternary structures), and unique motifs (glycosylation and 
glycation sites) [94], where each of these properties results in a greater capacity to 
distinguish the protein from self-proteins, allow for single epitopes to be bound multiple 
times across a single antigen, as well as maintain the allergen for the immune system to 
identify. Predictive tools aid in distinguishing plausible allergenic proteins, for example 
AllergenOnline [95], AllerCatPro [96], and BepiPred [97], to predict allergenic proteins 
on the basis of their sequence, structure, and B-cell epitopes. Guidelines on predicting the 
allergenic potential of proteins based on sequence alone include CODEX guidelines of 
greater than 35% identity over segments of 80 amino acids or 100% identity in 6 or 8 
amino acids, but prediction based on greater than 50% identity over the full length has 
been regarded as the most predictive [95]. 
  
1.3.6 Food processing and food allergens 
 For known allergenic proteins in commonly consumed foods the question is what 
can be done about them. Various forms of food processing are common in preparation of 
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food such as thermal, high pressure, enzymatic, and fermentative processing. Thermal 
processing is one of the most common and preferable methods to prepare food for 
desirable organoleptic properties [98]. Thermally processing allergenic proteins can result 
in reduced IgE-binding for some proteins but can expose hidden epitopes for others. For 
example, Bet v 1-like allergens tend to show greatly reduced IgE binding after heat 
treatment but Ara h 1 shows similar IgE binding before and after baking. High-pressure 
processing (HPP) is an emerging nonthermal technique often used for inhibition of 
microbial growth. The underlying principle is that application of pressures above 200 
MPa can affect higher order structures of protein without affecting covalent bonds, which 
allows for nutritional value, flavors, and aromas to be unaffected. The efficacy of high-
pressure processing is still under investigation but shows promise as an alternative to 
thermal processing for microbiological hazards.  
 Processing methods that directly impact the sequence of allergenic proteins tend 
to have great effect in reducing their capacity to bind IgE. Enzymatic hydrolysis is a well-
known nonthermal processing technique commonly used for foods such as milk, lentils, 
and peanuts, although this technique is heavily reliant on proteins that are susceptible to 
the proteolytic cleavage for the end result to be a greatly diminished allergenic protein 
[99]. Further, a major drawback of enzymatic hydrolysis are the negative impacts on 
functional properties and emergent bitterness and astringency from resultant small 
polypeptides [98]. Alternatively, fermentation is one of the oldest food preservation 
methods. Utilizing microbes to produce enzymes and act upon the food results in changes 
in texture, flavor, and functional properties [99]. Milk and wheat have consistently shown 
that fermentation can result in reductions in IgE binding, although the range of foods 
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where fermentation is applicable is limited as the fermented product is often greatly 
different from the starting material in terms of both function and taste [98].  
 
1.3.7 Novel sources of food allergens 
 Accompanying novel foods and processing comes food allergens that may be 
themselves novel, processed to render a well-known allergen to be modified in a novel 
manner, or a well-known allergen being consumed or ingested in an alternative manner. 
Understanding a novel source of food allergens then demands insight into which proteins 
are present, how they are affected by processing, as well as how to both detect and 
quantify present proteins that may be hazardous to consumers. Accurate identification 
and evaluation of the presence and quantity of food allergens is heavily dependent on the 
methodology used. 
 
1.4 Quantitative methodologies for the detection of food allergens 
 There are currently a wide variety of methodologies that can detect food 
allergens, although a smaller subset has been widely accepted and utilized for 
quantitative determinations. Methods for quantitative evaluation of food allergens include 




1.4.1 Polymerase chain reaction 
  Polymerase chain reaction (PCR)-based methods allow for highly specific and 
sensitive detection and quantification of DNA stretches, rather than protein, from 
allergenic sources of interest beginning with extraction and purification of present DNA, 
amplification of DNA, and subsequent detection of the DNA [100, 101]. PCR utilizes 
thermal cycling and repeated cycles of both heating and cooling to denature DNA and 
enzymatic replication with Taq polymerase [100]. Repeated cycles of denaturation, 
annealing, and extension takes place until DNA of interest is sufficiently amplified. Key 
factors in an effective PCR are the specificity of the stretch of DNA and the specificity of 
the oligonucleotides chosen as primers for the reaction [100, 101]. 
Table 1.2 Pros and cons of quantitative methodologies to detect food allergens. 
 
Methodology Pro Con 
Polymerase chain 
reaction 
• High throughput 
• Multiplex potential 
• Fast 
• DNA is tolerant of 
robust extraction 
• Detects DNA rather 
than protein 
• DNA may not 




• High throughput 
• Industry standard 
• Fast 
• Requires antibodies  
• Antibodies can cross-
react  
• Requires calibration 
to reference materials 
• Extraction requires 
antibody tolerance 
Mass spectrometry 
• Multiplex potential 
• Can be absolutely 
quantitative 
• High sensitivity to all 
present proteins 
• High capital inputs  
• High levels of 
expertise 
• Time consuming 




  Real-time PCR is preferred for quantitative analysis of allergenic food- derived 
DNA [100]. In real-time PCR, the reaction tube additionally contains a target specific 
oligonucleotide probe and fluorescent reporter dye attached to a quencher. Detection of 
fluorescence is prevented due to proximity of the dye and quencher but when the DNA-
hybridized probe is exposed to the 5’ exonuclease activity of Taq polymerase, the dye is 
displaced into solution. As the reaction progresses, more dye is displaced into solution 
and the reaction can be monitored and measured as fluorescence is proportional to the 
amount of target DNA present. 
 In principle, PCR allows for a greater diversity of valid methods to be developed 
per allergenic food compared to protein-based methods as three nucleotides represent 
single codons as translated to amino acids where degenerate use of codons allows for 
otherwise indistinguishable proteins to be distinguished by PCR in addition to 
untranslated introns [101]. PCR methods only require the genetic code and so could be 
utilized as open-source methods as compared to the limited and often proprietary 
antibodies utilized by antibody-based methods. The time to run a PCR is comparable to 
that of enzyme-linked immunosorbent assays (ELISA) and faster than mass spectrometry 
(MS). In a well-designed PCR, simultaneous detection of several DNA stretches, i.e. 
multiplex allergen detection, is possible. 
 DNA is generally more tolerant toward harsh extraction procedures than protein 
and so PCR benefits; however, matrix impurities can impair detection more so than 
protein-based methods such as polysaccharides, polyphenols, fats, minerals, and enzymes 
[102]. PCR is not universally applicable to allergenic foods as both milk and egg are 
poorly detected by PCR due to low levels of present DNA [100]. Use of PCR requires 
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calibration curves to convert quantified allergenic food-derived DNA into total allergenic 
food as quantities of DNA are not universal across foods [101]; further, as PCR does not 
directly detect the proteins, their utility in assessment of the risk posed is limited [100]. 
 
1.4.2 Enzyme-link immunosorbent assays 
 Enzyme-linked immunosorbent assays (ELISA) are the most widely used tool by 
the food industry for detection of specific allergenic proteins [100]. The antibodies used 
for ELISA are typically IgG from animal sources, usually rabbits, goats, or sheep, which 
allow for suitable quantities of antibody with minimal variability as compared to using 
human serum IgE. Quantitative ELISAs come in either of sandwich or competitive 
formats, each with their own benefits and drawbacks. Sandwich ELISAs are the most 
common format for allergen detection where an IgG capture antibody is immobilized on 
a solid phase, such as a 96-well plate, and the food is extracted and applied to the plate 
and subjected to the immobilized IgG. After incubation and washing, a reporter IgG 
labelled with an enzyme (e.g. horseradish peroxidase) is added to sandwich present 
allergenic proteins. To quantify present allergenic protein a substrate is added, and the 
enzyme labelled IgG develops a colored product that can be measured. Color is 
proportional to the amount of present allergenic protein and is quantified by comparison 
to a standard curve. 
 Alternatively, competitive ELISAs are available where allergenic proteins of 
interest are immobilized on the solid phase and separately the sample extract is pre-
incubated with allergen-specific IgG [100]. When the sample-IgG mixture is applied to 
the wells, IgG that are unbound will bind to the plate. After washing, a reporter IgG is 
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added, color developed, and colored product is measured. In competitive ELISA, the 
color developed is inversely proportional to present allergenic protein. 
 Sandwich ELISAs require two IgG epitopes per target protein whereas 
competitive ELISA only requires a single IgG epitope [100], which allows competitive 
ELISA to have an advantage detecting fermented or hydrolyzed proteins where target 
proteins may not be wholly intact for a sandwich ELISA to be wholly effective. ELISA 
can be performed relatively simply with trained personnel and using inexpensive 
equipment [101]. There are many commercially available ELISA kits that encompass 
most food allergens, although different kits for the same allergenic food may not detect 
the same protein fractions or allergens (e.g. the whey versus casein fractions of milk) 
[100]. 
 The performance of ELISA can vary among samples from different food sources 
according to matrix effects and food processing effects [101]. Proteins may not be 
effectively extracted due to protein aggregation, denaturation, or chemical modification, 
which limits comparison to calibrants that may not be representative of the same matrix, 
processing state of the allergenic protein in the food [101, 103]. Polyclonal IgG and the 
calibration curves are subject to batch variation and may further vary across 
manufacturers, producing different results across kits detecting the same allergenic 
proteins [101].  
 
1.4.3 Mass spectrometry 
 Mass spectrometry has historically been applied to the identification and 
characterization of proteins, but only more recently has been applied to quantification of 
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food allergens [100, 104]. The most applied quantitative workflow is called bottom-up, 
where the measured targets are peptides derived from enzymatic digestion of allergenic 
food-specific proteins [105]. A generalized quantitative workflow has four steps: 1) 
protein extraction, 2) proteolytic digestion, 3) analysis of identified peptides for 
evaluation, 4) iterative targeted evaluation of selected peptides. Extraction is often the 
most important for sensitive detection of target peptides as the food matrix can contain 
many non-target proteins and peptides as well as starches, fats, and other interfering 
molecules that can be a detriment to accurate quantification [106]. After extraction, the 
proteins can be prepared for mass spectrometry by reduction to break present disulfide 
bonds, alkylation to prevent reintroduction of disulfide bonds, and proteolysis that 
commonly features either trypsin or chymotrypsin to reproducibly cleave the proteins 
into peptides [100]. 
 To analyze the complex mixture of peptides, mass spectrometers are commonly 
coupled with reverse phase high performance liquid chromatography (RP-HPLC) to 
fractionate the peptides according to their hydrophobicity and feed the peptide fractions 
into an electrospray ion source (ESI) [101]. Mass spectrometers can be any of an array of 
different analyzers such as a quadrupole (Q), ion-trap, time-of-flight (ToF), OrbitrapTM, 
or Fourier-transform ion cyclotron (FTICR) as well as used in tandem configurations, 
such as a triple quadrupole (QqQ), to increase sensitivity, resolution, and accuracy [100]. 
The mass spectrometer measures ions according to their mass-to-charge ratio (m/z) and 
so first measures the whole peptides and, for tandem mass spectrometry, fragment the 
peptides to generate further information about the sequence of the peptide and generate 
further actionable information about the peptide. 
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 An initial investigation proceeds without prior knowledge of present proteotypic 
peptides representing the allergenic food to identify suitable candidates. Identification of 
peptides is performed bioinformatically with software, such as Mascot or PEAKS, and 
compared with databases of proteins representing the targeted allergenic foods and 
background matrices [100]. Candidate peptides are screened on a wide array of criteria 
not limited to uniqueness against the food matrix, conservation among varieties of the 
allergenic food, high abundance, lack of modifications (i.e. Maillard reaction products, 
oxidation sites, deamidation sites), efficient extraction and digestion, reproducible and 
unique fragments, a predominant charge state, and of length between 6-12 amino acids 
[105]. Optimal peptides from the allergenic food may be appropriate in some food 
matrices but not others and therefore sub-optimal peptides may have to be used. Further, 
it is a continuous challenge that the databases assessed for peptide identifications may be 
incomplete for one or both of the allergenic food and matrix such that better peptides 
could be present and not utilized. Once suitable candidate peptides are identified and 
initial verification of their uniqueness and utility are established, chemically pure 
peptides labelled with heavy isotopes (commonly C13 and N15) can be included with the 
unlabeled target peptides to act as standards for quantification [101].  
 Mass spectrometry enables the detection of multiple proteins per allergenic food 
and allergenic foods in a single analysis in addition to highly degraded proteins [101]. 
Mass spectrometry detects proteins from the allergenic food without the need for 
immunochemistry, which can be affected by food processing [100]; however, the effects 
of food processing must be evaluated with respect to mass spectrometry detection as 
protein extraction can be greatly influenced by processing. Taking a sample through the 
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entire process of mass spectrometry, data analysis, and quantification requires lengthy 
periods of time, expensive equipment, and highly trained personnel. The use of mass 
spectrometry is currently very well suited to confirmatory analysis, but as a young 
technology can grow to distinguish itself.  
 
1.5 Risk analysis and food allergens 
 Risk can be defined as a function incorporating both the probability and severity 
of adverse health effects caused by a hazard, where a hazard is an agent that can cause 
adverse health effects [107]. With respect to food allergens, the hazard is the food 
allergen, and the risk is a function of an individual with allergy to that food allergen 
consuming the allergen as well as the dose consumed. Risk analysis is a three-part 
scientific process incorporating risk assessment, risk management, and risk 
communication (Figure 1.3). By virtue of new developments or considerations, risk 
analysis iteratively incorporates information, concerns of stakeholders, and feasibility to 
gauge the level of risk posed relative to the level of risk permissible. Application of risk 




1.5.1 Risk assessment 
 Risk assessment incorporates four steps consisting of hazard identification, hazard 
characterization, exposure assessment, and risk characterization [107]. For food 
allergens, these steps can be summarized as identifying plausible allergens of concern, 
 
 
Figure 1.3 The constituent parts and sub-parts of an iteratively applied risk 
analysis. 
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evaluation of the effects to allergic consumers, determination of likely consumption 
patterns, and culminating in an estimation of the risk posed to allergic consumers. 
 
1.5.1.1 Hazard identification 
 Hazard identification is the identification of agents capable of causing adverse 
health effects [107], where for the hazard identification of a food allergen would be the 
range of plausible food allergens that may be present in a given food. Identification of 
relevant allergenic sources can be performed relative to data attributed to human 
consumption, including clinical studies, provided that the allergenic source was attributed 
correctly and judgment and/or guidance that the allergen is of significant concern to the 
overall population [108]. For example, strawberries can cause severe reactions in those 
with strawberry allergy; however, in the U.S. strawberries do not warrant delineation on 
package labels as an allergen nor handling as an allergenic hazard. Such ingredients may 
yet be judged as a hazard for a manufacturing plant or company if the packaged food 
were to be sold specifically to those with food allergies. 
 
1.5.1.2 Hazard characterization 
 Hazard characterization is the qualitative and/or quantitative evaluation of the 
nature of the adverse health effects caused by agents [107]. If data is available, a dose-
response assessment should be included to determine the relationship between the 
magnitude of exposure and the severity or frequency of adverse health effects. Non-
allergen food safety (conventional) risk assessments may estimate the likelihood of the 
presence of a hazard on a scale of 1-3 ranging from unlikely to very likely and similarly 
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estimate the severity of the hazard from 1-3 ranging from minor injury to death and 
further multiplying these to generate an overall risk score per hazard and thereby 
determine a hierarchy of hazards to control [109]. Transposing such a scheme to allergens 
does not adequately characterize present hazards as the severity of an allergen can be 
further evaluated in terms of the physical nature of the allergen (liquid, powder, 
granules), amount of allergenic protein present (concentration), processing applied to the 
allergen, and clinical thresholds among allergic individuals [109]. As the severity of 
allergic reactions are related to the exposure dose, consideration and discrimination 
among allergen-containing ingredients provides a greater level of nuance. For example, a 
soy protein isolate as compared to soy lecithin contains a far greater amount of protein 
(allergens) as well as being a free-flowing powder rather than a viscous liquid where 
without characterizing the nuances between the two would be regarded as equally 
hazardous. 
 At the population level, allergic individuals begin to demonstrate symptoms at a 
wide range of doses [110]. Individual minimum eliciting doses can be determined using 
DBPCFC studies to determine the highest dose observed not to produce an adverse effect 
(No Observed Adverse Effect Level (NOAEL)) and/or the lowest does that does produce 
an adverse effect (Lowest Observed Adverse Effect Level (LOAEL)). Aggregation of 
individual minimum eliciting doses by modelling can be used to determine eliciting doses 
(ED) predicted to result in reactions in percentages of the population (i.e. 1% or 5% is 
then ED01 and ED05, respectively). This approach has been applied in the Voluntary 
Incidental Trace Allergen Labelling (VITAL) scheme for 14 allergens for manufacturers 
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to use as reference doses for manufacturers and guide risk assessment and management 
[7]. 
 
1.5.1.3 Exposure assessment 
 Exposure assessment is the qualitative and/or quantitative evaluation of the likely 
intake of agents and other relevant sources [107]. Exposure can be quantitatively 
determined by incorporating probabilities that allergic consumers purchase a product and 
the amount of the food consumed in a single sitting. It has been demonstrated that food 
allergic consumers do not differ in food intake as compared to non-allergic counterparts 
[111], and so general data on food intake can be used to evaluate likely consumption and 
exposure patterns allergic individuals will face. Country-wide dietary surveys can be used 
to determine values for both purchasing and consumption. Examples include the U.S. 
National Health and Nutrition Examination Survey (NHANES) and the Canadian Health 
Measures Survey (CHMS). Exposure assessments can incorporate further variables such 
as the propensity to heed specific wordings of precautionary allergen labeling as well as 
proprietary marketing data to narrow the assessment to specific products or a single 
company.  
 
1.5.1.4 Risk characterization 
 Risk characterization is the qualitative and/or quantitative estimation including 
uncertainties of the probability of occurrence and severity of potential adverse health 
effects in a given population per hazard identification, hazard characterization, and 
exposure assessment [107]. In order of increasing complexity and requirements for data 
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quality, methods to characterize risk include safety assessments, benchmark dose [112], 
and probabilistic modelling [113]. Evaluation in order of increasing complexity clarifies 
if simpler methodologies are sufficient prior to application of more rigorous methods. 
 Briefly, a safety assessment is a classical toxicological approach where available 
data is surveyed for the lowest NOAEL and/or LOAEL and further divided by an 
uncertainty factor reflecting human variability to arrive at a dose that should be safe to 
consume in a single sitting [108]. The benchmark dose method involves constructing a 
dose-distribution curve from population data and determining a benchmark dose from the 
lower confidence limit of a dose corresponding to a predetermined increase in reactions 
(e.g. 1% or 10% or more) [108, 112]. Probabilistic modelling leverages distributions of 
minimum eliciting doses, concentration of allergen present, and consumption amounts to 
sample from using Monte Carlo simulations and calculate the likely number of expected 
allergic reactions [108, 113]. Both safety assessment and benchmark dose methods 
produce qualitative estimates of risk whereas probabilistic models are quantitative. Each 
tend to produce estimates that are risk-adverse such as probabilistic models 
overestimating the total number of reactions [108]. As the methodologies continue to 
improve coupled with higher quality data, more accurate estimates of the true risk can be 
produced. 
 
1.5.2 Risk management 
 Risk management is weighing policies with respect to stakeholders and 
considerations of risk assessment to select adequate prevention and control options [107]. 
In context of the risk assessment for a particular hazard, risk management seeks to 
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actively control hazards considering all present hazards and heeding good manufacturing 
practices. Managing allergens seeks to make food products such that allergic consumers 
can make informed and safe choice [108]. Managing risk involves the entire supply chain 
to the consumer. Examples of steps to control include the sourced ingredients, where 
allergenic ingredients are stored in a facility, how manufacturing areas are cleaned and 
validated, and ensuring packages are accurate and reflect the food therein. 
 
1.5.3 Risk communication 
 Risk communication is the interactive exchange of information and opinions 
throughout risk analysis including the explanation of risk assessment findings and the 
basis of risk management decisions [107]. Much of the communication directly between 
the manufacturer and consumer regarding the risk involved with foods is provided in the 
form of labeling. Major allergenic sources are commonly mandated to be clearly 
displayed such that concerned individuals can make safe choices. In the case of 
unintentional allergens, precautionary labeling is voluntary but ought to be used to reflect 
uncertainty where hazards cannot be controlled such that a preponderance of 
precautionary labels are not used for foods that such a warning is not warranted [108]. 
Ensuring that allergic consumers are well-informed is important but precautionary 
labeling should not be used in lieu of appropriate risk management as the result is undue 
restrictions on the diets on those with allergy. 
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1.6 Allergic risks of consuming insects 
1.6.1 Background 
There is increased interest and activity working toward production and use of 
insects as food sources in industrialized countries. Certain insects (locusts, termites, and 
other related arthropods such as scorpions) have been consumed for centuries in 
Southeast Asia and elsewhere, usually as whole identifiable organisms. New food 
products being developed now require processing of the insects into powders or 
emulsions that are added to processed foods. Thus, regulatory authorities and developers 
are interested in considering potential safety issues. The primary predictable risk is 
potential IgE allergic reactions for those already allergic to crustacean shellfish (also 
arthropods) or to other insects, who might react upon their first ingestion. This review is 
intended to consider the prevalence and identity of proteins that might cause cross-
reactivity or de novo sensitization, but currently there is a lack of information on methods 
for accurately predicting de novo sensitization. 
 
1.6.2 Crickets 
1.6.2.1 Food allergy to crickets 
Allergic reactions to crickets can occur from either airway, contact or oral 
exposure as discussed in a recent review [114]. Currently, there is little data regarding 
food allergy to crickets, with only one reference to the possibility of reactions to cricket 
as a food source [115]. There is little documentation of the use of insects as food sources 
in the United States. However, it is not uncommon to find insects used as food in some 
international cultures. Yet food allergy to crickets has been regarded as relatively rare in 
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light of notable consumption of crickets around the globe [114]. Allergy to crickets, 
locusts, and grasshoppers are often conflated, especially in light of the many species that 
are classified in each of these categories and that healthcare professionals may have 
difficulty in distinguishing them [114]. Published reports suggest that allergy to locusts or 
grasshoppers is more severe and common than cricket allergy [114, 116, 117]. 
Consumption of edible insects has resulted in severe reactions in Thailand and China. A 
Thai university hospital reported 24 cases of food-induced anaphylaxis over 6 years of 
which a single instance was to unspecified fried insects [118]. Another study from a 
tertiary care hospital found 36 food-induced anaphylaxis cases and 7 of those to fried 
insects, predominantly grasshoppers and crickets, over 2 years [115]. A review of 
Chinese allergy literature found that edible insects comprised the third leading cause of 
food-borne anaphylaxis in China with 7.5%, 7.5%, and 1.4% of all cases attributed to 
locusts, grasshoppers, and silkworm pupa respectively [119]. It should be noted that 
anaphylaxis is defined differently by some clinicians and some studies do not define their 
scoring system clearly. A common description is observable clinical signs involving at 
least two organ systems, such as respiratory tract (asthma or rhinitis), skin (atopic 
dermatitis or hives) or gastrointestinal involvement (pain, emesis, or diarrhea). 
 
1.6.2.2 Non-food allergy to crickets 
In adults, there are many reports that food allergic reactions can stem from cross-
reactivity with airway allergens [120, 121], where exposure to airway allergens can 
sensitize individuals potentially leading to food allergy [122]. Inhalant allergies are more 
associated with symptoms including asthma, rhinitis, and atopic dermatitis whereas food 
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allergies may also include cutaneous symptoms and anaphylaxis [123]. Environmental 
exposure can occur outside homes as in the case of field allergy which results from 
exposure to swarms of insects or indoors such as exposure to cockroach matter such as 
hair, scales, feces, and body parts that result in generalized dust [123, 124]. Individuals 
with field allergy to grasshoppers and locusts have reported asthma and fatalities during 
large outbreaks of insects can occur [124].  
Immediate hypersensitivity to cricket has been detailed only once in the literature 
where a teenager was using crickets as bait while fishing and exhibited lacrimation and 
angioedema within 30 minutes and wheeze within 5 hours [114, 125]. Chronic 
environmental exposure to Acheta domesticus in a cricket breeder resulted in a case of 
hypersensitivity pneumonitis with arginine kinase as the implicated allergen [126]. A 
case of occupational asthma with rhinoconjunctivitis due to occupational allergy to 
Acheta campestris where monosensitization to cricket was demonstrated and several IgE 
reactive proteins were described but not identified or characterized [127].  
Cases of occupational allergy with grasshoppers and locusts have been reported in 
the scientific literature as early as the 1950s [124]. A case study by Rauschenberg et al. 
details a zookeeper with occupational allergy to locust (Locusta migratoria) with contact 
urticaria occurring by direct cutaneous exposure to whole dead or live locusts [128]. The 
patient was found to have specific IgE to locust without specific IgE to tropomyosin nor 
other arthropods. Lopata et al. investigated ten subjects exposed to locusts (L. 
migratoria) in a laboratory [129]. Six experienced symptoms of urticaria, 
rhinoconjunctivitis, and asthma, seven had positive skin prick tests (SPT), and five had 
specific IgE to L. migratoria. The authors suggested that a 35 kDa band identified from 
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L. migratoria by immunoblot was likely tropomyosin according to similar weight of 
reactive bands identified in cockroaches (Blattella germanica and Periplaneta 
americana). Further, a 70 kDa immunoreactive protein was identified in locust wings. 
Tee et al. investigated a research center breeding locusts (L. migratoria and Schistrocera 
gergaria) and identified multiple IgE reactive bands of between 18 to 68 kDa by western 
blot in extracts [130]. The source of the allergens was traced to the peritrophic membrane 
in the gut where the allergens were aerosolized in the excreted feces.  
Cross-reactivity is not complete across members of Orthoptera including 
grasshoppers, locusts and crickets [114], but crickets have been suggested to be broadly 
cross-reactive amongst crickets [131]. An early study of allergic asthmatic children found 
that a significant proportion of children had IgE that bound to moth, cricket, grasshopper, 
and housefly extracts as determined by radioallergosorbent tests (RAST) used to measure 
specific IgE. Most were found to have cross-reactivity across the insects [132]. Cross-
reactivity of crickets and crustaceans has been explored as in a case study by Lineres et 
al. which reported reactions upon exposure to crickets (Gryllus campestris, Gryllus 
bimaculatus, and A. domesticus) in a farmworker that was related to occupational rhinitis 
and asthma without cross-reactivity to prawns (Penaeus sp) or specific IgE to 
tropomyosins [131]. However, Srinroch et al. tested IgE binding to field cricket (G. 
bimaculatus) and giant freshwater prawns (Macrobrachium rosenbergii) with a pool of 
16 prawn-allergic subjects’ sera and found IgE reactivity to both cricket and prawn 
arginine kinases [133]. Additionally, hexamerin 1B was identified as a novel and minor 
allergen of G. bimaculatus. Phiriyangkul et al. used shrimp allergic sera to probe the 
effects of thermally processing Bombay locust (Patanga succincta) and identified 
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hexamerin, enolase, and arginine kinase as allergens in raw locust and hexamerin, 
pyruvate kinase, enolase, and glyceraldehyde-3-phosphate dehydrogenase as allergens in 
fried locust [134]. These proteins are highly conserved in function and to a great degree 
in amino acid sequence and structure across broad evolutionary taxa. 
 
1.6.3 Mealworm 
Mealworm (Tenebrio molitor) is an upcoming edible insect and currently has no 
listed allergens by the WHO/IUIS, however studies have begun to illustrate the specific 
associated risks. Verhoeckx et al. assayed mealworm protein fractions using sera with 
inhalation or food allergy to house dust mites or crustacea [135]. IgE from some subjects 
was found to cross-react with tropomyosin and arginine kinase and these proteins were 
found to be moderately stable by pepsin stability assay. Broekman et al. investigated 
thermal processing of mealworms and tested with shrimp allergic patients by SPT, 
Basophil activation test (BAT), and immunoblot [136]. The authors found that arginine 
kinase decreased in solubility upon heating whereas tropomyosin became soluble after 
heating, but there were no significant differences noted in allergenicity of heated 
compared to unheated samples despite changes in protein solubility. Further work by 
Broekman et al. utilized double blinded placebo controlled food challenges (DBPCFC) 
with 15 shrimp allergic patients using mealworm [137]. Confirmed oral mealworm 
allergy was found in 13 patients with individual protein doses resulting in objective 
symptoms ranging from 216 mg to 13 g with symptoms including oral allergy symptoms, 
urticaria, nausea, abdominal cramps, and dyspnea. Four of the patients were also 
challenged with shrimp and found to have similar eliciting does and severity even 
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compared with dose threshold data for shrimp [137, 138]. The authors concluded that 
mealworm allergy was not only likely in shrimp-allergic patients but also with severe 
outcomes despite acknowledging the limited power of the study [137]. Exploring 
potential cross-reactivity between primary airway and oral allergy to mealworm, 
Broekman et al. used C3H/HeOuJ mice and 4 mealworm breeders, half of which reported 
inhalant allergy and the other half reported food allergy to mealworm [139]. All four 
were found to be sensitized to mealworm by ImmunoCAP, SPT, and BAT but were all 
negative to oral challenge to shrimp. Only those with reported food allergy to mealworm 
tested positive to mealworm by DBPCFC. Immunoblots using sensitized mice and 
humans showed binding to tropomyosin, arginine kinase, and both myosin light and 
heavy chain. Further, larval cuticle proteins were identified and suggested as a major 
source of primary mealworm allergy, where larval cuticle proteins have been identified to 
bind to chitin [139, 140]. 
 
1.6.4 Allergens of edible insects and related species 
 A review by Barre et al. identified 13 likely cross-reactive allergens of edible 
insects: alpha-amylase, arginine kinase, chitinase, glutathione-S-transferase, triose 
phosphate isomerase, trypsin, hemocyanin, hexamerin, actin, sarcoplasmic calcium 
binding protein, myosin, tropomyosin, and troponin [141]. The list by Barre et al. was 
formed according to their ability to cross-react IgE of patient sera allergic to shrimp and 
dust mites. Arthropods with well-characterized allergens can be used as a measure to 
assess the most likely and most dangerous risks associated with edible insects. Those 
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related to crickets, in order of increasing taxonomic distance, include cockroaches (order 
Blattodea), mealworms (order Tenebrionidae), and crustaceans (subphylum Crustacea).  
 
1.6.4.1 Cockroaches 
Of Blattodea, P. americana (American cockroach) and B. germanica (German 
cockroach) are the primary focus of allergy research [142], however Blatta orientalis 
(Oriental cockroach) and Supella longipalpa (brown-banded cockroach) are also 
important environmental pests [143]. Cockroach is an important indoor allergen 
associated with severe asthma particularly in urban inner-cities where 40-60% of 
asthmatics have IgE to cockroach antigens [144, 145]. Cockroach allergens from feces, 
saliva, or bodily debris can persist in homes post-infestation and increase the risk of 
developing asthma as well as asthma morbidity [146-148]. Wang et al. investigated the 
correlations between IgE-medicated sensitization to shrimp, cockroach, and dust mite 
related to exposure in inner-city children [149]. It was found that across 504 subject sera 
a strong positive correlation was found between shrimp and cockroach IgE levels and 
higher exposure to cockroach was significantly correlated with higher shrimp and 
cockroach IgE. 
Cockroach allergens have been well reviewed elsewhere [142, 150, 151] and a 
brief summary is provided here. Cockroaches currently have twelve groups of allergens 
listed by the by the World Health Organization/International Union of Immunological 
Societies (WHO/IUIS online at www.allergen.org). Group 1 allergens (B. germanica 1, 
Bla g 1; P. americana 1, Per a 1) are midgut and fecal proteins with a repeating tandem 
structure and unique fold and a hydrophobic core understood to bind phospholipids. It is 
53 
found as intertwined polymers resulting in varying molecular weights and has been 
shown to have cross-reactivity with fruit flies as well as mosquitos. Group 2 allergens 
(Bla g 2, Per a 2) are inactive aspartic proteases with a highly stable structure of 5 
disulfide bonds as well as zinc binding domain and has also been found to cross-react 
with mosquito and fungal allergens. Group 3 allergens (Bla g 3, Per a 3) are 
hemocyanins, which are hexameric proteins similar to arylphorins and hexamerins and 
are known to cross-react between arthropods. Group 4 allergens (Bla g 4) are lipocalins 
and are calcium-binding proteins excreted or secreted and exclusively found in adult male 
reproductive tracts, but as a class these are important inhalant allergens from dog, cats, 
horses, and cows. Group 5 allergens (Bla g 5) are glutathione-S-transferases (GST) that 
have been shown to have cross-reactivity with helminth but not dust mite due to low 
surface similarity. Further, principal GSTs produced by B. germanica and P. americana 
belong to separate subclasses of GST with low sequence identity and with low cross-
reactivity, but each cockroach does have homologs of each with high sequence identity. 
Groups 6 (Bla g 6, Per a 6) and 8 (Bla g 8) are troponin C and myosin light chain, which 
are EF-hand proteins associated with muscle contraction. Group 7 (Bla g 7, Per a 7) is 
tropomyosin, which has been regarded as pan-allergen after shrimp tropomyosin was 
found to have IgE cross-reactivity with crustaceans, mollusks, dust mites, and insects. 
Group 9 (Bla g 9, Per a 9) are arginine kinases, which was identified to cross-react 
between Indian meal moths and tiger shrimp, but also between shrimp and arthropods 
more broadly. Group 10 (Per a 10) are serine proteases identified to be a major allergen 
in India. Group 11 (Bla g 11, Per a 11) are alpha-amylases that were initially identified in 
fecal extracts. With potential cross-reactivity to mite homologs, it has been suggested as a 
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significant allergen in Korea. Group 12 (Per a 12) are chitinases with some identity to 
mite homologs and more recently identified as a major allergen in China. Lastly, chitin is 
known to be proinflammatory (promoting overall inflammation and Th1 responses) as 
well as being able to induce Th2 cytokine responses in some cases [151].  
Major allergens of cockroach are regarded as groups 1-5 while groups 1, 7, and 9 
are regarded as cross-reactive, but the nature of the observed cross-reactivity among 
cockroaches and other arthropods is not fully understood [150]. Groups 1, 2, and 10 are 
released into the environment through feces, whereas the remaining are proteins found 
within the insect bodies that can be released into the environment upon death [142]. In a 
review focusing on the first ten groups of allergens in Taiwan, the most abundant P. 
americana allergens in homes were groups 9, 10, and 2 [147]. Groups 6-8 are regarded as 
minor allergens of cockroaches due to relatively low IgE sensitization [148], but the high 
rate of sensitization to cockroaches makes relatively minor allergens potentially 
significant. However, the prevalence of specific IgE to each of the allergens is known to 
vary depending on regional exposure [150].  
 
1.6.4.2 Crustaceans 
Crustacean shellfish IgE cross-reactivity with insects has been well documented 
[152-154]. Shellfish allergy is one of the most common food allergies with self-reported 
rates of 1.9% in the United States [155], but also tends to persist through life [156]. 
Cross-reactivity is possible across airway and food allergens as in the IgE cross-reactivity 
across house dust mites, shrimp, and cockroaches [153, 157]. Historically the source of 
the cross-reactivity has been focused on tropomyosin. However other allergens have 
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more recently been implicated in the cross-reactivity between insects and shellfish [152, 
154]. The most relevant crustacean allergens are tropomyosin (Litopenaeus vannamei 1, 
Lit v 1), Arginine kinase (Lit v 2), myosin light chain (Lit v 3), sarcoplasmic calcium 
binding protein (Lit v 4), and hemocyanin [158]. Of shrimp allergens, tropomyosin, 
sarcoplasmic calcium binding protein, and myosin light chain are suggested to be more 
specific to shrimp, whereas arginine kinase and hemocyanin are cross-reactive among 
arthropods [159]. Other allergens have been identified in crustaceans such as triose 
phosphate isomerase (Crangon crangon 8, Cra c 8) and troponin I (Pontastacus 
leptodactylus 7, Pon l 7). Consumption habits are important to consider for crustaceans 
compared to insects. In the United States only the tail-muscle is consumed of shrimp and 
lobster, while crab legs are the major tissues consumed. However, some people consume 
the digestive glands and abdominal parts. In other cultures it is more common to eat most 
of the soft-parts of these crustaceans. Insects such as crickets will be consumed whole. 
Some insects (silkworm and meal worm) are immature larvae, and the body composition 
can differ, which may alter the profile of proteins that consumers could become 
sensitized to.  
 
1.6.5 Allergen classes of concern 
1.6.5.1 Arginine kinase 
With respect to the composition and identified allergens of crickets, as well as 
related species, the principal allergenic concerns are arginine kinase, tropomyosin, 
hexamerin, and chitin. Arginine kinase been shown to be a cross-reactive allergen across 
shrimp (M. rosenbergii) and crickets (G. bimaculatus) [133]. Arginine kinase from 
56 
Indianmeal moth (Plodia interpunctella) has been demonstrated to be a cross-reactive 
allergen across crustaceans and insects via serum IgE and SPT [160]. High levels of IgE 
prevalence have been shown against arginine kinases from cockroaches (P. americana, B. 
germanica) [142], and arginine kinase has been shown to be a major allergen among Thai 
cockroach allergic patients [161]. Further, sensitization to arginine kinase without shrimp 
allergy has been associated with allergy to house dust mite and/or cockroaches [159]. 
Cockroach (P. americana) arginine kinase is moderately thermostable and retains half of 
enzymatic activity after heating for 10 minutes at 50 °C [162]. Crayfish (Procambarus 
clakrii) arginine kinase shows low-level aggregation at above 44 °C and diminished IgE 
binding after boiling [163]. However, mealworm (T. molitor) arginine kinase was only 
found to decrease solubility when heated but not lose allergenicity despite lower 
solubility [136]. The IgE reactivity of shrimp-allergic sera to arginine kinases of other 
crustaceans has been shown to vary depending on denaturation [164]. Crayfish (P. 
clarkii) and mealworm (T. molitor) arginine kinases have been shown to be stable by 
pepsin stability assay [135, 163].  
 
1.6.5.2 Tropomyosin 
Tropomyosin has been identified as an inhalant allergen of cockroaches [165-
167], a food allergen of crustaceans [168, 169], as well as an occupational allergen in 
crab processing workers [170, 171]. It has also been implicated as a cross-reactive 
allergen across crustaceans, dust mites, and insects [154, 172, 173]. Investigations have 
compared insects, dust mites, and crustaceans and shown tropomyosin has a very high 
sequence similarity and therefore may also act as a cross-sensitizing allergen [174]. 
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Heating crustaceans and mollusks has been demonstrated to result in increased 
tropomyosin reactivity post-heating according to a monoclonal tropomyosin antibody 
[175]. However, heating in tandem with high pressure treatment was found to decrease 
allergenicity of shrimp (L. vannamei) tropomyosin via pooled shrimp-allergic sera and 
tropomyosin-sensitized BALB/c mice fed orally according to cytokines and IgE levels 
[176]. Purified tropomyosin from Penaeus modon and Litopenaeus vannamei have been 
shown to be resistant to pepsin digestion with Litopenaeus vannamei tropomyosin being 
more resistant than Penaeus modon [177], but crab tropomyosin (S.paramamosain) has 
been found to become more digestible after boiling and high pressure steam was found to 
increase digestibility as well as decrease IgE binding [178]. 
 
1.6.5.3 Hexamerin 
Hexamerins are multimeric proteins and belong to the same protein family as 
hemocyanins and arylphorins, which have low sequence similarity but similar structure 
[179, 180]. Hemocyanin has been suggested to be a clinically relevant crustacean allergen 
due to the high prevalence of allergic individuals with IgE binding to the protein, but also 
because a significant proportion of those have histories of anaphylactic reactions [181]. 
Again, Srinroch et al. has identified hexamerin 1B from cricket (G. bimaculatus) as a 
novel and minor allergen [133]. Van Broekhoven et al. explored processing and in vitro 
digestion across mealworm species and found that IgE from crustacean or dust mite 
allergic patients were able to bind mealworm hexamerin 1B precursor without IgE cross-
linking observed in heat processed fractions [182]. The observed hexamerin shared 
approximately 40% sequence identity with the cockroach arylphorin Per a 3. Giant 
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freshwater prawn (M. rosenbergii) hemocyanin was identified as heat-stable after it 
bound IgE of shrimp-allergic patients after thermal treatment but Penaeus modon was 
unable to inhibit M. rosenbergii reactivity using 13 shrimp-allergic sera [183]. However, 
Ayuso et al. found that hemocyanin may be cross-reactive amongst crustaceans and 
cockroach using 34 shrimp-allergic sera against recombinant hemocyanin and dot blot 
assays demonstrated inhibition of hemocyanin by cockroach extract [184].  
 
1.6.5.4 Chitin 
Chitin is a thermostable polysaccharide comprising insect exoskeletons, but also 
found in crustaceans [185-187]. Multiple studies have shown that chitin has 
immunomodulatory effects. De Silva et al. used TLR2-2/TLR-4 null, MyD88-null, and 
IL-17A null mice intraperitoneally injected with mixtures of chitin and ovalbumin or 
alum and ovalbumin with subsequent challenge to aerosolized ovalbumin [186]. The 
authors found that chitin induced adaptive immune responses and functioned as an 
adjuvant similar to alum. Dubey et al. used crab chitin and C57BL/6 mice sensitized by 
intraperitoneal injection of Aspergillus fumigatus culture filtrate or mixed with either 
alum or chitin [188]. Compared to alum, chitin resulted in lower inflammatory responses, 
depressed Th2 cytokines, enhanced Th1 cytokines, yet had similar total and specific IgE 
and IgG1 levels. Bae et al. used C3H/HeJ mice sensitized by intraperitoneal injection of 
ground whole peanut and challenged intragastrically where mice were given either α-
chitin, β-chitin, or β-chitosan in their food [189]. It was found that oral administration of 
chitin and chitosan is protective against IgE-mediated anaphylaxis and inhibited Th2 
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responses. Chitin has the potential to function as an adjuvant similar to alum and can 
therefore contribute to de novo sensitization.  
Oral, cutaneous, or inhalant exposure to chitin can result in sensitization to 
proteins bound to the chitin or other protein antigens present [190]. Therefore, the chitin 
content of insects could impact the potential allergenicity risk. By dry basis, crickets 
(Gryllus testaceus) have been found to comprise of 8.7% chitin [191], three Blattodea 
species (Blaptica dubia, Blaberus discoidalis and Blatta lateralis) had between 5.3 and 
8.3% chitin [192], and seven grasshoppers of Orthoptera had chitin ranging from 5.3 to 
8.9% [193]. The chitin content of these insects is similar and therefore risks associated 
with chitin from cockroaches may be comparable to Orthoptera and crickets. 
 
1.6.6 Allergen Carryover from Feed 
Insects are commonly consumed whole, as a powder or paste, or as extracts; each 
of which include gastrointestinal content of the insect [194]. Insects are commonly fasted 
prior to freezing or may be fed a nutrient-rich diet prior to freezing, referred to as gut 
loading. Fasting assists in mitigating the risks posed by allergens, otherwise the content 
of the insect’s gastrointestinal tract could expose consumers to allergens from the feed 
[195, 196]. For example, crickets raised on insect farms are often fed with high-quality 
feed such as chicken feed or pet food [194, 197]. Chicken feed may contain a number of 
allergenic ingredients including wheat, milk, soy, peanut, or fish in forms such as wheat 
bran, dry whey, oilseed cake, and fishmeal [198]. A limited amount of research has been 
done regarding identifying consumed proteins in insects including tomato defense 
proteins in tobacco hornworm (Manduca sexta) and cabbage looper (Trichoplusia ni) 
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[199] and wheat proteins in sunn pest (Eurygaster integriceps) [200]. Allergic reactions 
to residual proteins from feed have yet to be attributed in the literature; however, the 
insects’ diet may result in non-insect allergenic material passing to consumers to pose a 
risk to allergenic consumers. 
 
1.6.7 Summary 
 IgE binding and IgE cross-reactivity is not a measure of allergenicity. However, it 
is clear that IgE binding to specific proteins is required to trigger immediate reactivity by 
eliciting mediator release from mast cells and basophils. There are many studies that 
demonstrate some IgE binding or low-levels of cross-reactivity that do not parallel 
allergic reactions. The studies reviewed here rarely used food challenge, much less 
double-blinded studies, to demonstrate clinical importance of the IgE binding. Few 
studies used titrated inhibition to evaluate differences in affinity and epitope recognition, 
however, this data is used by most for judging cross-reactivity. Some biological assays 
such as skin prick test also over- or under-predict allergic reactivity. This review 
demonstrates that there is shared IgE binding between a number of proteins that have 
been reported to be important IgE binders, or in a few cases clearly proven allergens. The 
level of risk for allergic consumers will vary by their specific sensitivities. Additional 
steps are being taken to evaluate the likelihood of cross-reactivity between various 
crustaceans and between crustaceans and insects. It is important to note that the sequence 
identity of two proteins and overall structure influence likely cross-reactivity as does the 
abundance of the protein in the source material that humans are exposed to. Some 
proteins also denature and in foods that are highly processed or cooked, some proteins 
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will aggregate and be difficult to extract and test. Others may unfold and if the IgE 
binding epitopes are conformational, may be markedly reduced or lost following cooking. 
It is important to consider those factors in judging potential cross-reactivity. 
 
1.7 Peanut food allergy and the effects of thermal processing 
1.7.1 Background 
 Peanuts (Arachis hypogaea) are a non-novel legume of the family Fabaceae 
shared with other legumes such as soybeans, green peas, and chickpeas. Peanuts are 
cultivated for a wide variety of products derived from the plants such as the peanuts 
themselves as well as skins, hulls, oil, and press cake. As a food, peanuts are a relatively 
protein rich food at approximately 25% protein per weight [201]. Four varieties are 
peanuts are commonly produced in the US including Virginia, Spanish, Valencia, and 
Runner [201]. The protein content, protein profiles, and IgE-binding profiles are largely 
comparable among peanut varieties in terms of the major allergens with some variation 
among minor allergens. The majority of U.S. peanut production is focused on either 
Runner peanuts, commonly used for peanut butter, or Virginia, which is often a snack 
peanut or for in-shell products. Peanuts are commonly processed to improve their flavor 
and aroma such as by boiling, frying, or roasting. This review is intended to consider the 
effects of thermal processing on peanut food allergy and allergens to explore how peanuts 
may be extensively thermally processed into a novel source of food allergens. 
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1.7.2 Peanut allergy 
 Peanuts are a known food allergen with a prevalence of 1.8% in U.S. adults and 
2.2% of U.S. children and adolescents with increasing incidence [81, 202, 203]. In the 
U.S., peanuts are a member of the eight classes of allergenic foods comprising 90% of 
U.S. food allergies and use of peanuts must be signified on package labels [204]. Food 
allergens are considered as a major allergen if recognized by IgE of >50% of the allergic 
population, then minor allergens are recognized by <50% of the allergic population [1]. 
In peanut, the major allergens are Ara h 1, 2, 3 and 6 while the remainder are minor 
allergens. On a weight basis, Ara h 3 is the most abundant allergen of peanuts followed 
by Ara h 1, and then Ara h 2 and 6 [201]. Currently, a total of 16 peanut allergens have 
been characterized (Table 1.3) [1, 2].  
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 A. hypogaea is an allotetraploid resulting from the genomic merger of the 
ancestral species A. duranensis and A. ipaënsis resulting in both sets of chromosomes 
being part of A. hypogaea [205]. Efforts have since mapped the genomes of the ancestral 
species [206] and A. hypogaea [207].Progress in annotating the genome of A. hypogaea 
has expanded the diversity of proteins known to be present, particularly novel isoforms of 
known allergens but these have yet to be evaluated as allergens [208, 209]. 
 
1.7.2.1 Classification and superfamilies of seed storage proteins 
 Each of the major allergens of peanut are seed storage proteins, whose principal 
function is as a storage reservoir for amino acids but may have other functions [210]. 
Table 1.3 Major and minor allergens of peanut [1, 2] 
Peanut allergens Biochemical name 
Major allergens  
Ara h 1 Cupin 
Ara h 2 Prolamin 
Ara h 3 Cupin 
Ara h 6 Prolamin 
  
Minor allergens  
Ara h 5 Profilin 
Ara h 7 Prolamin 
Ara h 8 Pathogenesis related protein 
family 10 protein (PR-10) 
Ara h 9 Non-specific lipid-transfer 
protein (nsLTP) 
Ara h 10 Oleosin 
Ara h 11 Oleosin 
Ara h 12 Defensin 
Ara h 13 Defensin 
Ara h 14 Oleosin 
Ara h 15 Oleosin 
Ara h 16 nsLTP 
Ara h 17 nsLTP 
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Seed storage proteins are classified based on their sedimentation coefficient and 
conditions of solubility. Solubility classifications include the water-soluble albumins, 
dilute saline- soluble globulins, dilute alcohol-soluble prolamins, and dilute acid or 
alkali-soluble glutelins. In peanut, the major storage proteins are albumins and globulins 
[1]. 
 2S albumins are a major group of seed storage proteins that are synthesized as a 
single polypeptide and subject to proteolytic cleavage commonly at both the N- and C-
termini and trimming of linker peptides [210]. 2S albumins are compact globular proteins 
with a conserved cysteine structure and disulfide bonds. The stability offered by the 
compact and tightly bound structure offers 2S albumins a high degree of resistance to 
gastrointestinal conditions; however, the flexible loops are solvent-exposed and 
predominate known IgE epitopes [211]. Coinciding allergies to peanuts and various tree 
nuts has been attributed in part to the homology and similar physiochemical properties 
shared among 2S albumins [212].  
 The other major group of seed storage proteins in peanuts are the globulins as 
either the 7S vicilin-type or 11S legumin-type [210]. In legumes, 11S legumins are the 
major storge protein of legumes and consist of six pairs that interact noncovalently. Each 
pair consists of a single polypeptide that is proteolytically cleaved after disulfide bond 
formation to produce an acidic and basic subunit. 7S vicilins are often trimeric proteins 
lacking significant cysteine residues and therefore disulfide bonds. The family of globulin 
proteins have dissimilar sequences but share physiochemical properties and structures 
where 7S globulins are trimers (3) and 11S globulins are either trimers (3) or dimer-
trimers (3, 3). 
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1.7.2.2 Ara h 1 and Ara h 3 
 Ara h 1 and Ara h 3 are bicupin seed storage proteins belonging to the cupin 
superfamily [2]. Ara h 1 is a 7S vicilin-type cupin and Ara h 3 is an 11S legumin-type 
cupin. Ara h 1 has a β-barrel core domain and secondary domain predominantly made 
from α-helices [213], which is conserved among other legume 7S vicilins such as lentil, 
pea, and soy and has been leveraged to explain cross-reactive allergy among edible 
legumes. While Ara h 1 can be observed naturally as the trimer, it can also be found in 
oligomeric forms that are more resistant to enzymatic digestion [214]. Epitope mapping 
studies have found that the IgE binding sites of Ara h 1 include the pepsin-resistant N-
terminus [214], on connecting loop domains and coils in the core region [215], as well as 
inside the β-barrel domain per monomer. Epitopes buried due to trimer formation have 
been speculated to protect these regions from enzymatic digestion and preserve their 
allergenicity [215, 216]  
 Ara h 3 is composed of multiple sub-units including an acidic and basic subunit 
which are proteolytically processed prior to maturation and held together by disulfide 
bonds [217]. Use of reducing conditions with Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) evidences a 42-45kDa acidic and 25 kDa basic subunit. Ara 
h 3 is known to have trypsin inhibitory functionality and so contributes to the enzymatic 
resistance of peanut [218]. It has been long understood that multiple Ara h 3 isoforms are 
present in peanut as per the depreciated Ara h 4, which has since been understood as an 
isoform of Ara h 3 [219]. 
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1.7.2.3 Ara h 2 and Ara h 6 
 Ara h 2 and 6 belong to the 2S albumin seed storage proteins and the prolamin 
superfamily [2]. The structure of Ara h 2 consists of a five-helix bundle held together by 
four disulfide bonds and noted to have a structure similar to trypsin inhibitors [220], and 
has been confirmed as having trypsin inhibitory activity [221]. Ara h 2 contains multiple 
hydroxyprolination motifs, DPYSPS [222], which have been shown to have profound 
effects on IgE binding. Tscheppe et al. produced mutant Ara h 2 in insect cells to exclude 
flexible loop regions, including hydroxyprolination motifs, and further unfolded through 
reduction and alkylation demonstrate substantially decreased IgE binding and 
anaphylactic potency [223]. Notably, comparison of the mutant to wildtype was marred 
by lack of attention to the effects of hydroxyprolination, which may have made the 
decreases more drastic. 
 Ara h 6 has a nearly identical structure to Ara h 2 in terms of both fold and 
disulfide bonds [224], but does not contain the hydroxyprolination motifs of Ara h 2 
[222]. Multiple forms of Ara h 6 have been characterized as both an intact polypeptide 
and one posttranslationally cleaved in the core [225, 226]. The two forms of Ara h 6 do 
not show differences in IgE binding or abundance [225]; however, the intact form is more 
susceptible to thermal denaturation than the cleaved form [226]. 
 
1.7.2.4 Relationships between major allergens 
 Ara h 1, Ara h 2, and Ara h 3 do not share significant sequence or structural 
similarities, but localized similarities have been implicated in IgE cross-reactivity among 
these allergens [227]. Ara h 2 and Ara h 6 has been observed as cross-reactive due to 
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shared homology [228]. Both Ara h 2 and Ara h 6 are resistant to pepsin digestion 
whereas Ara h 1 and Ara h 3 are readily digested by pepsin [229]. Despite a higher 
seroprevalence of Ara h 6 compared to Ara h 2, Ara h 6 has demonstrated weaker 
biological activity via human basophils than Ara h 2 [230]. This has been corroborated 
using rat basophil leukemia cells showing that Ara h 2 is a more potent allergen than Ara 
h 6, but both are far more potent than either Ara h 1 or Ara h 3 [231]. A majority of the 
allergenic activity attributable to crude peanut extracts have been attributed to Ara h 2, 
Ara h 6, and their variants [232]. 
Ara h 2 coupled with Ara h 6 have been cited as the most accurate in diagnosing 
peanut allergy as compared to other peanut allergens or specific peanut IgE [233, 234]. In 
children, both Ara h 2 and Ara h 6 are the most frequently recognized major peanut 
allergens and this pattern remains stable over time [235]. Further, co-sensitization to both 
Ara h 2 and Ara h 6 is associated with severe allergic reactions as opposed to mild 
reactions [236]. 
 
1.7.2.5 Minor peanut allergens 
 Profilins are one type of actin-binding proteins acting to regulate the organization 
and function of the actin cytoskeleton [2]. Ara h 5 is a member of the profilin family and 
related to other pollen allergens such as Hev b 8 (latex) and Bet v 2 (birch) [237]. The 
structure of Ara h 5 is a seven stranded antiparallel β-sheet with two α-helices flanking 
one side and another helix on the other side. 
 Ara h 7 is the third 2S albumin of peanut and has been found to be equally potent 
compared to Ara h 2 and Ara h 6, but is far less abundant [238]. Multiple isoforms of Ara 
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h 7 are known to exist but Ara h 7.0101 has not been demonstrated to exist as a protein 
[238, 239]. In those with sensitivity to any of the peanut 2S albumins, sensitivity to each 
of Ara h 2, Ara h 6, and Ara h 7 is most frequent. 
 Ara h 8 is a member of the family 10 of pathogenesis-related (PR-10) proteins and 
related to the cross-reactive allergen Bet v 1 (birch) [240]. Members of PR-10 are 
associated with sensitization to plant pollen and sensitization to food allergens [241]. 
Ara h 8 has a seven stranded antiparallel β-sheet with two short α-helices between the 
first two strands of the β-sheets with a third α-helix at the C-terminus [242]. Ara h 8 has 
similar structure and ligand binding to Bet v 1 including binding to various flavones 
including quercetin, apigenin, and daidzein, and resveratrol [2, 240]. Reactions to Ara h 8 
tend to be mild and likely mediated through individuals with cross-reactivity to Bet v 1 
and other homologues. Monosensitization to Ara h 8 has been associated with tolerance 
to peanuts rather than allergy [243]. 
 Ara h 9 and 17 are regarded as type I non-specific lipid transfer proteins (nsLTP) 
and Ara h 16 is a type II nsLTP [2]. The types of nsLTP are differentiated by their 
molecular weight, primary sequence identity, and disulfide bond pattern where type I 
nsLTP are approximately 9 kDa and type II are approximately 7 kDa [244]. Functionally, 
nsLTPs can serve many purposes including membrane stabilization, cell wall 
organization, signal transduction, and assist in growth and development [2]. nsLTPs have 
been shown to be very stable to enzymatic digestion and thermal treatment due to a 
structure of four α-helices stabilized by four disulfide bonds [245]. Associations have 
been noted between peanut, peach and hazelnut allergies owing to homologies between 
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Ara h 9, Pru p 3, and Cor a 8, respectively [240], specifically those with peanut allergies 
for those in the Mediterranean area [245, 246]. 
 Peanut oleosins (Ara h 10, Ara h 11, Ara h 14, and Ara h 15) function as 
structural proteins of oil bodies to stabilize the oil body [247]. Allergies to oleosins is 
relatively common but underestimated partially due to their underrepresentation in 
aqueous extracts owing to their lipophilic nature [248]. Oleosins show resistance to both 
temperature and enzymatic digestion. Peanut oleosins have been observed as multimers 
on SDS-PAGE [249]. Sensitization to oleosins is associated with severe reactions, 
although sensitization to peanut oleosins is highly associated with Ara h 2 sensitization 
[247]. 
 Defensins, such as the peanut defensins Ara h 12 and Ara h 13, are a large group 
of small, cationic, and disulfide-rich proteins associated with the innate immune system 
across animals, plants, and fungi [250]. Peanut defensins have demonstrated inhibitory 
effects to some molds but without effects on bacteria [251]. Structurally both Ara h 12 
and Ara h 13 are lipophilic proteins consisting of an alpha-beta fold and 4 disulfide 
bonded structure [250, 251].  
 
1.7.3 Effects of thermal processing on peanut allergenicity 
Thermal processing of food proteins can lead to several modifications including 
unfolding, aggregation, and chemical modifications [252]. Structural modifications can 
further affect digestion stability as well as the manner that the allergens are presented to 
the immune system. Through the Maillard reaction, chemical modifications of free 
amines with free reducing sugars, proteins can be chemically modified not limited to 
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cross-linking of proteins [1]. Through cross-linking, Ara h 1 and Ara h 2 can form higher 
molecular weight aggregates that bind IgE more effectively than unmodified forms [252]. 
The type of thermal processing affects resultant advanced glycation end (AGE) products 
as boiling generates approximately 10x fewer AGE than roasting. While peanut allergens 
with AGE modifications are more frequently recognized by peanut allergic patients, there 
is a level of bias given that consumers will typically consume peanuts that have been 
thermally processed. 
Thermal processing affects the proteins and their allergenicity by how the 
processing was applied. Studies of thermally processed Ara h 1 and Ara h 3 are a 
challenge as they tend to become insoluble, although in roasted peanuts IgE binding 
shows minimal differences [252]. The trypsin inhibition activity of Ara h 2 increases after 
roasting [221]. Both Ara h 2 and Ara h 6 retain similar IgE reactivity after roasting and 
maintain their structure [253]. Ara h 8 increases IgE reactivity and resistance to 
enzymatic digestion with roasting, which may be associated with binding to lipophilic 
ligands [254]. Oleosins have also demonstrated a higher IgE binding capacity when 
roasted in-shell [255]. The type of thermal processing does affect the structure of Ara h 1 
as boiling causes the formation of rod-like aggregates with reduced IgE binding capacity, 
whereas roasting causes the formation of globular aggregates with IgE reactivity similar 
to non-thermally processed [256]. Boiling peanuts can decrease the IgE binding capacity 
of Ara h 1, Ara h 2, and Ara h 3 compared to roasting, given that Ara h 2, Ara h 6, and 
Ara h 7 tend to leech out of the peanuts into the water [2]. 
 Extraction conditions can also result in differences in assessing relative 
allergenicity. Assessments of Ara h 1 and Ara h 2 have shown that extraction procedures 
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incorporating defatting and the buffer of choice can affect the protein yield and 
sensitivity of subsequent immunoassays [257]. The extractability of peanut proteins is 
also interconnected with the type of processing applied [258]. Further, the extraction 




 As a staple food for many people around the world peanuts are a nutritionally and 
economically valuable food, but for those with peanut allergies they are a significant 
hazard and source of distress. To adequately inform stakeholders of the potential risks 
associated with peanuts and their products, it is imperative to understand the breadth of 
information known about the allergenic proteins of peanut. Thermal processing has wide 
ranging effects on peanut proteins and assessment of the proteins can have similar effect 
when attempting to evaluate the potential risk they pose to consumers. 
 
1.8 Allergic risks of exposure to food allergens by inhalation 
1.8.1 Background 
 The principal route of exposure for food allergens is through consumption of 
foods that contain the allergen either as an intended ingredient or as a contaminant. 
Similarly, inhalant allergens are principally encountered through inhalation; however, 
these categories are not strict in that food allergens can be inhaled and result in elicitation 
of allergic reactions and visa-versa. Cases of pancake syndrome also known as oral mite 
anaphylaxis demonstrate that oral consumption of inhalation allergens can result in 
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allergic reactions [260], whereas inhalation of food allergens is most detailed in terms of 
occupational asthma due to handling or cooking of food and food allergens. This review 
is intended to introduce how allergic individuals may be exposed to food allergens 
through inhalation and result in novel sources of food allergens.  
 
1.8.2 Defenses, barriers, and transport of allergens 
1.8.2.1 Oral route 
 Consumption of food and exposure to food proteins begins in the mouth and has 
been identified as both a means to effectively absorb proteins via sublingual and buccal 
mucosa as well as a route for treatment of food allergies [261]. The oral cavity is 
protected by mucosal associated lymphoid tissues. After swallowing, food proteins are 
exposed to low pH via hydrochloric acid to assist protein denaturation as well as active 
pepsin to begin proteolysis of proteins [262]. Passing the bolus to the small intestine 
begins by partially neutralizing the pH and thereby allowing gastric proteases and 
peptidases such as trypsin, chymotrypsin, elastase, and carboxypeptidases to continue 
degradation the food proteins. The intestines include further defenses such as secretory 
IgA, mucus, and microbes that can influence the rates of absorption of intact proteins as 
well as provide extra time for proteolysis to occur [263]. Digestion of dietary proteins 
ends with intestinal brush border cells uptake amino acids as well as di- and tripeptides 
through various mechanisms [262]. 
 Uptake or transport of partially digested or undigested proteins across the 
intestinal tract can vary depending on the characteristics of the protein including size, 
shape, and structure [263]. Transport routes for proteins include para-cellular and trans-
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cellular transport, where para-cellular transport refers to the movement of compounds 
through the intercellular space between cells and is regulated by tight junctions, but the 
maintained integrity of the tight junctions in healthy adults leaves this route of lesser 
concern. Para-cellular transport is typically relegated to compounds that are far smaller 
than allergic fragments capable of causing reactions, but some evidence suggests that 
smaller intact proteins (insulin) may be able to pass [263, 264]. Allergic sensitization can 
reduce the integrity of the tight junctions via presence of mast cells and increase the 
permeability to intact proteins.  
 Several routes are possible for trans-cellular transport, but only endocytosis is 
viable for non-degraded proteins [263]. Enterocytes are the most abundant cells in the 
intestinal barrier and act as absorptive cells and endocytose soluble particles including 
proteins that may include both degraded and intact protein. To assess if intact proteins 
can be successfully transported across the intestine, Warshaw et al. assessed the 
proportion of intact tritium labelled bovine serum albumin reaching the lymph and blood 
circulation after duodenal infusion, finding that approximately 2% was able to be 
identified [265]. Immune cells have also been suggested to take part in trans-cellular 
transport including mast cells, dendritic cells, and macrophages [263]. 
 
1.8.2.2 Inhalation route 
 Compared to oral intake, inhalation has fewer strict barriers to restrict intact 
protein. Upon taking a breath the first barrier to inhaling particles that may contain 
protein is the particle size itself, where the inhalable range of proteins is less than 100 µm 
[266]. Larger particles, greater than 8 µm, tend to deposit in the lung further up in the 
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respiratory airway in a size-dependent manner from the nose to the larger bronchioles. 
Smaller particles, up to 3 µm, tend to diffuse throughout the lung tissue including 
deposition in the alveoli. Tidal breathing can also inhibit deposition of present particles 
by removing the particles prior to deposition upon respiratory tissues. The epithelial 
lining of the alveoli is principally responsible for resisting the transport of proteins across 
the lung [267]. The alveolar surfaces of the lung are lined principally by thin, single-cell 
thick, type I pneumocytes that are joined by tight junctions [267, 268].  
 Protein clearance from lung tissues often focus on pulmonary edema and 
therefore endogenous proteins rather than exogenous but can be used to inform how the 
mechanisms may apply to exogenous proteins. The rate of protein clearance in the 
alveolar spaces of the lung is approximately 1-2% per hour for albumin [267], but 
transport of albumin may be assisted through an albumin-specific receptor [269]. 
Depending on the amount of albumin present, mechanisms of transport proceed by 
receptor-mediated endocytosis at lower concentrations but by para-cellular transport at 
high concentrations. The rates that specific proteins are cleared from the lung depend on 
molecular size and or weight as smaller proteins clear faster than larger proteins. Further, 
insoluble proteins are degraded more slowly than soluble proteins. Degradation of 
proteins is mediated by proteases and peptidases as well as alveolar macrophage 
recruitment [269]. Proteases are first present to degrade proteins, but studies have not 
demonstrated that this is a significant means to remove present proteins as repeated 
studies have shown that greater than 95% of proteins remain intact and transport into the 
blood [269]. In the long term (>24 hours), macrophages can be recruited to the alveoli 
and significantly clear present proteins in a time scale from 2 to 6 days. 
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1.8.3 Inhalation of food allergens 
 Exposure and inhalation of food allergens can occur during food preparation or 
handling to generate aerosols and dust that can be inhaled by individuals and elicit 
allergic reactions [270]. Case reports have implicated many foods including fish, 
shellfish, seeds, soy, grains, eggs, and milk in causing allergic reactions due to inhalation 
of a food allergen. Examples of specific proteins implicated in inhalation based allergic 
reactions include shrimp tropomyosin [271] as well as hen’s egg lysozyme [272]. 
 Baker’s asthma, an occupational allergic disease due to inhalation of cereal flours 
such as wheat flour, provides insights into comparing inhalation and oral allergies [273]. 
Many of the same proteins that are associated with oral wheat allergy are also implicated 
to some degree in inhalation allergy suggesting these proteins retain their allergenicity 
through either route of exposure. Notably, the serodominance of each protein allergen 
differs between oral and inhaled wheat allergy indicating that there are other key factors 
to consider such as their relative stability after aerosolization compared to consumption 
and capacity and ease to be aerosolized.  
 
1.8.4 Insights into routes of exposure from biopharmaceuticals 
 The goal of a biopharmaceutical is to have an individual take an appropriate dose 
resulting in positive effects. This is contrasted with allergens causing negative effects. 
Studies of biopharmaceutical proteins and polypeptides can provide insight into how 
different routes of administration impact the amount found systemically. To better 
understand the differences among oral and inhalation the following examples of well 
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characterized biopharmaceuticals are explored in terms of their contrasting 
bioavailability. 
Insulin is a 51 amino acid anabolic hormone with the mature form comprised of 
two peptide chains and therapeutically used to assist individuals with either type 1 or 2 
diabetes [274]. Reviews of the bioavailability, the systemic exposure, of inhaled insulin is 
approximately 10% relative to injected [275], whereas the oral bioavailability has been 
regarded as less than 1% [276]. Then the inhaled bioavailability of insulin is 
approximately 10 times greater than when taken orally. 
 Human growth hormone is a 191 amino acid anabolic hormone comprised of a 
single polypeptide prescribed in cases of deficiencies or stunted growth [277]. A study in 
infants has measured the inhaled bioavailability of human growth hormone at 
approximately 3.5% [278], compared to a study in rats estimating that the oral 
bioavailability is 0.01% [279]. Each taken at face value, this results in a relative 
bioavailability of 350 times greater when inhaled compared to oral. 
Using these examples, we can infer how allergens may differ depending on their 
route of exposure. If bioavailability limitations are due to the route of exposure, this 
suggests that the impact upon sequence and structure is a key factor. As inhalation of a 
protein does not have the same rigorous barriers to systemic entry as oral ingestion, the 
protein structure can be expected to be less impacted and without the excess of 
proteolytic enzymes similarly the primary sequence will also be kept intact. The risks of 
either oral or inhaled intake are not clear as these studies of biopharmaceuticals indicate 
that while the bioavailability is generally greater when inhaled it does not clarify typical 
scenarios when an allergen may be alternatively inhaled as opposed to consumed in terms 
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of dose. It is not realistic for an individual to inhale a similar dose that they may 
otherwise consume orally; however, the doses required can be expected to be lesser if 
they were to be inhaled as opposed to consumed orally. 
 
1.8.5 Summary 
 While exposure to food allergens is predominantly through consumption, 
inhalation of food allergens is also possible during handling, preparation, and cooking of 
food and can similarly sensitize and elicit allergic reactions. The barriers and defenses 
against intact proteins entering the body differ greatly between oral and inhalation and 
may significantly impact consumers. Understating that those with a known food allergy 
may be at risk when inhaling food proteins is critical to adequately protect individuals.  
 
1.9 Concluding remarks 
 The principles of risk analysis are sufficiently broad to be readily applicable to 
any hazard and keen understanding of allergens allows for specific considerations to be 
applied to novel allergens. Methods to characterize the potential allergenicity of novel 
foods is principally focused on cross-reactivity of proteins as evaluation of risk of de 
novo sensitization is limited by the limitations of in vivo (animal) models [280]. Further 
assessments of taxonomic relationships, homology of proteins to known allergens, and 
analysis of sera with allergies to the novel food or taxonomically similar sources can be 
utilized [281]. Given an intended use of the novel food, exposure may be estimated based 
on similar products and uncertainty incorporated reflecting information gaps to allow for 
characterization of the risk. 
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 Food allergy is a present and increasing threat to public health and adequate 
controls are required to protect those with food allergies. Novel foods will continue to be 
discovered and produced; therefore, novel sources of food allergens need to be carefully 
scrutinized. The goal is not to unduly dissuade innovation but rather to inform consumers 
and producers of the risks associated with novel foods. With pertinent and wide-spread 
information stakeholders can more informed choices regarding novel foods and sources 




CHAPTER 2: PREDICTED ALLERGENS AND QUANTITATIVE 




Background: Insects are increasingly important alternative food source to 
conventionally grown animal sources of protein, but consumption of insects poses a risk 
to those with shellfish allergy. A. domesticus (crickets) are commercially available in the 
form of several life stages with unclear differences in the potential risks posed to 
consumers. We evaluated life stages of crickets to determine the relative risks posed by 
consumption of crickets. 
 
Methods: Eight life stages of crickets were extracted and their proteins quantified by 
mass spectrometry. Databases representing ab initio genomic predicted genes and 
translated transcriptomic genes were applied and identified proteins annotated for 
homology to known allergens. Predicted allergens with statistical differences among life 
stages were evaluated to compare relative risks. 
 
Results: Ten proteins were robustly identified among life stages with significant 
differences among life stages and were predicted as allergens: a tropomyosin, arginine 
kinase, alpha-tubulin, paramyosin, two myosin light chains, and four hexamerins. 
Proportions of allergenic proteins to total proteins were equivalent excluding adult 
females, which were significantly lower.  
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Conclusions: Adult female A. domesticus were predicted to be of less risk to consumers 
than other life stages. Segregating adult crickets may pose an undue burden on producers 
posing a challenge to leverage the differences in predicted risk.  
 
2.2 Introduction 
 Insects are an alternative protein source to conventional animal sources. While 
consumption is increasing and perceptions are improving in Western countries, 
entomophagy is still not widespread faces both neophobia and reports of allergic 
reactions associated with shellfish allergy [282]. Food allergies affect approximately 
10.8% of US adults and shellfish allergy affects approximately 2.9% [81]. Evaluation of 
proteins present in Acheta domesticus crickets can help inform consumers as to the risks 
associated with consumption and inform producers as to what can be done to manage 
risks posed. 
 A. domesticus is a member of order Orthoptera and undergoes a hemimetabolous 
life cycle, where upon hatching from an embryo the nymph resembles an adult but 
without wings nor sexual organs and undergoes molts until finally reaching sexually 
dimorphic adulthood [283]. Proteomic shifts are expected to accompany the development 
of A. domesticus that may similarly result in possibly allergenic proteins changing in 
abundance. The phylum Arthropoda contains numerous allergens that demonstrate cross-
reactivity among species including both the panallergens tropomyosin and arginine 
kinase [284]. The related two-spotted cricket, Gryllus bimaculatus, has demonstrated 
reactivity to hexamerin [133]. Allergens specific to A. domesticus are yet unknown and 
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so insight into potentially cross-reactive proteins can permit an evaluation of the risks 
present. 
 This study addresses the potential relative risk posed to consumers by various life 
stages of A. domesticus crickets. The potential risk is evaluated utilizing protein 
quantification supplied by mass spectrometry. Annotation of quantified proteins in terms 
of identity and associations with known allergens clarifies which proteins are of 
importance. We evaluated the quantifications and annotations of proteins to describe how 
the life stages differ and how that translates into allergenic risk to consumers. The aim 
was to evaluate if there are life stages of crickets that may pose relatively less risk to 
consumers. 
 
2.3 Methods and Materials 
2.3.1 Chemicals and samples 
 Tris, iodoacetamide (IAA), and rabbit glycogen phosphorylase B (GP; P6635; 
Uniprot P00489.3) were obtained from Sigma (St. Louis, MO, USA). Trypsin (Pierce, 
MS grade) was obtained from Thermo Scientific (Waltham, MA, USA). Dithiothreitol 
(DTT) was obtained from Arcos Organics (Geel, Belgium). Ammonium bicarbonate 
(ABIC) was obtained from Honeywell Fluka (Charlotte, NC, USA). Acetone, methanol, 
hexanes, acetic acid, acetonitrile (ACN), and formic acid were obtained from Fisher 
(Hampton, NH, USA). Precision plus ProteinTM Dual Xtra standards and Coomassie 
R250 were obtained from Biorad (Hercules, CA, USA). NuPage LDS sample buffer, 
Nupage MES SDS running buffer (20x), and 4-12% NuPage Bis-Tris gels were obtained 
from Invitrogen (Carlsbad, CA, USA). 
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 Crickets (Acheta domesticus) were purchased from a cricket farm representing 7 
developmental stages: pinhead, 1 week, 1/3 grown, 2 weeks, 1/2 grown, 2/3 grown, and 
adults; adults were segregated as males and females for a total of 8 samples (Appendix A 
Figure 2.1.1). Triplicate samples were taken per stage (n=24) to an approximate 200 mg 
(wet basis) of material per sample and ground by mortar and pestle under liquid nitrogen. 
Samples were stored -80 °C until use. 
 
2.3.2 Extraction and SDS-PAGE 
 Samples were individually prepared for defatting in 2 mL Eppendorf tubes by 
adding 0.5 mL of acetone and vortexed to saturate the material. Defatting was performed 
by adding an additional 1 mL of acetone (>1:5 w/v) followed by vortexing, shaking for 
10 minutes, and centrifugation (10 minutes, 17 k x g). The supernatant was discarded and 
acetone defatting repeated three additional times. The material was then defatted by 
substituting the acetone for hexanes and repeated as before four times. Pellets were dried 
in a fume hood overnight and were then stored at -80 °C.  
 Defatted samples (n=24) were extracted 1:20 (w/v) using a zwitterionic 
chaotropic buffer (50 mM Tris pH 8.8, 5 M urea, 2 M thiourea, 2% CHAPS, 67 mM 
DTT) in a heated sonicating water bath (60 °C, 30 minutes) and centrifuged (10 minutes, 
17 k x g). Per extraction, half of the extraction buffer was removed as supernatant and 
fresh buffer added to maintain volume. Each pellet was extracted a total of three times 
and the three supernatants per defatted sample were pooled (n=24). Samples underwent 
protein quantification via 2D-Quant kit (GE healthcare, Chicago, IL, USA). 
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Samples were prepared for SDS-PAGE by adding sample buffer with 50 mM 
DTT. An equivalent of 500 µg of tissue per sample was fractionated. Gels were fixed 
with a solution of 50% methanol and 10% acetic acid for 1 hour and visualized with 
Coomassie R250. Gels were imaged using a UVP Biospectrum 815 Imaging System 
(Analytik Jena US LLC, Upland, CA, USA) with VisionWorks software (Version 8.20, 
Analytik Jena US LLC). 
 
2.3.3 Mass Spectrometry 
2.3.3.1 In-solution digestion 
 Sample volumes equivalent 250 µg of tissue were diluted 1:10 in zwitterionic 
chaotropic buffer and 4 volumes of chilled acetone added for an acetone precipitation (-
80 °C, overnight). The samples were then centrifuged (4 °C, 30 minutes), decanted, and 
the pellet washed with 200 µL of 80% acetone and the centrifugation repeated. The pellet 
was then allowed to dry in a fume hood and stored at -80 °C until use. 
 In-solution digestion of acetone precipitated pellets was preformed according to 
Palmer et al. [285]. Briefly, proteins were reduced with DTT for 5 minutes at 95 °C, 
alkylated with IAA for 20 minutes in the dark, and digested twice with trypsin first for 3 
hours at 37 °C and secondly overnight at 30 °C.  
 
2.3.3.2 Preparation for mass spectrometry and running parameters 
 Digested peptides were cleaned, and MS preformed as previously described with 
modifications [285]. In brief, digests were cleaned using Pierce C-18 Spin columns 
(Thermo scientific), the eluate dried, and peptides resolubilized in 30 µL of 0.1% (v/v) 
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formic acid with 5% (v/v) ACN. Samples were aliquoted into vials with 12 µL of 
peptides and 2 µL of 200 fmol µL-1 GP. A 3.5 µL injection is equivalent to 25 µg of 
tissue and 100 fmol GP. Samples were injected into the MS in triplicate (N=72). 
 One-dimensional microscale liquid chromatography separation of tryptic peptides 
was performed with an UltiMate 3000RSL® liquid chromatography system (Thermo 
Scientific), equipped with a Hypersil Gold C18 1.9 μm, 100 x 1 mm analytical reversed 
phase column (Thermo Scientific). Mobile phase A consisted of 99.9% (v/v) water 
containing 0.1% (v/v) formic acid and mobile phase B was 99.9% (v/v) ACN containing 
0.1% (v/v) formic acid. 3.5 µL of the sample was injected on-column and peptides were 
eluted from the analytical column and separated using a gradient of 2-40 % mobile phase 
B over 60 minutes at a flow rate of 60 µL/min. The analytical column temperature was 
maintained at 35 ⁰C.  
 Mass spectrometric analysis utilized a Q Exactive PlusTM Hybrid Quadrupole-
OrbitrapTM MS (Thermo Scientific) in the data-independent mode with survey scans and 
fragment ion spectra acquired at a resolution of 70,000 at m/z 400. Up to the top 20 most 
abundant isotope patterns with charge 2 to 4 from the survey scan were selected with an 
isolation window of 2 m/z with a window offset of -0.4 m/z and fragmented by higher 
energy collisional dissociation with normalized collision energies of 27. The maximum 
ion injection times for the survey scan and the MS/MS scans were 100 and 240 ms, 
respectively, and the ion target value for scan modes were set to 3E6 and 1E5, 
respectively. Repeat sequencing of peptides was minimized by dynamic exclusion of the 
sequenced peptides for 20 s. 
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 Injection quality was assessed via consistency of GP quantification using PEAKS 
8.5 (Bioinformatics Solutions Inc., Waterloo, ON, Canada) [286]. against a Polyneoptera 
database (Uniprot, accessed 190403) and including GP. PEAKS search parameters were 
5 ppm mass error tolerance, 0.05 da fragment mass error tolerance, no missed cleavages, 
and fixed carbamidomethyl cysteine. Data representing individual injections were 
handled independently and assessed together in PEAKS. GP was quantified via Top3 
excluding peptides that were identified within the Polyneoptera database. Quantifications 
were tested for normality via Shapiro-Wilk Test using GraphPad Prism version 4.03 for 
Windows (GraphPad Software, La Jolla California USA) at a significance level of 0.05 
both including and excluding outliers. Injections indicated as outliers from normality 
were regarded as injection failures. In this case, the injection was freshly prepared again 
and reinjected to replace the data from the injection failure.  
 
2.3.4 Data Analysis 
2.3.4.1 Protein identifications 
 Protein databases for MS analysis included ab initio genes predicted from the 
genome by Dovetail Genomics (Santa cruz, CA, USA) and an A. domesticus 
transcriptome (GenBank GHUU00000000.1) [287], translated in 6-frames by EMBOSS 
transeq [288]. Both databases were appended with 348 sequences representing GP and 
347 decoy sequences identified from Uniprot from a search for “glycogen 
phosphorylase” within Insecta (obtained 18/09/2020). Data was analyzed using PEAKS 
8.5 with search parameters including tryptic peptides, maximum of 3 missed cleavages, 5 
ppm parent mass error tolerance, 0.05 fragment mass error tolerance, carbamidomethyl 
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cysteine as a fixed modification, and a contaminant database (www.thegpm.org/crap; 
version 3/3/19). Searches including post-translational modifications (PTM) were 
preformed using the default 313 modifications included by PEAKS. Data was analyzed 
using the multi-round search feature in four rounds in the order of ab initio predicted 
genes, the A. domesticus transcriptome, PTMs of ab initio predicted genes, and lastly 
PTMs of the A. domesticus transcriptome where de novo only spectra remaining from 
each prior search were passed to the following search.  
 Each search was quantified using the label-free quant feature with a 6-minute 
retention time shift tolerance and data adhering to a peptide-spectrum match FDR < 0.1% 
and at least 1 unique peptide per protein was exported for analysis. Data was aggregated 
from each analysis and searches without PTMs was used for quantification. PTMs were 
assessed relative to their unmodified forms. Proteins were evaluated for robust presence 
requiring that each protein be present in at least 2 technical replicates of a single 
biological replicate and 2 biological replicates of a single sample.  
 
2.3.4.2 Protein quantification 
 Peptides were normalized to GP and converted to fmol. Proteins robustly 
identified within developmental stages were quantified by averaging across valid 
technical replicates and quantified by average of the top 3 most abundant unique peptides 
per protein, if possible. Data was handled in Microsoft Excel 365 and Graphpad Prism 
(version 9.0.0; GraphPad Software, San Diego, CA, USA). For statistical analyses, 
missing values were imputed with zeroes. Heatmaps are presented as log2(fmol) without 
imputation. Life stages and proteins were analyzed by two-way ANOVA at a significance 
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level of 0.05 with multiple comparisons tested by two-stage step-up method of 
Benjamini, Krieger, and Yekutieli at a significance level of 0.01.  
 
2.3.4.3 Protein annotation 
 Proteins were queried against AllergenOnline by sliding 80mer windows with 
matches of greater than 35% (Version 20, Accessed 201027) [95]. Proteins with a full 
length E-value below 1E-7 and > 50% shared identity were regarded as predicted 
allergens [289]. Hits were not excluded based on taxonomy. Hexamerins identified by 
Oppert et al. were included as predicted allergens regardless of their evaluation by 
AllergenOnline [287]. The originating species of matched proteins were phylogenetically 
visualized by IcyTree [290]. 
 Proteins identified by MS were compared with the non-redundant protein 
sequences database from NCBI using BLASTp-fast limited to Hexapoda (taxid: 6960) 
with a default E-value of 1E-3 [291]. Proteins were mapped and annotated in Blast2GO 
v5.2.5 (BioBam, Valencia, Spain) [292]. Sequences were also annotated by InterPro 
within Blast2GO with default settings and the annotations merged [293]. Gene ontology 
enrichment analyses were performed using Blast2GO using Fisher’s exact test. Proteins 
representing the top 10% of proteins by quantification per life stage were submitted as the 
test set compared to the reference set of the remaining proteins (FDR < 0.05). Enriched 




2.4.1 Characteristics of samples and cricket life stages 
 Crickets were handled to ensure at least 200 mg of sample was used during 
sample processing resulting in an increasing number of individuals used for earlier stages 
of development compared to later stages (Appendix A Table 2.1.1). There were no 
significant differences in protein content among life stages. Fractionation by SDS-PAGE 
evidenced more shifts in protein composition in adults than in earlier stages as a 35 kDa 
band in adult males and a band above 100 kDa in adult females but otherwise differences 
were indistinguishable from differences in total protein applied per lane (Appendix 
Figure A 2.1.2) 
  
2.4.2 Proteomic shifts across life stages 
 Use of the multi-round search methodology resulted in most (97.5%) of all 
acquired spectra assigned to one of the databases (Appendix A Table 2.1.2). After label-
free quantification requiring at least one unique peptide, the total number of valid 
proteins dropped to 675 encompassing 3977 peptides without and 81 peptides with non-
carbamidomethyl post-translational modifications. Among life stages, there were no 
statistical differences in the mean peptides, mean proteins, or summed quantification of 
all proteins (Table 2.1). There were significant differences in the quantification of the top 
10% most abundant proteins per stage and the proportion these proteins encompassed 
particularly in adult females. 
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 Comparison of quantifiable proteins across life stages resulted in most being 
similar with correlation coefficients between 0.45-0.99 comparing all proteins (Figure 
2.1). Focusing only on proteins that were robustly identified in at least 7 of 8 life stages 
(74.5% of all proteins), comparison of the quantifiable proteins demonstrated correlation 
coefficients between. 0.84-0.99. Adult females were less correlated due to several highly 
abundant proteins that were uniquely identified in adult females.  























































































































Values that do not share common letters are significantly different by one-way 
ANOVA (p < 0.05) and two-stage linear step-up procedure of Benjamini, Krieger, and 
Yekutieli (FDR < 0.01). 
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 Data were further assessed for biologically derived posttranslational modifications 
to match as much of the data possible to the databases used. A total of six modifications 
were identified in the form of N-terminal acetylation, acetylation of lysine, and 
methylation but only one, [YPIEHGIITNWDDMEK]3+, was also identified as 
unmodified, which was observed almost exclusively as the modified form in later stages 
(85.1% in pinheads, 96.3% in adult females; Appendix A Figure 2.1.3 and Appendix A 
Table 2.1.3). Each peptide was observed in at least 66 injections (91.6%) with spectra 
that substantiated the position of the modification.  
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2.4.3 Proteome annotation and gene ontology enrichment 
 Of quantified proteins, 85.5% were successfully annotated, 9.5% identified 
without gene ontology (GO) terms, and the remaining 5% did not have significant 
 
Figure 2.1 Heatmaps and Pearson correlation matrices of all proteins and robust 
proteins 
 
Heatmaps (A and C) and Pearson correlation matrices (B and D) of all quantified 
proteins (A and B) and proteins robustly identified across at least 7 of 8 life stages (C 
and D). Data are presented from the Log2
 (fmol) per protein without imputation. 
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BLAST search results (Appendix B). A total of 64 proteins (9.5%) were predicted to be 
allergens, most of which (75%) had their best allergenic match to members of Arthropoda 
(Appendix A Figure 2.1.4). For allergen hits that were well described, most closely 
matched the descriptions assigned via BLAST; however, proteins that did not meet the 
cutoff criteria for predicted allergens had more mismatches between BLAST and 
Allergenonline searches.  
 GO enrichment was applied to evaluate the primary functional focus during each 
life stage (Figure 2.2, Appendix A Table 2.1.4). Life stages were similar in a focus on 
higher representation of proteins associated with motor activity, actin filament binding, 
and myosin complex terms. Prior to 2 weeks of development, terms including purine 
ribonucleotide and triosephosphate binding were enriched. Between 2 weeks and 2/3 
grown, enriched terms indicate an increasing focus on cuticular structure and 
monophenol oxidase activity with relatively less focus on metabolism. The shift into 
monophenol oxidase activity is associated with proteins annotated as hexamerins that are 
highly abundant in 2 weeks and 1/2 grown crickets. Adult males and females continued 
with a lesser focus on metabolism while females greatly increased proteins associated 
with lipid transport. These lipid transport proteins were predominantly annotated as 





2.4.4 Predicted allergens across life stages 
 The quantitative distribution of predicted allergens showed no pattern and was not 
significantly different compared to the remaining non-predicted allergens for any of the 
life stages (Figure 2.3).  
 
Figure 2.2 GO enrichment of life stages 
 
Summary of GO enrichment results of top 10% of proteins per life stage of A. 
domesticus. GO terms significantly enriched (FDR<0.05) and reduced to most specific 
terms (FDR<0.05). Cell color represents log10 (p-value) from a floor of p=0.01 and 
numbers per cell represent number of proteins with enriched term. MF: Molecular 




 Most proteins identified (73.0%) were robustly identified in 7 of the 8 life stages 
(Figure 2.4). Only a small subset of 10 proteins were robustly identified, predicted as 
allergens, and statistically differed among the life stages. Predicted allergens that were 
robustly identified comprised a vast majority of the quantifiable protein (97.3%) 
compared to proteins not robustly identified across life stages and therefore were the 
primary focus.  
 
 
Figure 2.3 S-curves of quantifiable proteins and predicted allergens per life stage 
 
Quantifiable proteins per life stage differentiated by predicted allergens (red) and non-
predicted allergens (black). The x-axis is arbitrary and scaled. No differences were 
found in average quantity of predicted allergens and non-predicted allergens in any 
life stage by two-way ANOVA (p < 0.05) and two-stage linear step-up procedure of 
Benjamini, Krieger, and Yekutieli (FDR < 0.01). 
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 Of predicted allergens that were robustly identified but found to be significantly 
different among life stages, four hexamerins were identified and demonstrated far greater 
amounts in crickets at 2 weeks, 1/2 grown, and to a lesser degree adult females (Figure 
2.5 A). The remaining six predicted allergens either were variable from stage to stage or 
broadly increasing over development. Evaluation of the variable predicted allergens to all 
predicted allergens evidenced a significant and increasing trend toward a greater 
proportion of the allergens being encompassed by these variable predicted allergens 
(Figure 2.5 B). Comparison between all predicted allergens and all remaining proteins 
only was significant for adult females, which had significantly less predicted allergenic 
content compared to other life stages. 
 
Figure 2.4 Venn diagram of protein assignments and annotations 
 
(A) 182 proteins identified by mass spectrometry were not robustly identified across at 
least 7 of 8 life stages with 64 proteins predicted as allergens and 11 not robustly 
identified and predicted as allergens. (B) Within 493 robustly identified proteins, 65 
were significantly different among life stages by two-way ANOVA (p < 0.05) and 
two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli (FDR < 
0.01). 10 proteins were robustly identified, predicted as allergens, and significantly 





Figure 2.5 Robust and variable predicted allergen heatmap and characteristics of 
predicted allergens across life stages 
 
(A) Heatmap of predicted allergens robustly identified across at least 7 of 8 life stages 
with significant differences across life stages presented as Log2 of the sum of each 
group per life stage. (B) Proportions of quantified variable predicted allergens 
compared to all predicted allergens and the proportion of predicted allergens to all 
proteins. Values per protein or data point that do not share common letters are 
significantly different by two-way ANOVA (p < 0.05) and two-stage linear step-up 






 This study was devised to follow the development of A. domesticus crickets from 
a proteomic perspective, evaluate the identity of present proteins, predict plausible 
allergenic proteins, and examine the protein-level differences among life stages. We 
sought to explain what various A. domesticus life stages are doing at the protein level as 
well as if there were any differences among life stages that could be leveraged to 
decrease the risk posed to consumers. 
 Comparison of the GO enrichment performed here based on protein abundance to 
that of Oppert et al. based on transcript abundance shows little correlation via the terms 
shared by similar life stages [287]. Far fewer proteins were identified here to serve as a 
test set for GO enrichment as opposed to highly abundant transcripts resulting in a less 
rich comparison of life stages at the protein level. Terms enriched at the protein level for 
all stages related to muscle development and similar terms can be seen sparingly in the 
transcriptome in the form of myosin complex, troponin complex, and calcium ion binding 
(e.g. tropomyosin and myosin light chain); however, terms enriched among highly 
abundant transcripts such as cytochrome-c oxidase activity or related to DNA were not 
enriched in abundant proteins. Notably, terms related to lipid transport that were enriched 
among highly abundant proteins were absent in adult female transcripts. The model 
insect, Drosophila melanogaster, has also evidenced a poor correlation between mRNA 
and protein [294]. Factors explaining the discrepancy includes protein stability as related 
to protein turnover as highly stable proteins do not require high levels of transcription to 
become abundant as well as post-transcriptional controls that maintain protein levels 
[295]. 
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 Protein annotation identified homologues to many known allergens of 
cockroaches, shellfish, and house dust mites and were predicted as allergens in A. 
domesticus. As many of the predicted allergens were identified as robust and stable 
among the life stages, focus was given to predicted allergens that showed variation 
among life stages. Given the cumulative stability in overall predicted allergen abundance 
it is likely that the variability observed reflects both the choice to normalize samples on a 
tissue basis rather than protein as well as the naturally greater noise observed in the 
quantity of highly abundant proteins [296]. Of the focused upon predicted allergens, both 
tropomyosin and arginine kinase are known as panallergens among arthropods [160, 
297]. Myosin light chain is known as an allergen in cockroaches (Bla g 8), shrimp (Pen m 
3), and house dust mites (Der p 26) and cross-reactivity has been speculated among 
invertebrates but not clearly established [92, 298]. Both alpha-tubulin (Der p 33) and 
paramyosin (Der p 11) are known as allergens in house dust mites. Alpha-tublin of 
Tenebrio molitor, the yellow mealworm, was identified using immunoprecipitation using 
sera of patients with known shellfish allergy and regarded as a putative allergen [299]. 
Paramyosin has been described as potentially cross-reactive among house dust mites and 
mollusks [92], but paramyosin from the mollusk Halitosis discus discus, the disc abalone, 
has been demonstrated to have cross-reactivity with tropomyosin [300]. 
 Hexamerin has been identified as a novel allergen in Gryllus bimaculatus [133], 
the two-spotted cricket, although the evidence provided was limited to possible IgE-
binding and 2 peptides matched to Tribolium castaneum Hexamerin 1B precursor but 
without reporting the identity of the peptide sequences matched. Hexamerins are a 
member of the greater hemocyanin superfamily, which comprises many similar proteins 
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with diverse function, and care was taken to ensure that the proteins identified were 
attributable to the appropriate storage hexamerins as opposed to phenoloxidases, 
hormone binding proteins, or hemocyanins [301]. Ten members of the superfamily were 
identified in part with allergen hits to either Per a 3 or Fenneropenaeus merguiensis 
hemocyanin, of these three (ANN16672.RA, ANN17126.RA, GHUU01045934.1.4) were 
annotated as phenoloxidases rather than storage hexamerins by Oppert et al. [287], and 
another two (ANN20571.RA, ANN20572.RA) were evaluated as juvenile hormone 
binding proteins via matching peptides and N-terminal sequencing according to the work 
of Tawfik et al. on G. bimaculatus [302]. The remaining five (ANN12312.RA, 
ANN12313.RA, ANN12314.RA, ANN12315.RA, GHUU01039257.1.1) were identified 
using contigs from Oppert et al. [287]. Members of the hemocyanin superfamily have 
been demonstrated as allergens across Arthropoda, but cross-reactivity is less clear but 
may be achieved through cross-reactive carbohydrate determinants [303]. 
 Among the surveyed life stages, predicted allergenic content was relatively stable 
saving the exception of adult females, which had significantly less predicted allergenic 
content. However, adult females were highly rich in vitellogenins. Various vitellogenins 
are known allergens such as Api m 12 and Ves v 6, which are injection allergens and 
cross-reactive despite low shared identity (40%) [304]. Cockroach vitellogenins have also 
been demonstrated to bind IgE at relatively higher rates than other cockroach allergens 
[305]. Cockroach vitellogenin is distantly identical to other known allergenic 
vitellogenins such as Der p 14, although fragments of Der p 14 has been shown to be 
highly IgE reactive and speculated to act as an adjuvant to enhance IgE responses to itself 
and other potential allergens [306]. It is not clear if the distances in identity would result 
100 
in vitellogenins of A. domesticus sharing characteristics of other known allergenic 
vitellogenins but should be a consideration if IgE binding is identified in the future. 
 Many of the allergens identified are principally known as airway allergens, which 
suggests that farming operations should be aware of the risks posed during cricket 
rearing. For consumers, the risks are yet unclear. A. domesticus poses risks at each life 
stage surveyed and while current data suggests adult females may pose lesser risk the 
need to segregate male and female crickets to leverage this difference may pose undue 
burden on producers. We suggest that consumers be adequately informed of the risks they 
are undertaking and that crickets be cautiously consumed by those with current allergies 
to arthropods. 
101 
CHAPTER 3: PROTEOMIC EVALUATION OF YELLOW MEALWORM, 
TENEBRIO MOLITOR, WITH EXPERIMENTAL GENETIC MODIFICATIONS  
 
3.1 Abstract 
Background: T. molitor (yellow mealworm) larvae are an important alternative food and 
protein source to conventionally grown animal protein but retain risks to those with 
crustacean shellfish allergy. Genetic modification can result in unintended effects to the 
presence and quantity of other proteins present, including potential allergens. We 
evaluated wildtype and proprietary genetically modified variants of T. molitor to assess 
the allergenic risks posed as well as the effects of the modifications on the proteome. 
 
Methods: Three mealworm samples including one wildtype and two genetically 
modified variants were extracted and proteins investigated by mass spectrometry. 
Databases representing ab initio genomic predicted genes and publicly available protein 
sequences were used and identified proteins annotated for homology to known allergens. 
Predicted allergenic proteins with statistical differences among samples were used to 
assess the relative risks posed. 
 
Results: A total of 655 proteins were identified among samples with 531 identified 
robustly in each sample. 45 proteins were predicted as allergens representing many 
known allergens of Arthropods, but 2 proteins, arginine kinase and a myosin light chain, 
were predicted as allergens and significantly elevated in one of the genetic variants.  
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Conclusions: Compared to wildtype T. molitor one of the genetically modified samples 
posed no greater allergenic risk but the other posed an elevated risk. Wildtype T. molitor 
poses risks to consumers particularly those with allergies to crustacean shellfish, 
cockroaches, or house dust mites. 
 
3.2 Introduction 
 Food allergies affect approximately 10.8% of U.S. adults with shellfish allergy 
affecting 2.9% [81]. Symptoms of a food allergic reaction varies but can include rash, 
hives, shock, and anaphylaxis. Tenebrio molitor has been assessed by the European Food 
Safety Authority (EFSA) as a safe novel food with respect to whole insects and as a 
powder at a maximum level of 100% in the form of snack foods [307]. The scientific 
opinion notes that T. molitor as a food contains risks of both de novo sensitization as well 
as cross-reactions with those with allergies to either crustaceans or dust mites. 
 Safety assessment of genetically modified organisms relies on establishing 
substantial equivalence relative to the unmodified organism and can be performed at the 
level of the metabolome, transcriptome, or proteome [308]. Proteomic evaluations rely on 
evaluating the effects on protein levels due to the genetic modification and so the natural 
variability observed in accepted unmodified organisms plays a key role in assessing 
genetically modified organisms. Food allergens are predominantly proteins and therefore 
assessment of the effects of genetic modification on allergen levels is important. 
Allergens of interest in mealworms include the panallergens tropomyosin and arginine 
kinase as well as other proteins known to be allergenic in other Arthropods such as 
crustaceans, cockroaches, and house dust mites [309, 310]. 
103 
 This study evaluated the risk posed by wildtype T. molitor as well as two 
genetically modified variants. The risk was assessed by protein quantification using mass 
spectrometry. Annotation of quantifiable proteins clarified what proteins were identified 
and searches against allergen databases predicted which proteins were of relevance. We 
evaluated both the quantification and annotations of proteins to evaluate the relative 
allergenic risks of T. molitor samples as well as the effects of genetic modification. 
 
3.3 Methods and Materials 
3.3.1 Samples and Chemicals 
 Tris, iodoacetamide (IAA), 3-[(3-Cholamidopropyl)dimethylammonio]-1- 
Propanesulfonate (CHAPS), and rabbit glycogen phosphorylase B (GP; P6635; Uniprot 
P00489.3) were obtained from Sigma (St. Louis, MO, USA). Trypsin (Pierce, MS grade) 
was obtained from Thermo Scientific (Waltham, MA, USA). Dithiothreitol (DTT) and 
Thiourea were obtained from Arcos Organics (Geel, Belgium). Ammonium bicarbonate 
(ABIC) was obtained from Honeywell Fluka (Charlotte, NC, USA). Acetone, acetonitrile 
(ACN), hexanes, LC/MS grade water, and formic acid were obtained from Fisher 
(Hampton, NH, USA). Urea was obtained from Biorad (Hercules, CA, USA). 
 Yellow mealworm larvae (Tenebrio molitor) were obtained from the Dossey 
laboratory including wildtype mealworms and two genetically modified variants denoted 




3.3.2 Sample preparation and protein extraction 
 For each type of mealworm (N=3), individual mealworms were ground by mortar 
and pestle under liquid nitrogen in triplicate (N=9). Ground samples were stored at -80 
°C until use. Samples were individually prepared for defatting in 1.5 mL Eppendorf tubes 
by adding 0.5 mL of acetone and vortexed to saturate the material. Defatting was 
performed by adding an additional 1 mL of acetone (>1:5 w/v) followed by vortexing, 
shaking for 10 minutes, and centrifugation (10 minutes, 17 k x g). The supernatant was 
discarded and acetone defatting repeated three additional times. The material was then 
defatted by substituting the acetone for hexanes and repeated as before four times and the 
pellets dried in a fume hood overnight. 
 Defatted samples (N=9) were extracted 1:20 (w/v) using a zwitterionic chaotropic 
buffer (50 mM Tris pH 8.8, 5 M urea, 2 M thiourea, 2% CHAPS, 67 mM DTT) in a 
heated sonicating water bath (60 °C, 30 minutes) and centrifuged (10 minutes, 17 k x g). 
Per extraction, half of the extraction buffer was removed as supernatant and fresh buffer 
added to maintain volume. Each pellet was extracted a total of three times and the three 
supernatants per defatted sample were pooled (N=9).   
 
3.3.3 Mass Spectrometry   
3.3.3.1 Sample preparation for mass spectrometry 
 Per sample, 10 µL of each extract was diluted 1:10 in zwitterionic chaotropic 
buffer and to 10 µL of the diluted extract (equivalent to 1 µL undiluted) 4 volumes of 
chilled acetone added for an acetone precipitation (-80 °C, overnight). The samples were 
then centrifuged (4 °C, 30 minutes), decanted, and the pellet washed with 200 µL of 80% 
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acetone and the centrifugation repeated. The pellet was then allowed to dry in a fume 
hood and stored at -80 °C until use. 
 Pellets were reduced by adding 45 µL of 50 mM ABIC, 4.5 µL of 100 mM DTT, 
26.7 µL of water, and 4.8 µL of 100% ACN and incubating at 95 ⁰C for 5 minutes. The 
samples were alkylated by adding 9 µL of 100 mM of IAA and incubating at room 
temperature in the dark for 20 minutes. The samples were digested by adding 3 µL of 100 
ng µL-1 trypsin (Pierce, MS grade) and incubating at 37 ⁰C for 3 hours. A further 3 µL of 
100 ng µL-1 trypsin was added and incubated at 30 ⁰C for overnight. The reaction was 
quenched by freezing. 
 Pierce C-18 Spin columns (Thermo Scientific) were used according to 
manufacturer’s instructions excluding the final elution, which was performed using 50% 
ACN. Eluted samples were dried by centrifugal vacuum evaporation (RC1010, Jouan, 
Saint-herblain, Pays de la Loire, France). Dried samples were resolublized in 27 µL of 
0.1% (v/v) formic acid and 5% (v/v) ACN. Samples were aliquoted into vials with 9 µL 
of resolublized peptides and 1.5 µL of 200 fmol µL-1 rabbit glycogen phosphorylase B 
(GP; Uniprot sequence P00489.3; Sigma-Aldrich #P6635) where a 3.5 µL injection 
would be equivalent to 100 fmol of GP. Samples were injected in triplicate (N=27). 
 
3.3.3.2 Running parameters for mass spectrometry 
 One-dimensional microscale liquid chromatography separation of tryptic peptides 
was performed with an UltiMate 3000RSL® liquid chromatography system (Thermo 
Scientific), equipped with a Hypersil Gold C18 1.9 μm, 100 x 1 mm analytical reversed 
phase column (Thermo Scientific). Mobile phase A consisted of 99.9% (v/v) water 
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containing 0.1% (v/v) formic acid and mobile phase B was 99.9% (v/v) ACN containing 
0.1% (v/v) formic acid. Two µL of the sample was injected on-column and peptides were 
eluted from the analytical column and separated using a gradient of 2-40 % mobile phase 
B over 60 minutes at a flow rate of 60 µL/min. The analytical column temperature was 
maintained at 35 ⁰C.  
 Mass spectrometric analysis utilized a Q Exactive PlusTM Hybrid Quadrupole-
OrbitrapTM MS (Thermo Scientific) in the data-independent mode with survey scans and 
fragment ion spectra acquired at a resolution of 70,000 at m/z 400. Up to the top 20 most 
abundant isotope patterns with charge 2 to 4 from the survey scan were selected with an 
isolation window of 2 m/z with a window offset of -0.4 m/z and fragmented by higher 
energy collisional dissociation with normalized collision energies of 27. The maximum 
ion injection times for the survey scan and the MS/MS scans were 100 and 240 ms, 
respectively, and the ion target value for scan modes were set to 3E6 and 1E5, 
respectively. Repeat sequencing of peptides was minimized by dynamic exclusion of the 
sequenced peptides for 20 s.  
 
3.3.4 Data Analysis 
3.3.4.1 Protein identification 
 Protein databases for mass spectrometry data analysis were constructed using 
translated genes predicted using Augustus (v 3.4.0) against a T. molitor genome acquired 
from NCBI (WGS Project JABDTM01) [311, 312]. Parameters for Augustus included 
softmasking, the species set to tribolium2012, alternatives from evidence set to true, and 
a hints file generated using Peptimprove with default settings and utilizing the prior 
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genome along with raw mass spectrometric data generated from wildtype T. molitor 
[313]. A total of 26806 translated genes were predicted using Augustus. The database 
appended with 348 sequences representing GP and 347 decoy sequences identified from 
Uniprot from a search for “glycogen phosphorylase” within Insecta (obtained 
18/09/2020) as well as 13 tropomyosin sequences of T. molitor manually curated by 
comparison of genomic contigs to the tropomyosin-2 gene structure of Tribolium 
castaneum (NCBI LOC656914; Appendix C Table 3.1.1 and Appendix C Table 3.1.2). 
Translated genes representing tropomyosin-1 and arginine kinase were also compared 
with T. castaneum gene structures (NCBI LOC656904 tropomyosin-1 and LOC660479 
arginine kinase) but predictions were of sufficient quality and were not altered (Appendix 
C Figure 3.1.1). A second database of 626 T. molitor proteins was acquired from Uniprot 
(Obtained 10/01/2021). 
 Data was analyzed using PEAKS 8.5 with search parameters including tryptic 
peptides, maximum of 1 missed cleavage, carbaminomethyl cysteine as a fixed 
modification and a contaminant database (www.thegpm.org/crap; version 03/03/2019). 
Searches including post-translational modifications (PTM) were preformed using the 
default 313 modifications included by PEAKS. Data was analyzed using the multi-round 
search feature in four rounds in the order of the concatenated Augustus predicted gene 
database, Uniprot database, PTMs of the concatenated Augustus database, and lastly 
PTMs of the Uniprot database where de novo only spectra remaining from each prior 
search were passed to each following search. 
 Each search was quantified using the label-free quant feature with a 6-minute 
retention time shift tolerance and data adhering to a peptide-spectrum match FDR < 0.1% 
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and at least 1 unique peptide per protein was exported for analysis. Data was aggregated 
from each analysis and searches without PTMS used for quantification. PTMs were 
assessed relative to any unmodified forms. Proteins were evaluated for robust presence 
requiring that each protein be present in at least 2 technical replicates of a single 
biological replicate and 2 biological replicates of a single sample. 
 
3.4.4.2 Protein quantification 
 Peptides were normalized to GP and converted to fmol. Proteins robustly 
identified within samples were quantified by averaging across valid technical replicates 
and quantified by average of the top 3 most abundant unique peptides per protein, if 
possible. Data was handled in Microsoft Excel 365 and Graphpad prism (version 9.0.0; 
GraphPad Software, San Diego, CA, USA). For statistical analyses, missing values with 
imputed with zeroes. Heatmaps are presented as log2(frmol) without imputation. Samples 
and proteins were analyzed by two-way ANOVA at a significant level of 0.05 with 
multiple comparisons tested by two-stage step-up method of Benjamini, Krieger, and 
Yekutieli at a significance level of 0.01. 
 
3.4.4.3 Protein annotation 
 Proteins were queried against Allergenonline by Full Fasta 36 with an E-value 
cutoff of 1 and 20 max alignments shown (Version 20, accessed 13/01/2021) [95]. 
Proteins with a full length E-value below 1E-7 and > 50% shared identity were regarded 
as predicted allergens and the top hit retained for annotation [289]. Hits were not 
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excluded based on taxonomy. The originating species of matched proteins were 
phylogenetically visualized by IceTree [290]. 
 Proteins identified by mass spectrometry were compared with the non-redundant 
protein sequences database from NCBI using BLASTp-fast limited to Hexapoda (taxid: 
6960) with a default E-value of 1E-3 [291]. Proteins were mapped and annotated in 
Blast2GO v5.2.5 (BioBam, Valencia, Spain) [292]. Sequences were also annotated by 
InterPro within Blast2GO with default settings and the annotations merged [293]. Gene 
ontology enrichment analyses were performed using Blast2GO using Fisher’s exact test. 
Proteins representing the top 10% of proteins by quantification per life stage were 
submitted as the test set compared to the reference set of the remaining proteins (FDR < 
0.05). Enriched terms were reduced to the most specific terms (FDR< 0.05).  
 
3.4 Results 
3.4.1 Proteomics of T. molitor samples 
 The multi-round search methodology allowed for most (93.8%) of acquired 
spectra assigned to any of the four databases (Appendix C Table 3.1.3). After filtering the 
label-free quantification results by requiring at least one unique peptide, the pool of valid 
proteins decreased to 655 encompassing 4154 peptides without and 129 peptides with 
non-carbamidomethyl post-translational modifications. There were no statistical 
differences identified among mealworm samples regarding quantification metadata such 
as the mean number of peptides, proteins, or quantification of proteins (Table 3.1). 
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 Assessing quantifiable proteins among mealworm samples evidenced minimal 
differences assessing either all proteins or only proteins quantified in each of the three 
samples (Figure 3.1). Each of the samples were highly comparable regardless of the set of 
proteins used as Pearson correlation coefficients were each above 0.97. Proteins that were 
robustly identified across samples were of principal focus as they embodied most proteins 
identified (79.5%) and encompassed most all the quantifiable protein (Table 3.1). 
Table 3.1 Sample quantification characteristics 
  WT GM 1 GM 2 
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Values per category were assessed by one-way ANOVA (p < 0.05) and none were 
significantly different. Robustly identified proteins were those identified as present in 
each of the three samples as opposed to all proteins that were found in a single sample 
independent of other samples. WT: Wildtype Tenebrio molitor, GM: genetically 
modified Tenebrio molitor. 
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 Data were evaluated for biologically derived posttranslational modifications to 
make the most of the data. A total of four modifications were identified as N-terminal 
acetylation and methylation of serine and histidine. Only one of these peptides, 
[NLLISASSQYTK]2+ was also identified as unmodified, although only in WT (Appendix 
C Figure 3.1.2 and Appendix C Table 3.1.4). Excluding the unmodified 
[NLLISASSQYTK]2+, each of the modified peptides were observed in at least 22 




Figure 3.1 Heatmaps of all proteins and robustly identified proteins 
 
Heatmaps of all quantified proteins (A) and proteins robustly identified across each of 
the three mealworm samples (B). Pearson correlation coefficients were greater than 
0.97 for each comparison per data set (p < 0.001). Data are presented from the 
log2(fmol) per protein without imputation. WT: Wildtype Tenebrio molitor, GM: 
genetically modified Tenebrio molitor. 
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3.4.2 Proteome annotation and gene ontology enrichment 
 Among quantified proteins, 90.0% were annotated or assigned gene ontology 
(GO) terms, 8.6% were not assigned GO terms, and the remaining 1.4% had no 
significant BLAST results (Appendix D). Proteins predicted to be allergens encompassed 
45 proteins (6.9%) with most (73.3%) having their best allergenic match to members of 
Arthropoda (Appendix C Figure 3.1.3). Matches to allergenic proteins closely resembled 
assigned annotations. 
 GO enrichment was utilized to evaluate differences in functionality among T. 
molitor samples in terms of either all proteins or only proteins robustly identified among 
each sample (Figure 3.2, Appendix C Table 3.1.5 and Appendix C Table 3.1.6). GO 
enrichment did not show large differences through assessment of all proteins as opposed 
to robust proteins indicating that the cutoff of the top 10% of quantified proteins was a 
contributor to differences among samples. WT mealworms evidenced an enrichment of 
proteins associated with the structure of the cuticle among highly abundant proteins as 
well as a lack of representation of terms associated with metabolism. Both GM 
mealworms showed similar trends compared to WT mealworms with some differences in 





Figure 3.2 GO enrichment of samples against all proteins or robustly identified 
proteins 
 
Summary of GO enrichment results of top 10% of proteins of wildtype and genetically 
modified T. molitor using (A) all quantifiable proteins or (B) all proteins robustly 
quantifiable across samples as a reference set. GO terms significantly enriched 
(FDR<0.05) and reduced to most specific terms (FDR<0.05). Cell color represents 
log10 (p-value) from a floor of p=0.01 and numbers per cell represent number of 
proteins with enriched term. MF: Molecular function, BP: Biological process, CC: 
Cellular component, +: Overrepresented term, -: Underrepresented term. WT: 
Wildtype Tenebrio molitor, GM: genetically modified Tenebrio molitor. 
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3.4.3 Predicted allergens of T. molitor 
 Quantitative distributions of predicted allergens did not differ compared to 
remaining non-predicted allergens of any of the samples (Figure 3.3); however, on 
average proteins predicted as allergens were significantly more abundant than non-
predicted allergens for each of the three samples without significant differences across 
samples.  
 A majority of proteins identified were robustly identified among mealworm 
samples (81.1%; Figure 3.4). Every predicted allergen was robustly identified among 
mealworm samples but only two also statistically differed among samples: g5623t1 – 
arginine kinase and g4621t1 – myosin light chain alkali (Figure 3.5 A). These variable 
predicted allergens were exclusively significantly different in GM 2 with WT and GM 1 
being not significantly different from each other. This significant difference transferred to 
the proportion of these two variable predicted allergens compared to the remaining 43 
predicted allergens (Figure 3.5 B). With respect to the proportion of predicted allergens 
to non-predicted allergens there were no significant differences identified among 
samples. 
 Evaluation of the tropomyosins present found that the sequence present in 
AllergenOnline for T. molitor (g11661t1) is less identical to other known allergenic 
Arthropod tropomyosins than the sequence manually curated (ManualTM1.2.n; Appendix 
C Figure 3.1.4 and Appendix C Figure 3.1.5). While both sequences were relatively 




Figure 3.3 S-curves of quantifiable proteins 
 
Quantifiable proteins per sample differentiated by predicted allergens (red) and non-
predicted allergens (black). The x-axis is arbitrary and scaled. On average, predicted 
allergens were significantly more abundant than non-predicted allergens for each oof 
the three T. molitor samples by two-way ANOVA (p < 0.05) and two-stage linear 
step-up procedure of Benjamini, Krieger, and Yekutieli (FDR < 0.01). WT: Wildtype 




Figure 3.4 Venn diagram of protein assignments and annotations 
 
(A) 124 proteins identified by mass spectrometry were not robustly identified across 
T. molitor samples with 45 proteins predicted as allergens and 0 not robustly identified 
and predicted as allergens. (B) Within 513 robustly identified proteins, 28 were 
significantly different among samples by two-way ANOVA (p < 0.05) and two-stage 
linear step-up procedure of Benjamini, Krieger, and Yekutieli (FDR < 0.01). 2 






Figure 3.5 Selected predicted allergen heatmap and characteristics of predicted 
allergens across life stages 
 
(A) Heatmap of predicted allergens arginine kinase (g5623t1) and myosin light chain 
(g4621t1) that were robustly identified in all T. molitor samples with significant 
differences among samples presented as Log2 of the sum of each protein. (B) 
Proportions of quantified variable predicted allergens compared to all predicted 
allergens and the proportion of predicted allergens to all proteins. Values per protein 
or data point that do not share common letters are significantly different by two-way 
ANOVA (p < 0.05) and two-stage linear step-up procedure of Benjamini, Krieger, and 






 This study was designed to examine the proteome of T. molitor yellow mealworm 
larvae, annotate proteins, predict the allergenicity of present proteins, and lastly evaluate 
the effects of genetic modification on two proprietary samples of mealworms. In effect, 
this study first evaluated T. molitor and the various proteins present to then compare 
wildtype and genetically modified variants to frame both what typical proteins and 
possible allergens are present to then judge if these genetically modified variants could 
pose a modified level of risk to consumer relative to the wildtype. 
 The use of Augustus for ab initio prediction was to both compare with the 
predictions by Eriksson et al. as well as incorporate further data into the prediction [311]. 
Predictions here was preformed including alternative predictions according to evidence 
provided as the wildtype mealworm raw data and partial gene models allowed as opposed 
to Eriksson et al. only incorporating partial gene models. An additional 32% of complete 
and incomplete gene models were predicted here compared to Eriksson et al. despite 
using the same prediction software and reference gene database; however, a newer 
version of Augustus was used here. Augustus is highly accurate compared to other ab 
initio gene prediction tools, although such tools are not yet perfect and still have 
difficulty with correctly identifying coding regions for proteins [314]. Notably, the 
sequence for tropomyosin-2 was predicted with numerous errors and inconsistent with 
that of T. castaneum and manually added.  
 Homologues to many known Arthropod allergens were identified particularly 
among shellfish, house dust mites, and cockroaches and were predicted as allergens in T. 
molitor. Barre et al. identified a number of T. molitor proteins that bound IgE of shrimp-
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allergic patients including heat shock protein 70, α-amylase, arginine kinase, 
tropomyosin, apolipophorin-III, larval cuticle protein, and a 12 kDa hemolymph protein 
[309], where many of these proteins were predicted here as allergens excluding 
apolipophorin-III, larval cuticle protein, and the 12 kDa hemolymph protein. Both 
apolipophorin-III and the 12 kDa hemolymph protein were identified in part as g19557t1 
and g5735t1, respectively; however, many proteins were identified and annotated as 
larval cuticle proteins and so it is unclear which protein was identified with IgE binding. 
Further, the total number of proteins identified by Barre et al. was just 106 whereas 655 
were identified here with stringent sample-wise filtration requiring repeated 
identifications for acceptance, which makes it unclear if the proteins identified as IgE 
binding were in fact the only proteins present. They did similarly note the presence of 
both a tropomyosin-1 and a tropomyosin-2 as was identified here. Tropomyosins are 
known pan-allergens of Arthropoda [297], and have been implicated in cross-reactivity 
between mealworms and shellfish [310]. With respect to multiple tropomyosins present, 
it may be speculated that these are important for reactivity and cross-reactivity. 
 Functional annotation of T. molitor unigenes by Liu et al. provides insights into 
the GO enrichment based on protein abundance performed here [315]. Many T. molitor 
genes have been annotated principally with terms including binding, cellular process, and 
metabolic process, which were found to be underrepresented in the highly abundant 
proteins as opposed to extracellular matrix, which was only assigned to approximately 
1% of genes by Liu et al. but was overrepresented in the highly abundant proteins. These 
exhibit an inverse relationship suggesting that a greater diversity of proteins are needed 
for binding, cellular processes, and metabolic processes that may discourage any 
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particular proteins from becoming highly abundant. These proteins may also have 
significant differences in protein stability and therefore protein turnover as highly stable 
proteins do not require high levels of transcription to become abundant [295]. 
 Some differences were observed among wildtype and genetically modified 
variants. The observed differences in GO enrichment were likely associated with the 
limited number of samples and the arbitrary cutoff of the top 10% most abundant 
proteins. The relatively higher content of arginine kinase and myosin light chain content 
identified in GM2 would indicate that these pose a potentially higher risk to individuals 
with clinical reactivity to these proteins. GM1 did not show any significant differences in 
abundance compared to WT and therefore from this assessment would not be of greater 
risk to consumers. Both arginine kinase and myosin light chain are recognized as food 
and airway allergens depending on the source and therefore care should be observed 
either with respect to production or use of any of these mealworms.  
 Risk is present regardless of the trait effect of genetic modification and allergenic 
proteins were predicted to be present in all samples assessed, including wildtype T. 
molitor. The risk posed may be higher in GM2 mealworms, but a greater number of 
samples would assist in clarifying the magnitude of the difference in risk. We suggest 
that stakeholders be informed of the mealworms they are handling or using to allow for 
individuals to make informed choices as to the risks they are willing to face. 
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CHAPTER 4: PERSISTENCE OF PEANUT ALLERGEN-DERIVED PEPTIDES 
THROUGHOUT EXCESSIVE DRY THERMAL PROCESSING 
 
4.1 Abstract 
Scope: Commercial dry roasting of peanuts can result in accumulation of extensively 
heated peanut residue in ovens. These residues could pose a potential allergenic risk if 
residues are transferred to food products subsequently processed in the oven. Peanut 
residues can be detected in food products using antibody-based methods, but detection is 
greatly affected by thermal processing. We investigated the detectability of peanut 
allergens after excessive thermal processing using mass spectrometry (MS).  
Methods and results: Peanut kernel halves were roasted in a muffle furnace, ground, 
robustly extracted, and probed by immunoblot with sera from patients with peanut allergy 
(anti-peanut IgE) and anti-peanut IgG. Extracts were further analyzed by MS. After 8 
hours at 176 °C, detectable allergenic protein content, by MS, decreased 54.6-fold, with 
surviving contiguous regions sufficient to bind IgE to Ara h 3.  
Conclusions: Failure to detect peanut residues with antibody-based methods should not 
be regarded as an indication of the absence of peanut residues as robust extractions 
coupled with MS were able to identify peanut from some of these processed samples. 
Peanut residues should be physically removed prior to thermal processing as reliable 
existing antibody-based methods are inadequate to detect peanut residues after extensive 
heating of products. 
Keywords: Food allergen, Mass spectrometry, Peanut, Thermal processing 
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4.2 Introduction 
Food allergies affect approximately 10.8% of US adults and peanut allergy affects 
approximately 1.8% [81]. Symptoms of food allergies range from rashes, hives, and 
anaphylaxis where harmful doses of allergenic protein can be as low as sub milligram 
quantities [316]. Representative quantification of present allergenic residues is required 
to support allergen management, which is required to adequately inform allergic 
consumers of the potential risk via labeling. 
 Residues of commercially dry roasted peanuts may accumulate in ovens, possibly 
resulting in harmful levels of exposure to peanut-allergic consumers. Thermal processing 
can hinder or even negate the detection of peanut residues when using enzyme-linked 
immunosorbent assays (ELISA) [209, 317]. Peanuts are commonly oven roasted at 160-
180 °C, but higher temperatures are used for cleaning. Detection of peanut residues in 
thermally processed material may be compromised by decreased solubility of peanut 
protein especially given that extraction buffers must be compatible with antibody 
binding. Thermal processing may also result in aggregation of, and chemical or structural 
modifications to, proteins that can further complicate accurate detection and 
quantification [318]. Thermal processing affects both the detectability of allergens and 
their allergenicity to variable extents dependent upon the type of thermal processing 
[319]. Inaccurate assessment of allergenic residues following thermal processing presents 
a challenge to industry and could pose a risk to peanut-allergic consumers. 
 This study addresses the identification of peanut allergens persisting after up to 8 
hours of dry thermal processing. The quantity of allergen present at each stage represents 
the potential risk and is addressed with antibody binding and quantitative mass 
123 
spectrometry (MS). The use of MS allows for the detection of many targets (peptides and 
modifications thereof) derived from peanut allergens. This contrasts to ELISA methods 
where only one measure of peanut presence is determined. We further describe the effects 
of thermal processing by examining the survival of potentially contiguous regions of 
allergens using MS. The aim was to determine if peanut residues with the capability to 
bind to peanut-specific antibodies would remain after excessive dry thermal processing. 
 
4.3 Materials and methods 
4.3.1 Chemicals 
 Acetone, hexane, methanol, sodium chloride, disodium phosphate, 
monopotassium phosphate, formic acid, water, ACN were obtained from Fisher 
(Hampton, NH, USA). Mass spectrometry solvents were Optima grade. Thiourea, 
CHAPS, Tris, and Iodoacetamide were obtained from Sigma Aldrich (St. Louis, MO, 
USA). DTT was obtained from Acros (Geel, Belgium). BSA and PVDF were obtained 
from Millipore (Burlington, MA, USA). Nupage 4-12% Bis-Tris SDS-PAGE gels, 
NuPage MES SDS running buffer, and LDS sample buffer were obtained from Invitrogen 
(Carlsbad, CA, USA). Urea, Tween 20, Coomassie Blue R-250, Precision Plus ProteinTM 
Dual Xtra standards, and 10x Tris Glycine buffer were obtained from Biorad (Hercules, 
CA, USA). Potassium chloride was obtained from Labchem (Zelienople, PA, USA). 
Pierce C18 spin columns, Pierce MS grade Trypsin, and SuperSignal West Dura 
Extended Release Substrate were obtained from Thermo Scientific (Waltham, MA, 
USA). MassPREP Phosphorylase b Standard was obtained from Waters (Milford, MA, 
USA). Milli-Q purified water (18.2 MΩ cm) was used throughout this study.  
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4.3.2 Thermal Processing 
Raw, blanched (deskinned) peanuts were obtained from the Golden Peanut 
Company (Alpharetta, GA, USA) and stored at 4 °C until use. Groups of 10 peanut 
kernel halves were placed into foil-lined crucibles. Crucibles were heated inside a 
Thermolyne muffle furnace (Model F30420C, Thermo Scientific, Waltham, MA, USA) 
preheated to either 176 °C or 260 °C. Crucibles were removed at 15, 30, 60, 120, 240, 
and 480 minutes. Non-heated controls were also prepared and appear as time=0 in results. 
Five replicates per time point and temperature combination were prepared.  
 
4.3.3 Protein Extraction 
Per replicate, pairs of peanut kernel halves were placed into a 2 mL microfuge 
tube and manually homogenized by metal spatula and glass rod in the presence of 500 µL 
of acetone. An additional 1 mL of acetone was added, samples vortexed, rocked for 15 
minutes, centrifuged at 17,000g for 15 minutes, and decanted. This was repeated three 
more times. The samples were then defatted with 1 mL of hexane, a total of four times as 
described for the acetone procedure. Samples were dried overnight at room temperature, 
vortexed to produce a homogenous powder, and then stored at -20 °C.  
Samples were extracted as modified from [285, 320]. In brief, 50 mg of each 
defatted sample was extracted in 1 mL of zwitterionic chaotropic buffer (50 mmol/L Tris, 
pH 8.8 containing 50 mmol/L 1,4-Dithio-D-threitol (DTT), 5 mol/L urea, 2 mol/L 
thiourea, and 32.5 mmol/L 3-[(3-Cholamidopropyl)dimethylammonio]-1-
Propanesulfonate (CHAPS)). Suspensions were vortexed, incubated in a heated 
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sonicating water bath (60 °C, 20 min), and extracts were clarified by centrifugation 
(17,000g, 20 min). The supernatants (500 µL) were taken and an equal amount of 
extraction buffer replaced. Each sample was sequentially extracted three times and 
pooled as a single replicate. Extracts were stored at -20 °C until further analysis.  
 
4.3.4 Mass Spectrometry and data analysis 
MS was performed as previously described [285] with modifications. Briefly, 1 
µL of extracts were precipitated with excess acetone and the pellet was reduced, 
alkylated, digested using trypsin, cleaned via C18 Spin columns, vacuum evaporated, and 
resolubilized with 28 µL of 0.96 mol/L acetonitrile (ACN), 26.5 mmol/L formic acid. 
Prior to injection, 1.5 µL of 200 fmol/µL rabbit glycogen phosphorylase B was added to 
9 µL of each sample and 3.5 µL were injected into Thermo Q Exactive Plus™ Hybrid 
Quadrupole-Orbitrap™MS coupled to UltiMate 3000RSL® liquid chromatography 
(UPLC) system (Thermo Scientific™). Each sample was injected twice as technical 
replicates.  
Data was analyzed using PEAKS 8.5 (Bioinformatics Solutions Inc., Waterloo, 
ON, Canada) using a peanut allergen database was generated by Marsh et al. including 
rabbit glycogen phosphorylase b (Uniprot.org P00489.3) and the common Repository of 
Adventitious Proteins contaminant database (thegpm.org/crap; obtained 190121) [209, 
286]. PEAKS search parameters were 5 ppm (mg/kg) mass error tolerance and 0.05 Da 
fragment mass error tolerance with no modifications of amino acids. Secondary PEAKS 
PTM search was performed with 3 missed cleavages per peptide and performed with 
fixed carbamidomethyl cysteine and 3 variable modifications against a base list of 313 
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modifications with 31 additional Maillard reaction and lipid peroxidation modifications 
representing 46 different potential modifications as well as a modification reflecting 
acetone aldol condensation (Appendix E Table 4.1.1) [321-324]. The base list was 
curated to remove overlap with the added modifications for a total of 337 modifications. 
Peptides identifications with both <1% FDR, and each PTM identified per peptide had an 
ambiguity score of 20 or greater (p< 0.01) were accepted. Peptides with potentially 
artefactual modifications, not limited to ion substitutions, carbamylation, or in-source 
decay, were disregarded from analysis.  
For peptide level data, peptides were filtered by requiring presence in both 
technical replicates of at least two biological replicates within a single time point. For 
peptide persistence, allergen-derived peptides were also filtered to only evaluate peptides 
that met requirements for inclusion for two time points. Contiguous peptides were 
evaluated per allergenic sequence and reported as the maximum contiguous length per 
allergenic family (e.g. Ara h 1) across all replicates. The longest contiguous peptide was 
determined using three methods: 1) only observed peptides, 2) extending observed 
peptides by the first contiguous tryptic peptide under 6 amino acids, 3) extending 
observed peptides by all contiguous tryptic peptides under 6 amino acids. PTMs of 
interest were curated relative to robust parent unmodified peptides. Peptides including a 
missed tryptic cleavage were included as unmodified. PTMs of interest included 
deamidation, pyroglutamate, and Maillard products. Peptides were grouped according to 
modification of interest and evaluated for trends. 
Protein quantification evaluated two lists of peptides with either a focus on 
robustness in raw peanuts or robustness to dry thermal processing (Appendix E Table 
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4.1.2). Only Ara h 1, 2, 3, and 6 were investigated as the remaining allergens were not 
robust through dry thermal processing, were not highly abundant in raw samples, and/or 
prohibitively diverse. Proteins were regarded as present if both technical replicates had 
two peptides observed, quantified by averaging up to the top 3 peptides, and the 
quantities were averaged across replicates. 
Data were normalized via the top three predominantly present and abundant 
peptides from rabbit glycogen phosphorylase. Statistical analyses were performed using 
GraphPad Prism version 8.3.0 for Windows (GraphPad Software, La Jolla California 
USA) via two-way ANOVA with significant p-values at 0.05 and multiple comparisons 
via two-stage linear step-up method of Benjamini, Krieger, and Yekutieli with an FDR 
set at 0.05. Non-detect values were treated as zeroes.  
 
4.3.5 SDS-PAGE, sera, and immunoblotting 
Protein contents of raw peanut extracts were determined using a 2D Quant-KitTM 
per manufacturer’s instructions (GE Healthcare Life Sciences, Chicago, IL, USA). 
Volumetric aliquots of samples equivalent to 30 µg of raw peanut protein were separated 
by SDS-PAGE and visualized with Coomassie staining. 
Immunoblotting was performed as described elsewhere with the immunoblot 
transfer performed at 100 V for 60 minutes and dot blots were produced by applying 
extracts to activated polyvinylidene difluoride (PVDF) membrane and dried prior to 
treating them similarly [325]. Enzyme conjugated secondary anti-peanut antibody was 
obtained from a Morinaga Peanut ELISA Kit (Cat# M2104, Yokohama, Japan). Pooled 
sera from six peanut-allergic individuals were used. All individuals have positive skin 
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prick tests to peanut and compelling histories of allergic reactions upon peanut ingestion 
including laryngeal edema, angioedema of face/eyes, urticaria, vomiting, diarrhea, 
hypotension, and respiratory symptoms. All individuals had positive Immunocap scores 
ranging from 3.13-85.5 kIU L-1. Each individual provided informed consent as stipulated 
by The University of Nebraska-Lincoln IRB Approval 200305289FB, Project ID 6029. 
Dot blots included positive control Morinaga enzyme conjugated antibody and negative 
control bovine serum albumin that had been heated for 480 minutes at 260 °C (Extracted 
as in 4.3.3). A solution of 1 g of non-fat dry milk in 40 mL phosphate buffered saline, 
450 µM tween 20 (PBST) was used to dilute Morinaga antibody (1:20), human sera 
(1:10), and secondary mouse anti-human IgE Fc-HRP (1:1,000; Southern Biotech, 
Birmingham, AL, USA). Immunoblots were visualized by chemiluminescence using 
SuperSignal West Dura Extended Release Substrate and detected using a UVP 
Biospectrum 815 Imaging System (Analytik Jena US LLC, Upland, CA, USA) with 
VisionWorks software (Version 8.20, Analytik Jena US LLC). Maximum exposure time 
was 5 minutes and images taken were inverted with intensity range set to auto. 
 
4.4 Results 
4.4.1 Observable Properties of Thermally Processed Peanuts 
 Peanuts roasted at 176 °C developed off-odors and were visibly darkened after 60 
minutes (Appendix E Figure 4.1.1). At 120 minutes and beyond, the peanuts were 
blackened and smelled burnt. Peanuts roasted at 260 °C for 15 minutes had the same 
blackened appearance as peanuts roasted at 176 °C for 2-8 hours; however, the burnt odor 
was noxious. After 30 minutes, the peanuts were smoking and produced an oily resin. 
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Defatted powders prepared from the roasted peanut halves had colors matching the 
peanut halves (Appendix E Figure 4.1.2). Extracts of the peanuts roasted at 176 °C 
reflected the same color progression as the powders but extracts of the peanuts roasted at 
260 °C darkened through 120 minutes before lightening for the 240 and 480-minute time 
points (Appendix E Figure 4.1.3). 
 
4.4.2 Mass Spectrometry 
4.4.2.1 Quantification of Peanut Allergens over Time 
Peanut allergens were quantified in extracts from peanuts roasted for the 176 °C 
time series but not for the 260 °C time series as data was insufficient to be quantified. 
Quantification of the major peanut allergens (Ara h 1, 2, 3, and 6) after roasting at 176 °C 
is shown in Table 4.1. The variation observed reflects differences among peanuts and the 
effects of the entire workflow. The most abundant allergens present in the extracts was 
Ara h 3, followed by Ara h 1, 2, and 6. Significant decreases in the detected quantity of 
all allergens were observed during roasting at 176oC. Ara h 1 and 6 decreased 
consistently, whereas Ara h 2 and 3 showed a small, statistically significant, increase at 
15 minutes followed by consistent decrease. After 120 minutes, further decreases in 
detectable allergen content were not statistically significant, excluding Ara h 1. Ara h 3 
detection was least susceptible to heating, followed by Ara h 2, 6 then 1. The relative 
composition of detectable proteins therefore changes over time, with Ara h 3 accounting 
for 59% of quantified allergens at 0 min, and 87% of quantified allergens at 480 minutes 




4.4.2.2 Identification of Thermally Induced PTMs and Processing Biomarkers 
We examined the presence of PTMs in all time points of peanuts heated at both 
temperatures using label-free quantitation to evaluate chemical changes in peptides as a 
result of thermal processing (see Appendix F complete peptide list). At the peptide level 
per allergen, unmodified and modified peptides followed similar decreasing trends with a 
large range of values per time (Appendix E Figure 4.1.5). Focused assessment of PTMs 
used exemplar, robust peptides with high-quality identification of unmodified peptide as 
well as deamidation, pyroglutamate and Maillard products to assess prevalence of these 
modifications during heating (Figure 4.1). Heating at 176 °C dataset utilized the peptides 
[QQPEENACQFQR], [IESEGGYIETWNPNNQEFQCAGVALSR], and 
[FNLAGNHEQEFLR], all derived from Ara h 3. No equivalent, robust peptides were 
found for other allergenic proteins. Deamidation was observed in raw samples with 
Table 4.1 MS quantification and summary of peanut allergens after roasting at 
176 °C 
 
 Time (min) Fold Loss 
 0 15 30 60 120 240 480 0 vs 480 
Ara h 1 1775.4  2061.0  1572.0  359.6  38.5  11.7  4.4 405.49 
 (54.2)a (52.5)a (39.8)a (57.7)b (118.3)cd (65.7)c (97.6)d  
Ara h 2 2065.0  2523.7  1891.5  1167.2  214.3  56.4  19.9  103.69 
 (37.4)ab (35.1)a (35.8)b (48.0)b (110.5)c (122.2)c (148.8)c  
Ara h 3 8550.1  10859.9 8295.9 5842.6 980.2 516.5 232.7 36.74 
 (36.1)ab (41.3)a (24.6)ab (36.8)b (82.3)c (65.1)c (71.5)c  
Ara h 6 2081.6  2063.5  1329.4  903.2  103.5 32.0  8.1 258.31 
 (9.2)a (58.6)ab (52.7)ab (30.4)b (135.3)c (123.0)c (150.9)c  
Sum of  14472.0 17508.0 13088.8 8272.6 1336.6 616.6 265.1 54.60 
1, 2, 3, 6 (32.9)ab (40.0)a (27.0)ab (36.4)b (91.3)c (71.3)c (68.9)c  
 
Allergen quantifications are reported in fmol as mean (CV%) of five biological 
replicates with different superscript letters denoting significantly different individual 
allergen quantities over time via two-way ANOVA (p<0.05) and two-stage linear 
step-up method of Benjamini, Krieger, and Yekutieli (FDR<0.05). 
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further increases occurring with roasting until 120 minutes when a plateau was reached. 
Pyroglutamate products were also present prior to processing with a large increase 
occurring after 60 minutes of roasting and increasing thereafter. Maillard products were 
not observed in raw peanuts and showed gradual increases before peaking at 120 minutes 
of roasting but then decreased afterward. Interestingly a deamidated Ara h 3 peptide 
[FNLAGN(+0.98)HEQEFLR] was found to be abundant, robust toward heating, and  
present in all samples (including unheated peanut) (data not shown). Further, BLAST 
search of the peptide with substituted Asn (N) to Asp (D) yielded no hits, indicating that 
the deamidation is the likely source of the peptide. Heating at 260 °C data set resulted in 
only one peptide detection. The pyroglutamate modified, non-tryptic peptide  
 [E(-18.01)LQEGHVLVVPQ] was only detected at 15 minutes. It is possible that this 
peptide resulted from β-elimination induced by heating, which did not occur after 
roasting at 176oC. 
 
Figure 4.1 Trends of selected post-translational modifications in peanuts heated 
at 176 °C. 
Quantity of deamidation, pyroglutamate, and Maillard adduct (sum of the abundance 
of all modified peptides to the abundance of unmodified peptide) for selected peptides 
(n=5). 
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4.4.2.3 Evaluation of Maximally Contiguous Peanut Peptides 
 The maximum length of contiguous peanut peptides from extracts of peanuts 
roasted at 176 °C was assessed based on three scenarios to account for bias in the MS 
data (Table 4.2). Across the three scenarios, decreasing maximum peptide lengths were 
noted over time predominantly occurring at 120 minutes and later. Ara h 2 and 6 were 
both consistently present and decreased at 120 minutes whereas Ara h 1 and 3 had a more 
gradual decrease over time. 
 
Table 4.2 Maximum length of contiguous peptides of peanut allergens after 
roasting for 176 °C 
 
 Contiguous Peptide Time (min) 






1 87 147 146 85 61 26 25 
2 247 269 179 179 98 44 49 






1 41 70 57 70 68 9 9 
2 70 70 69 70 68 12 16 






1 138 155 155 155 138 99 69 
2 188 253 215 209 163 108 108 






1 67 67 67 67 34 29 14 
2 67 67 67 67 34 53 28 
3 67 67 67 67 67 67 28 
 
The maximum contiguous length of peptides (number of residues) was calculated 
using three methodologies: 1) only observed peptides, 2) extending observed 
peptides by the first contiguous tryptic peptide under 6 amino acids, 3) extending 
observed peptides by all contiguous tryptic peptides under 6 amino acids. 
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4.4.3 Antibody Binding to Thermally Processed Peanut 
 As shown in Figure 4.2, proteins in extracts of peanuts roasted at 176 °C showed 
evidence of aggregation after 15-60 minutes of roasting. The aggregated proteins were 
able to bind both IgE and IgG antibodies, with a gradual decrease in band intensity across 
the time points resulting in very little visible protein by 120 minutes. Extracts of peanuts 
roasted at 260 °C had no clear protein bands present in SDS-PAGE or immunoblotting, 
excluding smearing of lanes. Dot blotting of extracts of peanuts roasted at 176 °C showed 
antibody binding of the anti-peanut IgG through 60 minutes and allergic sera IgE through 
120 minutes (Figure 4.3). No non-specific binding was observed to peanut proteins on 





Figure 4.2 SDS-PAGE and immunoblots 
 
SDS-PAGE (left), Morinaga anti-peanut IgG (center), and pooled peanut allergic sera 
IgE (right) separated according to the 176 °C (top) and the 260 °C (bottom) roasting 
times. Lanes were loaded volumetrically relative to 30 µg of raw peanut 
(approximately 1.7 µL). Molecular weight of protein standards (kDa) indicated to left 





This study was designed to assess the persistence of peanut allergens after 
excessive dry thermal processing, evaluate the fate of the individual major peanut 
allergens, and examine the possibility for detection of peanut after extensive heating. 
From a practical perspective, would peanut allergens survive in dry baking ovens for 
extended time periods? And could peanut allergens potentially be removed by using high 
oven burnout temperatures over extended time periods? 
 
 
Figure 4.3 Dot blots 
 
Dot blots probed with either Morinaga anti-peanut IgG (left) or pooled peanut 
allergic sera IgE (right). Dot blots were prepared by applying either 0.5 or 0.25 µL 
of extracts of peanuts heated at 176 or 260 °C. Negative control was bovine serum 
albumin heated at 260 °C for 8 hours and extracted while positive control was 
directly applied Morinaga anti-peanut IgG. 
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Clear differences were observed in identifiable proteins present after roasting at 
176 °C and 260 °C. Work by Fu et al. using commercial ELISA kits found that assays of 
thermally processed peanut flours were hindered by decreased solubility and 
immunoreactivity of target proteins [317]. A key difference between this study and that 
of Fu et al. is that here we used a more robust, sequential extraction incorporating 
zwitterionic chaotropic buffer while the previous study was limited to an ELISA-
compatible heated PBS extraction. Even with more complete extraction, and multi-
analyte detection of proteins (with MS), quantitative detection of extensively heated 
peanut allergens was not possible. 
 IgE binding of extracted peanut allergens was observed extending to 120 minutes 
for peanuts roasted at 176 °C. Regardless of which bioinformatics method is used to 
assess the presence of contiguous peptides, Ara h 1, 2, 3 and 6 peptides of sufficient 
length to elicit IgE reactivity likely survive. Although estimates of minimum required 
peptide length to elicit IgE reactivity vary, Huby et al. estimated that 30 residues were 
sufficient for cross-linking [326]. After 120 minutes, IgE binding was not apparent. 
Interestingly, this decrease corresponds with a conspicuous decrease in longest 
contiguous peptide length, particularly with respect to Ara h 2. The ability to demonstrate 
detectable peptide length after proteolysis may be a useful predictor of potential IgE 
binding. It should be noted that IgE binding is not a biological measure of allergen 
reactivity. Much additional work would be required to establish the existence of a useful 
correlation between detectable contiguous peptides and clinically relevant reactivity in 
different scenarios.   
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 Quantification of present residues demonstrated that robustly occurring peptides 
were present in extracts of peanuts roasted at 176 °C, but not in extracts of peanuts 
roasted at 260 °C. These peptides represented each of the major peanut allergens 
including Ara h 1 and 3, which are regarded as becoming relatively less detectable after 
thermal processing due to their tendency to denature and aggregate [327]. However, even 
with chaotropic extraction conditions, Ara h 1 detection was most sensitive to thermal 
processing, as has been observed previously [209]. The robust extraction method used 
here likely contributes to detectable peptides leading to Ara h 3 acting as an abundant and 
robust target. Further, in contrast to previous studies, we find that Ara h 1, 2, and 6 
followed similar decreasing trends over time [328]. Continuous thermal processing can 
break disulfide bonds and denature tightly packed albumins [329, 330]. In effect, this 
may cause these allergens to extract similarly. Therefore, Ara h 3 represents an increasing 
proportion of detectable protein after thermal processing. 
IgE binding and peptide identifications decrease with increasing thermal 
processing times and temperatures, but it is unclear what happens to the proteins and 
peptides as they undergo thermal processing. Modifications are a potential reason for loss 
of identifiable allergen peptides. Deamidation and pyroglutamate modifications may 
function as processing biomarkers for evaluating the degree of processing [331]. Other 
potential modifications including crosslinking, Maillard, and peroxidative adducts make 
detection of residues more difficult as these products progressively react, degrade, and 
differentiate. Nonenzymatic cleavage was observed in conjunction with pyroglutamate-
containing peptides commonly following Gln, Glu, Asn, and Asp residues, which are 
known to cleave C-terminally [332, 333]. The only robust peptide identified from extracts 
138 
of peanuts roasted at 260 °C was doubly non-tryptic flanked by Glu and Gln and this 
peptide was not observed in extracts of peanuts roasted at 176 °C.  
Allergenic peanut proteins clearly persist, even after extended heating, at typical 
roasting (176 °C) conditions. Interestingly, even short periods of higher temperature (260 
°C) are dramatically more effective at diminishing detectable allergen-derived peptides. 
The robust, chaotropic, repeated extractions used in this study, combined with the 
inherent capability of MS to detect many, diverse analytes, represents likely the most 
comprehensive method for detection of peanut allergens in heated samples. However, the 
failure of detection should not be regarded as absence of allergenic risk. We suggest that 
biological or clinical models may be used to assess the reactivity of heavily thermally 
processed allergens.   
Current (e.g. ELISA) or even specifically designed MS detection methods are not 
capable of reliably detecting heavily heated peanut residues. This is unlikely to change 
using currently available technology. Care should therefore be taken in interpreting 
allergen analysis after the possible introduction of heavily heated peanut material. We 
suggest that the risk of product contamination by oven residue be controlled by cleaning, 
as high temperature heating may be insufficient. 
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CHAPTER 5: DETECTION OF FOOD ALLERGEN-DERIVED PEPTIDES 
FROM EXTRACTIVE-BASED E-CIGARETTE LIQUIDS 
 
5.1 Abstract 
Background: E-cigarette liquids may be flavored using either synthetic flavors, or those 
derived from plant material by extraction. Plant materials used for flavoring include 
many known and potent allergens. Although proteins are not significant flavor 
contributors to these liquids, the use of plant-derived flavors raises the possibility of 
presence of protein allergens in the resultant flavors and therefore in the inhaled vapors. 
The presence of such allergens may pose a risk of de novo sensitization or eliciting 
existing allergies. 
We investigated the possible presence of proteins in flavored vape fluids using SDS-
PAGE and protein mass spectrometry. Further, we estimate the risk that inhalation of the 
observed levels of allergenic protein may pose to consumers.  
 
Methods: Extractive-based E-liquids were purchased from online vendors based on 
potential presence of plant-derived flavors. We selected apple, cherry, peach, almond, 
coconut, hazelnut, pecan, and peanut brittle flavored liquids. Protein from E-liquids were 
dialyzed, precipitated, and analyzed by SDS-PAGE with subsequent in-gel digestion and 
LC-MS/MS, and by in-solution digestion and LC-MS/MS. Proteins were identified by 
comparison to relevant sequence databases, and relative quantitation performed using 
label-free quantitation. 
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Results: SDS-PAGE analysis showed the presence of a single protein in almond, peach, 
and coconut E-liquids. This protein was identified by LC-MS/MS as the basic subunit of 
11S globulin (Pru du 6 in almond) in each case. Comparison of the observed allergen 
concentration with VITAL®3.0 reference dose for almond of 0.1 mg of almond protein 
(based on the reference dose established for hazelnut), and using conservative but 
reasonable assumptions on dosing, suggests little risk in an ingestion scenario. However, 
estimation of inhalation risk is more difficult. We describe potential routes for estimating 
risk of inhalation of food allergens. Based on these assessments it is likely that some E-
liquids pose a credible risk to food allergic individuals.  
 
Conclusions: Some plant extract-based E-liquids likely pose a risk to allergic 
individuals. We emphasize the difficulty in estimating this risk due to the different route 
of exposure. We suggest that inhalation of proteins in E-liquids may also play a role in 
sensitization. We suggest that such liquids should be clearly labelled to mitigate risk 
posed to sensitized individuals. 
 
5.2 Introduction 
 Electronic nicotine delivery systems (ENDS) are a common alternative to 
cigarettes with an increasing proportion of young adults in the U.S. using ENDS with 
rates between 6-9% [334], and of these a positive association between use of non-tobacco 
and non-menthol flavors has been found with higher frequency and amounts consumed 
[335]. A mixture of nicotine, propylene glycol, vegetable glycerin, flavorings, and other 
ingredients, herein referred to as an E-liquid, are loaded into ENDS to be aerosolized and 
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inhaled. Flavorings included in E-liquids can be synthetic or extractives, where 
extractive-based E-liquids may include extracts of allergenic foods.  
 Food allergies affect approximately 10.8% of U.S. adults with symptoms ranging 
from rhinitis to anaphylaxis [81]. The doses of protein required to elicit allergic reactions 
can be as low as sub-milligram quantities [316]. Allergenic sources vary greatly in the 
amounts of inhaled allergens to result in allergic disease [336], but inhaled allergic 
responses tend to be less severe than responses to ingested allergens [337]. However, 
aerosolized proteins pose a risk of sensitization through inhalation [338]. As yet there are 
no cases in the literature reporting allergic reactions associated with ENDS use attributed 
to proteinaceous material in E-liquid [339]. Allergic consumers of extractive-based E-
liquids may be at risk for eliciting allergic reactions and both allergic and non-allergic 
consumers may be at risk of de novo sensitization. 
 This study addresses the identification of food allergens present in extractive-
based E-liquids. The quantity of allergenic proteins represents the potential risk and is 
examined using quantitative mass spectrometry (MS). Use of MS allows for broad 
identification of allergen-derived peptides without the need for specific antibodies that 
may not be specific to the proteins present in the extractive-based E-liquids. The aim was 
to determine if allergenic protein residues were present in extractive-based E-liquids and 
evaluate the risks posed to allergic and non-allergic consumers. 
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5.3 Methods and Materials 
5.3.1 Samples and Chemicals 
 Tris, iodoacetamide (IAA), and rabbit glycogen phosphorylase B (GP; P6635; 
Uniprot P00489.3) were obtained from Sigma (St. Louis, MO, USA). Trypsin (Pierce, 
MS grade), 3.5 kDa molecular weight cut-off dialysis tubing (Snakeskin), and tris(2-
carboxyethyl)phosphine were obtained from Thermo Scientific (Waltham, MA, USA). 
Dithiothreitol (DTT) was obtained from Arcos Organics (Geel, Belgium). Ammonium 
bicarbonate (ABIC) was obtained from Honeywell Fluka (Charlotte, NC, USA). Acetone, 
methanol, acetic acid, acetonitrile (ACN), and formic acid were obtained from Fisher 
(Hampton, NH, USA). Precision plus ProteinTM Dual Xtra standards and Coomassie 
R250 were obtained from Biorad (Hercules, CA, USA). NuPage LDS sample buffer, 
Nupage MES SDS running buffer (20x), and 4-12% NuPage Bis-Tris gels were obtained 
from Invitrogen (Carlsbad, CA, USA). 
 E-liquids were obtained based on either “may contains” labeling or marketed as 
an extractive of an allergenic food and purchased without nicotine or propylene glycol to 
simplify sample processing. The E-liquid flavors were labeled as green apple (apple), 
cherry, peach, sweet almond (almond), coconut, hazelnut, pecan, and peanut brittle 
(peanut). Of the E-liquids, peanut brittle was purchased from Vape Organics (Riverside, 
CA, USA) and the remainder were purchased from Velvet Vapors (Tucson, AZ, USA). 
The density of each liquid was measured three times and the mean reported. 
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5.3.2 Sample preparation 
 For each E-liquid, 2 mL were dialyzed against 1 L of 50 mM Tris, pH 8 with 
three changes of buffer. Dialyzed E-liquids were divided in half and up to 3 mL per 
sample were used for acetone precipitation. Samples were precipitated by adding 4 
volumes of acetone chilled at -20 °C and precipitated at -80 °C overnight. Samples were 




 Dried precipitated samples were prepared with 40 µL of SDS-PAGE sample 
buffer with 50 mM DTT and 20 µL of each sample was fractionated. SDS-PAGE gels 
were fixed with a solution of 50% methanol and 10% acetic acid for 1 hour and 
visualized with Coomassie R250. Images were taken using a Kodak Gel Logic 440 Image 
station (Kodak, Rochester, NY).  
 
5.3.4 Mass Spectrometry 
5.3.4.1 In-gel digestion 
 Protein bands were removed from the SDS-PAGE gel using a clean razor and 
slices were fixed with a solution of 50% methanol and 10% acetic acid for 2 hours. The 
gel slices were destained with 200 µL of destaining solution (50% ACN, 25 mM ABIC) 
and incubated at 37 °C for 30 minutes while shaking, the destain removed, and the wash 
repeated. Proteins were reduced with 30 µL of 50 mM tris(2-carboxyethyl)phosphine in 
25 mM ABIC and incubating at 60 °C for 10 minutes. Proteins were alkylated with 30 µL 
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of 100 mM IAA in 25 mM ABIC for 1 hour in the dark. Gel slices were destained twice 
before shrinking with 50 µL of 100% ACN for 15 minutes and air drying for 10 minutes. 
Proteins were digested by adding 10 µL of 10 ng µL-1 trypsin in 25 mM ABIC and 15 
minutes later adding 25 µL of 25 mM ABIC before incubating at 37 °C overnight. The 
slices were votexed, 30 µL of supernatant removed, and 1.6 µL of 100% ACN added. 
 
5.3.4.2 In-solution digestion 
 In-solution digestion of acetone precipitated pellets was preformed according to 
Palmer et al. [285]. Briefly, pelleted proteins were reduced with DTT for 5 minutes at 95 
°C, alkylated with IAA for 20 minutes in the dark, and digested twice with trypsin first 
for 3 hours at 37 °C and then overnight at 30 °C.  
 
5.3.4.3 Preparation for mass spectrometry and running parameters 
 Digested peptides were cleaned, and MS was performed as previously described 
with modifications [285]. Briefly, digests were cleaned using Pierce C-18 Spin columns 
(Thermo Scientific), the eluate dried, and dried in-solution digests and in-gel digests 
resolubilized in 20 and 30 µL, respectively, of 5% ACN and 0.1 % formic acid. Prior to 
injection, 1 µL of 500 fmol µL-1 GP was added to 9 µL of each sample and 2 µL were 
injected into a Thermo Q Exactive Plus™ Hybrid Quadrupole-Orbitrap™MS coupled to 
UltiMate 3000RSL® liquid chromatography (UPLC) system (Thermo Scientific™). 
 
5.3.4.4 Data Analysis 
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Data was analyzed using PEAKS 8.5 (Bioinformatics Solutions Inc., Waterloo, 
ON, Canada) against a concatenated database including Arachis hypogaea, Carya 
illinoinensis, Cocos nucifera, Corylus americana, Prunus avium, Prunus dulcis, Prunus 
persica, Malus domestica, and GP (Uniprot, 225786 sequences, accessed 08/11/2020) 
with a contaminant database (thegpm.org, accessed 08/11/2020, version last modified 
03/03/2019) [286]. PEAKS search parameters were 5 ppm mass error tolerance, 0.05 
fragment mass error tolerance, fixed carbamidomethylation of cysteines, and the protease 
set to no enzyme or trypsin with up to 3 missed cleavages. PEAKS searches were further 
analyzed with a post-translational modification (PTM) search including up to 3 variable 
modification per peptide from a curated list of 336 possible modifications including a 
base list of 312 PTMs provided by peaks [340]. Peptide false discovery rate (FDR) was 
set at 0.1% and protein identifications required a -10lgP score of ≥30, at least two 
peptides identified, and at least 1 unique peptide. Identified peptides underwent BLAST 
searches (Uniprot.org) to verify their species of origin. For quantitation, data were 
normalized via the top three GP peptides and proteins were quantified according to the 
top three peptides if possible. 
 
5.3.5 Risk assessment  
 Protein identifications and quantifications were compared with literature values 
and utilized assumptions to evaluate the allergic risk to consumers.  
 
5.3.5.1 Food allergen risk assessment 
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 Assumptions and literature values used for food allergen risk assessment are 
presented in Table 5.1. Exposure doses were calculated from the concentration of 
proteins identified, the hourly rate of E-liquid consumption, a maximum time limit to 
accumulate the dose, and a safety factor. Per allergenic source, exposure dose was 
compared to reference doses to determine if the risk of eliciting an allergic reaction was 
present. 
 
5.3.5.2 Respiratory allergen risk assessment 
 Assumptions and literature values used for respiratory allergen risk assessment 
are presented in Table 5.2. A framework and associated experiments from Costigan et al. 
was utilized incorporating a generalized derived minimum-effect level established for 
enzyme protein respiratory allergens and a safety factor but without adjustment for 
enzyme content instead substituting total quantified protein content [5]. 
 
5.4. Results 
5.4.1 Visualization of present proteins 
 Coomassie staining was performed to evaluate the presence of proteins in E-
liquids. Samples were dialyzed and precipitated with the relationship of used volumes to 
original volumes as seen in Table 5.3. Visualization of samples via SDS-PAGE (Figure 
5.1) demonstrates the presence of proteinaceous matter in the almond, coconut, and peach 
E-liquids as a band between 20 and 25 kDa, which was of identical among the three 
samples. The bands were excised for later in-gel digestion and analysis by MS. 
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Table 5.1 Literature values and assumptions used in food allergen risk 
assessment of E-liquids 
 
Literature values Associated 
value(s) 
Reference(s) 
Reference dose of 
ingested almond 
protein 
0.1 mg total 
almond protein 
[6, 7] 
Prunin fraction of total 
almond protein 
Total almond 
protein is 70% 
prunins 
[9, 10] 
High end of published 
E-liquid consumption 
30 mL day-1 [11, 12] 








Maximum duration of 
dose accumulation 
2 hours Excessive time to have 
inhalation rates correspond to 
elicitation via ingestion 
Perfect transfer of 
dose from E-liquid 
100% Limitations of literature on 
transfer of protein through 
ENDS systems 
Average waking day 
for an adult to 
consume E-liquid 
16 hours day-1 8 hours of sleep per night 
Total safety factor 100 Limitations of study and 
uncertainty of relationship of 
eliciting dose via inhalation 




Table 5.2 Literature values and assumptions used in respiratory allergen risk 
assessment of E-liquids 
 
Literature values Associated 
value(s) 
Reference(s) 
Transfer ratio of cocoa shell 
extract proteins from E-
liquid to filter pads 
1 / 12,500,000 [5] 
Proposed highest tolerable 
derived no effect level for 
enzyme respiratory allergens 
15 ng m-3 [8] 
Prunin fraction of total 
almond protein 
Total almond 
protein is 70% 
prunins 
[9, 10] 
Safety factor for efficient 
lung delivery 
10 [5] 




Cocoa proteins aerosolize 
from E-liquid equivalently to 
almond proteins 
 Required to substitute 
quantified protein values 
Total protein reported as 
ppm - mg protein per liter E-
liquid 
 Conservative assumption to 
maximize theoretical 
aerosolized allergenic dose 
E-liquids assessed in 
Costigan et al. 2017 are 
equivalent to those assessed 
here 
 Required to substitute 
quantified protein values 
Silver stained SDS-PAGE 
and standard BSA accurately 
reflect transferred protein 
 Required to substitute 

























4 100 1 0.5 1.1995 
2 Cherry 3 100 1 0.5 1.1692 








6.5 89 0.89 0.445 1.2027 
6 Coconut 6 100 1 0.5 1.1521 
7 Hazelnut 7.5 83 0.83 0.415 1.1246 




5.4.2 Assessment of Data Sets and Peptide Assignments 
 To identify proteins present in the E-cigarette liquids, the samples were 
proteolytically digested and analyzed by MS. Data was initially assessed with protease 
set to no enzyme or trypsin both with secondary PTM searches, but initial assessment 
found that compared to the tryptic search without additional PTM search that the 
remainder had inferior peptide or protein identifications without significant 
 
Figure 5.1 SDS-PAGE gel of E-liquids 
 
Dialyzed and acetone precipitated E-liquids visualized using SDS-PAGE and 
Coomassie stain with lanes as follows: (L) molecular weight standards, (1) green 
apple , (2) cherry, (3) peach, (4) sweet almond, (5) peanut brittle, (6) coconut, (7) 
hazelnut, and (8) pecan. 
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improvements in the breadth of data added and so only the base tryptic search was 
utilized. Identified peptides were scrutinized by individual BLAST searches on Uniprot 
to verify their origin. Peptides identified in almond E-liquid were attributable to P. dulcis 
and peptides identified in peach and coconut E-liquids were attributable to either P. 
dulcis or P. persica. Other species hits per peptide did not reach an alternative consensus 
species of origin.  
 Of the samples, only almond, coconut, and peach had at least 2 peptide matches to 
a single protein within a single MS injection and so the remaining samples were 
disregarded from further analysis. Coconut did not meet peptide identification criteria via 
in-solution digest but did meet criteria via in-gel digest and so was included for analysis. 
Among the remaining samples, a total of 14 peptides were identified (Appendix G Table 
5.1) and quantified (Appendix G Table 5.2) 
 Peptide spectra matched across injections for peptides that were identified in 
multiple injections (Appendix G Figure 5.1). Overall, two peptides identified from 
almond were identified both in-solution and in-gel, but only one peptide from peach 
overlapped between in-gel and in-solution digests, and further no peptides overlapped 
between digests from coconut. Of specific peptides that matched across injections, 
[GNLDFVQPPR] was identified in both the in-solution digests of almond and peach but 
in neither in-gel digest. [TEENAFINTLAGR] was identified in each of the in-solution 
digests of almond, coconut, and peach as well as the in-gel digest of peach but was not 
identified in the in-gel digest of almond or coconut. Both [ADIFSPR] and 
[QETIALSSSQQR] were identified in each of the three in-gel digests of almond, 
coconut, and peach as well as the in-solution digest of almond. Only 
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[ALPDEVLANAYQISR] was not likewise identified in the in-solution almond digest; 
however, this peptide identified in the in-gel peach digest without identified in the in-
solution digest. 
 
5.4.3 Identification of proteins present in E-cigarette liquids 
 Proteins identified among all samples were attributable to two protein groups 
headed by Q43607 and A0A5E4FK23 (Appendix G Table 5.3), which both are 
themselves or contain proteins with descriptions regarding the almond allergen Pru du 6. 
Only the almond in-solution digest identified the protein group A0A5E4FK23, whereas 
all remaining samples identified Q43607. Peptide matches from in-solution digests of 
almond and peach spanned the length of Pru du 6 whereas in-gel digests from almond, 
coconut, and peach exclusively had peptides representing the basic chain of Pru du 6 
proteins 
 
5.4.4 Quantification of proteins and evaluation of the risk of eliciting allergic 
reactions 
 Quantified protein groups are presented in Table 5.4. For use in risk assessment, 
protein quantifications from in-gel digests were not used due to lack of identifications 
from both basic and acidic chains of Pru du 6 proteins. For protein group Q43607, the 
annotated signal peptide was ignored, and the molecular weight of the mature protein 
used to determine a concentration of 2.30 and 136.56 ng mL-1 present in peach and 
almond E-liquids, respectively. For protein group A0A5E4FK23, the signal peptide was 
not well annotated for any proteins within the group and so Q43608 was used with the 
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end of the signal peptide inferred from identity to Q43607 to determine a concentration of 
4.40 ng mL-1 present in almond E-liquid and a summed protein concentration of 140.96 
ng mL-1 prunins or 201.37 ng mL-1 total almond protein. The peach E-liquid protein 
quantification was not similarly converted due to unclear protein origin. According to 
food allergen risk assessment, the exposure doses were calculated as 687.17 ng and 7.84 
ng for almond and peach E-liquids, respectively, and both were under the safety factor 
adjusted reference dose for almond of 1 µg. For respiratory allergen risk assessment, the 
exposure doses were calculated as 16.110 ng m-3 and 0.184 ng m-3 for almond and peach 
E-liquids, respectively. Compared to the safety factor-adjusted reference dose of 1.5 ng 




 This study sought to assess the presence of proteins present in a variety of 
extractive-based E-liquids, possible biological activity, evaluate their quantity, and 
examine the risk posed. In other words, are allergenic proteins present in extractive based 
E-liquids? And do these proteins pose a risk to allergic consumers? 
 Peptides representing Pru du 6 or a nearly identical homologue were identified in 
almond, peach, and coconut E-liquids. In decreasing order of both evidence and quantity 











Accession Almond Coconut Peach Almond Coconut Peach  
Q43607 201.89 0.00 2.82 28.33 19.53 19.56 60874.45 
A0A5E4FK23 7.09 0.00 0.00 0.00 0.00 0.00 55890.21 
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were almond, peach, and coconut. Both digests of almond confirmed the presence of 
almond peptides, peach identified either almond or peach peptides but was confirmed by 
both digests, but coconut only identified either almond or peach peptides by SDS-PAGE 
and corresponding digestion. The peptides identified in peach digests may have 
originated from peach, but this is unclear as seed storage proteins of genus Prunus are 
highly identical [341]; however, protein databases for species other than P. dulcis or P. 
persica are relatively small and are not similarly representative. The source of the almond 
peptides present in the coconut E-liquid is less clear, but we speculate that either the 
almond flavoring was mixed with coconut in preparation of the E-liquid or cross-contact 
of the flavoring itself or during mixing.  
 Each of the sequences identified are potentially allergenic as they have been either 
been themselves regarded as an allergen or nearly identical (>96%) to a known allergen. 
SDS-PAGE and its associated digestion of each of almond, peach, and coconut identified 
the presence of the basic subunit of Pru du 6 without accompanying acidic subunit [342]; 
however, in-solution digests of almond and peach did simultaneously identify both 
subunits. Linear epitopes have been identified across both subunits of Pru du 6 isoforms 
[343], as well as conformational epitopes to recombinantly produced whole or either 
independently produced subunit [344]. Peptides were identified for almond and peach 
that in-part encompassed epitopes and so the protein, if present in part or whole, may 
have the capacity to elicit allergic responses. 
 Inhalation of almond proteins, as opposed to ingestion, is atypical and not well 
documented in literature; therefore, risk was evaluated through both food allergen and 
respiratory risk assessments. As food allergens, assumptions were made such as 
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excessive E-liquid consumption as observed in a subset of ENDS users using heating 
coils rated to less than 1 Ohm of resistance [345], which can produce greater amounts of 
aerosol compared to conventional ENDS. These assumptions in factor of gross 
accumulation of allergenic protein did not permit a determination of risk of elicitation in 
allergic consumers. Alternatively, as respiratory allergens the primary assumptions were 
to allow substitution of observed total protein values to produce total aerosolized protein 
and therefore dose, which were weighed against the choice of threshold. Use of the 
highest proposed derived no effect level was still low enough to identify almond E-liquid 
as a sensitization risk, but not the peach E-liquid; however, Basketter et al. also reported 
levels for safe use of other respiratory sensitizers as low as 0.01 ng m-3 (1500x less than 
the generalized threshold used) [8], therefore the peach E-liquid may still pose a risk of 
de novo sensitization to consumers. 
 Food allergen aerosols have been assessed for egg [346], fish [347], and peanut 
[348], as well as wheat in the form of bakery dust [336]. Parallels can be drawn between 
extractive-based E-liquids and wheat allergies as those with oral wheat allergy commonly 
also have reactions to inhaled wheat [349], whereas those with inhaled wheat allergy are 
commonly observed to be tolerant to ingested wheat [350]. This divergence has been 
speculated to be due to differences in the epitopes where inhaled allergy to raw flour 
would utilize epitopes, likely conformational, that are not well represented in cooked 
wheat-based foods [349]; however, many of the same allergenic proteins implicated in 
oral wheat allergy have also been implicated in inhaled wheat allergy [351]. As the E-
liquids are directly inhaled it is likely that any proteins present in the E-liquid would pose 
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a risk of sensitization although the sensitization is likely specific to the inhaled 
aerosolized proteins as opposed to ingested food. 
 Beyond proteins, the ENDS itself may also be involved in allergic sensitization. 
The size of particulate matter influences the immune response, where fine particulate 
matter (0.1 – 2.5 µm) tends to encourage Th2 responses [352], and most of the aerosol 
produced by ENDS fall within this range [353]. Large proportions of the vapor produced 
by ENDS are of the size to penetrate the tracheobronchial and bronchoalveolar regions of 
the lung [354], and such particulate matter has been associated with the development of 
asthma, particularly those with atopy [355]. Aerosolized E-liquid itself has been found to 
be proinflammatory [356], which constitutes an impaired barrier for allergic sensitization 
[357]. Use of extractive-based E-liquids is likely to encourage allergic sensitization to 
proteins present from the extract. 
 This work was designed as an initial investigation and therefore individual 
techniques were not well replicated, but rather used in tandem to identify proteins present 
in E-liquids. Inclusion of further extractive-based E-liquids, controls per allergenic food 
source, as well as replication is required to further establish the risk posed. Further 
controls regarding ENDS in terms of design, aerosolization temperatures, power, and a 
standardized protein-containing E-liquid are required to correlate allergen presence in E-
liquids to dose inhaled. Lastly, biological testing is needed to establish the effects of 
inhaling these allergenic proteins on de novo sensitization as well as elicitation of current 
allergies. 
157 
CHAPTER 6: LITERATURE-BASED RISK ASSESSMENT OF ACTIVATED 




 Activated carbon (AC) is a common material in water purification, which can be 
made from various materials including walnut hulls. Unprocessed walnut hulls contain 
several hazards including food allergens, naphthoquinones, and ellagitannins. When 
properly processed, the present hazards are expected to be rendered inert to make the 
resultant AC not a significant risk to consumers. 
 
6.2 Background 
AC is a porous material with a high surface area with multiple uses including the 
purification of drinking water and is often used in sequence with several other materials, 
where AC is included for its ability to adsorb organic compounds [358-360]. Production 
of AC proceeds though dehydration, pyrolysis, and carbonization using high heat and is 
subsequently activated by using hot steam, acid, base, or salt [360, 361]. AC is made 
from carbonaceous materials such as walnut shells, coconut husks, wood, or coal [358, 
362, 363]. Walnut hulls are a byproduct of walnut shelling and can be used as a potential 
value-added source material for the production of AC. Walnut hulls form the outer husk 
around the shells and kernels and do not have a principal use beyond production of 
animal feed, applications as a dye, or as an herbal medicine [364-367]. In the U.S. there 
are two walnut species of economic importance: Juglans nigra, the Eastern black walnut, 
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and Juglans regia, the English walnut [368]. Walnuts contain a number of hazards such 
as food allergens and toxins, which may contaminate walnut hulls and may persist 
through processing [369, 370].  
   
6.3 Activated Carbon Processing 
Production of AC uses heat to cause dehydration, pyrolysis, graphene nucleation, 
and carbonization via heating at or above 600 °C under an inert atmosphere to increase 
the solid carbon content to more than 90% [361]. During carbonization solid, liquid, and 
gaseous byproducts are formed and can be separated to leave only carbonized biochar 
[371, 372]. Afterwards, the biochar is activated either by chemical means by adding 
inorganic acids, bases, or salts and heated for hours above 300 °C or alternatively by 
physical means using oxidizing gasses such as steam above 800 °C [360, 361, 373-375]. 
Diffusion of oxidizing agents into the biochar breaks the aromatic carbon structure and 
increases the porosity and surface area of the carbon [375]. For lignocellulosic biomass 
above 250 °C and up to 350 °C pyrolysis and depolymerization of cellulose occurs, above 
350 °C aromatic carbon is seen with growing graphene sheets, and above 600 °C the 
remaining non-carbon is expelled and the graphene structures coalesce to form the 
carbonized matter [361]. As Ioannidou et al. has explained, AC is often heated for 
excessive amounts of time (1-8 hours) at temperatures exceeding 600 °C, optimized per 
material, and this allows the assumption that the heating is homogenous across the 
biochar and has undergone both pyrolytic and carbonization temperatures [376].  
Activated carbon itself is a minor hazard, particularly powders due to 
combustibility, and it can also be an irritant. As an irritant it does have exposure limits, 
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however oral rat studies have shown that the LD50 was >10,000 mg/kg indicating that it 
is a minimal hazard because it is likely that a human would either see or taste the AC in 
the water prior to being able to consume enough for it to be a major health hazard [377, 
378]. However, AC is not intended to become part of the product, rather it is a food-
contact surface [379]. Therefore, if AC were continuously seeping into the water it was 
purifying that would be a major defect of the water purifier or a mistake of the granularity 
of the AC supplied. From this, AC itself is neither a likely or harmful hazard. 
 
6.4 Allergenic Hazards of Walnut Hulls 
Walnuts are a major allergen and part of eight classes of allergenic foods that 
comprise 90% of US food allergies as designated by the Food Allergen Labeling and 
Consumer Protection Act of 2004 [204]. Tree nuts can cause IgE-mediated reactions with 
symptoms ranging from oral allergy syndrome to anaphylaxis and are a major source of 
food allergy related fatalities [380, 381]. Among tree nuts, walnut allergy is the most 
common [382]. Allergic cross-reactivity can be seen across walnut cultivars and across 
tree nuts [383, 384]. Walnut hulls contain approximately 15% protein by dry wright 
[385]. Threshold doses for the walnut allergic population to have an allergic reaction 
have been determined such that 3.1 mg of walnut protein would be sufficient to cause an 
allergic reaction in 5% of the walnut allergic population (ED05) [386]. Assuming a soldier 
drinks 11.4 liters of water per day, a protein concentration of 0.28 µg/mL would be 
theoretically meet the ED05 for walnut allergic individuals while holding the over-
conservative assumptions that all walnut proteins are equivalent and that an allergic 
reaction could be elicited by accumulation across an entire day [387]. 
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6.5 Effects of Thermal Processing on Allergens 
Allergenic proteins elicit symptoms through a pair antibody binding epitopes on 
the protein, which are either bound to a conformational or linear epitope of the allergen 
[70]. Therefore, both unfolding and destruction of peptide bonds are necessary to 
eliminate allergenic potential. Protein denaturation temperatures vary by protein but can 
occur as high as 108 °C [388]. Protein pyrolysis and decomposition occur above 200 °C 
with volatile nitrogenous decomposition continuing through 400 °C [388, 389].  
Thermogravimetric analysis has been applied to peptides [390], milk [391], 
collagen [392], and microalgae [393] to show at what temperatures that gross 
decomposition of proteins occurs. Amino acid decomposition has been found to follow 
first-order rates [394]. Synthesized peptides were largely found to represent proteins 
where temperatures below 200 °C evaporated surrounding water and between 200 °C and 
500 °C degraded the peptides through decarboxylation, deamination, and 
depolymerization with rate maxima at 235 °C and 299 °C [390]. Camel and cow’s milk 
were indicated to have combined degradation of protein and fat around 380 °C [391]. 
Collagen decomposition has been indicated to occur between 220 and 380 °C with 
maximum rates between 285 and 300 °C with combustion occurring at 350 °C [392]. 
Another investigation of collagen found that through 100 °C absorbed water is 
evaporated and between 280 °C and 400 °C bound water is released [395]. Modeling 
theoretical thermogravimetry of microalgae has demonstrated that protein largely degrade 
upon heating to 350 °C [393]. However, decomposition has been found to proceed at a 
lower rate than hydrolysis and therefore hydrolysis can be expected to occur first [396].  
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Destruction of peptide bonds has been investigated in terms of spontaneous 
hydrolysis. Hydrolysis of peptides has been found to be a first-order process and has been 
calculated to have a half-life of approximately 6 minutes at 250 °C and neutral pH [396]. 
Although pH can affect the rate of hydrolysis, the rate only increases in acid or alkali 
[397]. The minimum length of peptide needed to elicit clinical symptoms has been 
suggested to be as little as 29 amino acids long [398]. Under the aforementioned 
conditions, it would theoretically take 66 minutes to reduce titin (approximately 35,000 
residues) to having no peptides over 29 amino acids. Properly processed AC is unlikely 
to have sufficient epitopes nor free amino acids remaining to cause allergic reactions, 
even if processed at relatively low temperatures. 
 
6.6 Allergen Labeling of Activated Carbon Derived from Walnut Hulls 
The Federal Food, Drug, and Cosmetic Act in the U.S. under section 409 (h) 
states “the term ‘food contact substance’ is any substance intended for use as a 
component of materials used in manufacturing, packing, packaging, transporting, or 
holding food if such use is not intended to have any technical effect in such food” [204]. 
The Food and Drug Administration has also clarified that AC is a food-contact substance 
as defined in section 409. Lastly, because the Food Allergen Labeling and Consumer 
Protection Act in the U.S. section 403 (w) requires labeling of products with ingredients 
that contain tree nuts it would typically require labeling of products made after use with 
the AC, however because by definition the carbon cannot become part of the food itself, 
it is not an ingredient and not subject to allergen labeling [204].  
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6.7 Chemical Hazards of Walnut Hulls 
Walnut hulls contain a number of phenolic compounds including ellagitannins 
and 1,4-naphthoquinones [399, 400]. The ellagitannin ellagic acid has been described as 
being present in walnut kernels up to 18% by dry weight and the 1,4-naphthoquinone 
juglone has been described as being present in walnut hulls up to 1.5% by dry weight 
[400-402]. 
Walnut hulls contain several similar 1,4-naphthoquinones including juglone, 
plumbagin, and 1,4-naphthoquinone. Naphthoquinones, including juglone and 
plumbagin, are known to be cytotoxic whereby they will bind DNA and inhibit 
replication, inhibit enzymes, and disturb membranes and are able to reduce cell viability 
in vitro at a concentration of 1 µM [403, 404]. Lawsone, an isomer of juglone, has an 
identified no-observed-adverse-effect level (NOAEL) of 2 mg/kg which corresponds to 
an acceptable daily intake of 1.4 mg for a 70 kg individual and assuming a soldier’s water 
intake of 11.4 L/day we find that 0.12 µg/ml or 130 ppb of total 1,4-naphthoquinones can 
be in the water and not be expected to be harmful [387, 405]. Data for decomposition 
temperatures are not available for juglone, however it is noted that it sublimes at 155 °C 
and therefore could be removed with the volatile gasses during production [406]. 
Similarly, plumbagin melts at 76 °C and 1,4-naphthoquinone melts at 121 °C, which 
generally indicates that the class of 1,4-naphthoquinones present could be separated out 
from the biochar and not be present in the produced AC [407, 408]. 
 Walnut hulls also contain a number of ellagitannins including ellagic acid [400, 
409]. Ellagic acid has been subject of a 90-day sub-chronic oral rat (F344) study and 
showed that female rats had a NOAEL level of 3254 mg/kg while male rats were 
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estimated to have a no-observed-effect level of 3011mg/kg (NOEL) where the only major 
effect was a decrease in female bodyweight and no changes in histopathology were 
observed [409, 410]. Using the NOAEL for ellagic acid, we can derive an ADI of 2278 
mg/day for a 70 kg individual and taking a soldier’s maximum daily water intake of 11.4 
L/day then we find that 0.2 mg/ml or 200 ppm of ellagic acid can be in the water and not 
be expected to harmful [387]. However, this assumes that ellagic acid is not removed or 
destroyed by heating. Ellagic acid melts at 300 °C, so this compound could be separated 
from the biochar and not be present in processed AC [411]. 
 
6.8 Conclusions 
 Use of walnut hulls to make AC is not a significant risk provided that the hulls are 
processed to at least 400 °C with a holding time to result in nitrogenous decomposition. 
Through a heating of this magnitude, allergenic and chemical hazards will have been 
destroyed or removed as liquids or gasses such that no significant hazards will be present 
from the walnut hulls. Therefore, if AC made from walnut hulls is produced to the 
standard of a food-contact substance, it is unlikely to contain any significant risks. 
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CHAPTER 7: LITERATURE-BASED RISK ASSESSMENT OF ALLERGENS IN 
SMOKE DERIVED FROM TREE NUT WOOD 
 
7.1 Summary 
 Smoking is a time-tested means to preserve food as well as improve flavor. Wood 
used for smoking includes wood from trees that produce tree nuts, which may pose a risk 
to tree nut allergic individuals. Due to differences in protein profiles between wood and 
tree nuts there is no demonstrated presence of tree nut allergens in the wood. Tree nut 
wood smoke is not a significant source of allergic risk.  
 
7.2 Background 
Smoke is an aerosol emitted upon combustion or pyrolysis of a material and is 
composed of water, gasses, and particulate matter [412, 413]. Wood smoke has desirable 
effects on food including color, flavor, and has antioxidant and antimicrobial effects 
[414]. Common woods for smoking include mesquite, fruitwood (e.g. apple, cherry), and 
tree nut wood (e.g. pecan, hickory) [415]. In this work, “tree nut wood” refers to wood 
derived from trees that produce tree nuts defined as major food allergens by the Food 
Allergen Labeling and Consumer Protection Act of 2004 with further clarification by the 
U.S. Food & Drug Administration: almond, beech, Brazil, butternut, cashew, chestnut, 
chinquapin, coconut, hazelnut, ginko, hickory, lichee, macadamia, pecan, pine, pili, 
pistachio, shea, and walnut [204, 416]. Tree nuts are part of the eight classes of allergenic 
foods that comprise 90% of U.S. food allergies and the presence of which in food must be 
labelled [204]. Tree nuts can cause IgE-mediated reactions with symptoms ranging from 
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oral allergy syndrome to anaphylaxis and are a major source of food allergy related 
fatalities [380, 381]. It is unclear if the use of tree nut wood to produce smoke is a risk to 
tree nut allergic individuals. 
 
7.3 Wood, Trees, and Logging 
Wood is formed from the secondary xylem of woody plants [417]. The wood and 
bark are segregated by the vascular cambium, which wraps around the secondary xylem. 
Bark is then all tissues surrounding the vascular cambium including the phloem. Wood is 
predominantly formed from cellulose, hemicellulose, lignin, and extractives that include 
a number of classes of compounds such as flavonoids, isoprenoids, and tannins [418]. 
Trees are divided into angiosperms and gymnosperms called hardwoods and softwoods 
respectively [419]. These differ in their lignin, hemicellulose, bark thickness, and 
seasonal senescence and abscission of foliage. Hardwood lignin subunits have a single 
methoxyl group as opposed to two of softwood, both have the hemicellulose xylan but 
hardwoods lack galactoglucomannan, hardwood bark tends to be thinner, and hardwoods 
tend to lose their foliage seasonally.  
Members of the genus Populus are hardwoods that are regarded as model trees 
[420-422] and includes poplar, aspen, and cottonwood species [423, 424]. In Populus, 
nitrogen in the tree varies seasonally and is stored in the form of proteins and free amino 
acids principally as arginine, glutamine, and asparagine [425]. In autumn, leaf proteins 
are broken down and amino acids are transported to bark and wood to produce bark 
storage proteins. In spring, bark storage proteins are broken down and moved to 
reproductive tissues, buds, and leaves. Amino acids have been regarded as a major means 
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of nitrogen both storage and transport in Populus [426], but also peach trees [427]. In 
peach trees, total nitrogen and soluble protein in wood is low and seasonally stable 
whereas the bark stores most of both nitrogen and soluble protein. Wood soluble protein 
was found to be approximately 1 mg.g-1 dry weight year-round whereas phloem soluble 
protein ranged from approximately 5 and 25 mg.g-1 dry weight varying by season. 
Broadly, the nitrogen content of wood has been found to vary among tree species, has 
been found to be generally proteinaceous, and a sampling of a variety of trees were found 
to average approximately 0.1% nitrogen in wood [428]. The protein composition of wood 
is not similar to that of nuts, with woods lacking seed storage proteins associated with 
commonly consumed plant parts [429-431]. 
Processing wood for smoking begins with standing trees. Trees are felled and they 
may optionally undergo limbing and bucking where the whole trees have their limbs 
removed and are then segmented into logs respectively [432]. If limbed, the branches are 
predominantly left by the stump and so not used [433]. Logs may then be debarked and 
either used as is or processed into wood chips [432]. Wood chips and sawdust are also 
obtained as byproducts of processing lumber [434]. Both wood chips and sawdust are 
commonly used in industrial smoke production [435].  
 
7.4 Industrial Smoke Production, Processing, and Usage 
The type of wood, temperature of burning, and method of burning can alter the 
qualities of resultant smoke [436]. Hardwoods are preferred over softwoods to produce 
smoke as softwoods contain higher levels of resin acids causing the smoke to impart 
more soot and acidic flavor [437]. Hardwood typically consists of 40-60% cellulose and 
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20-30% of hemicellulose and lignin each where the balance of these primary components 
affects the pyrolysis product balance of the smoke. The specific wood used for smoking 
can alter the color and flavor imparted on the food [435], but the smoke composition can 
also vary with the temperature and availability of oxygen [438].  
Upon heating, the wood will dry up to 170 °C and hemicellulose, cellulose, and 
lignin generally undergo pyrolysis between 200-260 °C, 260-320 °C, and 310-500 °C 
respectively [414, 437]. The desirable products stem from both primary pyrolysis and 
secondary breakdown of primary products. Incorporation of some oxygen during 
smoldering is important to high quality smoke as oxygen assists with secondary reactions 
[414]. Temperatures that are too low will not efficiently smoke whereas too high 
increases production of toxic polycyclic aromatic hydrocarbons [413]. However, if the 
wood is allowed too much oxygen at high enough temperature, then self-sustaining 
combustion or self-ignition of wood can result [439, 440], which results in a loss of 
consistency as well as quality. 
Industrial production of smoke most commonly uses smoldering generators where 
a tray is heated to around 350 °C, fed either wood chips or sawdust, and sustained with 
air blown from underneath to feed oxygen, control temperatures, and prevent self-
sustaining combustion [435]. The temperature of the wood varies according to the 
temperature of the plate, air flow, and the size of the wood used. The wood is often added 
continuously, so keeping the wood in a particular shape (e.g. cone) maintains a constant 
air flow to wood surface area to improve the consistency of the smoke and further hinder 
self-ignition [437]. 
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Alternative smoke generators include friction generators and steam condensers. 
Friction generators grind wood against a rotating barrel for short bursts resulting in 
contact temperatures up to 380 °C [441]. Steam condensers pass sawdust into overheated 
steam held between 300 and 450 °C to generate smoke, which is subsequently cooled 
[413].  
Uses of produced smoke can be divided into direct smoking, where emanating 
smoke is used on exposed product, or indirect smoking, where smoke is passed though 
water, distilled, refined, and concentrated and applied as a dip or mist [437]. Direct 
smoking can be separated into hot smoking, where products are smoked while cooked, or 
cold smoking, where the products are smoked without cooking [436]. Indirect smoking 
aims to reduce tar and soot content through washing and filtration steps as well as 
concentrating desirable flavor [414]. Smoke produced by passing it through water as in 
indirect smoking is referred to as liquid smoke. Cooling and condensing the water can be 
used with distillation or gravity to induce phase separation into oily resin, water soluble, 
and water insoluble phases [437]. The water soluble and insoluble phases can be then 
used as source materials for functional compounds to produce liquid smoke depending on 
product identity and desired qualities. 
Liquid smoke can be further processed into a dry powder either by plating or 
spray-drying [442]. Plating uses a carrier molecule to embed a liquid flavor onto a solid 
carrier such as salt, lactose, starch, or maltodextrin. Spray-drying incorporates the liquid 




7.5 Smoke as a Medium for Allergen Transport 
Although a number of tree nuts have been investigated, many do not have 
quantitative data regarding eliciting doses that cause reactions [443]. In light of this, 
hazelnut has been suggested as a placeholder for tree nuts in these cases. The reference 
dose for hazelnut via quantitative risk assessment was set at 0.1 mg of hazelnut protein 
based from the eliciting dose of 1% of the population (ED01), where this reference dose 
was set to protect 99% of the allergic population from objective reactions [316]. 
Inhalant allergens have been identified in the cedar wood (Juniperus ashei), 
however allergens were not identified in wood smoke by SDS-PAGE, cedar-pollen 
sensitive IgE, nor monoclonal antibody [444]. Mesquite wood smoke (genus Prosopis) 
has been investigated using SDS-PAGE and IgE immunoblots using sera from mesquite-
pollen SPT positive and self-reported mesquite-smoke-sensitive patients [445]. From an 
undescribed quantity of mesquite smoke passed through water and concentrated, More et 
al. identified protein bands by SDS-PAGE and immunoreactive bands were found in both 
sets of sera. This indicates that some amount of proteins and allergens from wood can be 
aerosolized and retain reactivity. 
The largest body of work regarding smoke, its composition, and effects on 
humans has been though tobacco cigarettes. In a study by Becker et al., an 18 kDa 
glycoprotein was purified from cured tobacco leaves and injected to a mix of smoker and 
non-smokers and demonstrated positive skin tests in a subset of both groups [446]. The 
purified protein was analyzed by polyacrylamide gel along with extracts purified 
similarly but starting with either cigarette smoke condensate (tar) or cigarette smoke 
saline (cigarette smoke passed through phosphate-buffered saline). The purified proteins 
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were found to be similar according to hemagglutination inhibition assay and were also 
cross-reactive. Similarly cross-reactive proteins were also found to be present in other 
members of Solanaceae including eggplant, green pepper, potato, and tomato. In the tar, 
the concentration of the protein was found to be between 1.8 and 3.6 mg/g and was used 
to extrapolate a range of 720 and 1440 µg of antigen per packet of 20 cigarettes assuming 
20 mg of tar per cigarette. Concentration of antigen in cigarette smoke saline was not 
determined. This study suggests that a quantity of proteins can be found and purified 
from smoke and therefore smoke can act as a medium for allergen transport. Neither the 
degree of transport relative to source material nor how ubiquitous the aerosolization is 
across proteins is not addressed. 
A study by Voisine et al. investigated the transfer of protein into tobacco smoke 
using cigarettes spiked with the subtilisin enzyme savinase [447], where subtilisins are 
used as detergent enzymes known to aerosolize and cause IgE-mediated allergy [448]. 
Savinase was detected by immunostaining method allowing detection of savinsae transfer 
down to 0.009% in mainstream smoke (directly smoked) or 0.054% in sidestream smoke 
(second hand). Detectible transfer was not found in any scenario and it was concluded 
that there was no significant protein transfer via smoke. This contradicts Becker et al. to a 
degree, however together these suggest that there is a low level of protein transfer. Liu et 
al. contextualized the study by Voisine et al. and explains that the upper limit of savinase 
transfer into mainstream smoke was found to be <0.009%, however a more rigorous 
smoking regimen to increase tar yield (from 15 mg to 35 mg tar) could increase the 
transfer to <0.021% or at most 4.4 ng savinase per cigarette with 700 mg of tobacco 
spiked at 6000 ppm savinase [449].  
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A number of assumptions would be required to appropriately apply this 
information to the transfer of tree nut allergens using smoke to food, which are not 
limited to: wood is a perfect substitute for tobacco, conditions to burn wood are 
functionally identical to experimental conditions to transfer savinase in tobacco smoke, 
no functional differences between the aerosolizability of wood proteins vs savinase, and 
tree nut allergens or immunoreactive homologues are present in wood at approximately 
6000 ppm. Wood and seeds do not share the same protein profile and so the main source 
of tree nut allergens in the wood would be tree nuts themselves, but processed wood 
would not carry tree nuts after limbing and debarking. The key assumption of allergen 
presence is not met in processed wood that would be used for smoking food. 
 
7.6 Effects of Thermal Processing on Allergens 
Allergenic proteins elicit symptoms through a pair of antibody binding epitopes 
on the protein, which are either bound to a conformational or linear epitope of the 
allergen [70]. Therefore, both unfolding and destruction of peptide bonds are necessary to 
eliminate allergenic potential. Protein denaturation temperatures vary by protein but can 
occur as high as 108 °C [388]. Protein pyrolysis and decomposition occur above 200 °C 
with volatile nitrogenous decomposition continuing through 400 °C [388, 389].  
Thermogravimetric analysis has been applied to peptides [390], milk [391], 
collagen [392], and microalgae [393] to show at what temperatures that gross 
decomposition of proteins occurs. Amino acid decomposition has been found to follow 
first-order rates [396]. Synthesized peptides were largely found to represent proteins 
where temperatures below 200 °C evaporated surrounding water and between 200 °C and 
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500 °C degraded the peptides through decarboxylation, deamination, and 
depolymerization with rate maxima at 235 °C and 299 °C [390]. Camel and cow’s milk 
were indicated to have combined degradation of protein and fat around 380 °C [391]. 
Collagen decomposition has been indicated to occur between 220 and 380 °C with 
maximum rates between 285 and 300 °C with combustion occurring at 350 °C [392]. 
Another investigation of collagen found that through 100 °C absorbed water is 
evaporated and between 280 °C and 400 °C bound water is released [395]. Modeling 
theoretical thermogravimetry of microalgae has demonstrated that proteins largely 
decompose upon heating to 350 °C [393]. However, decomposition has been found to 
proceed at a slower rate than hydrolysis and therefore hydrolysis can be expected to occur 
first [396].  
Destruction of peptide bonds has been investigated in terms of spontaneous 
hydrolysis. Hydrolysis of peptides has been found to be a first-order process and has been 
calculated to have a half-life of approximately 6 minutes at 250 °C and neutral pH [396]. 
Although pH can affect the rate of hydrolysis, the rate only increases in acid or alkali 
[397]. The minimum length of peptide needed to elicit clinical symptoms has been 
suggested to be as low as 29 amino acids long [398]. Under the aforementioned 
conditions, it would theoretically take 66 minutes to reduce titin (approximately 35,000 
residues) to having no peptides over 29 amino acids.  
In context of burning wood, some of the protein can be expected to be partially 
degraded as the wood burns. However, it cannot be assumed that all of the protein will be 
degraded. For example, it is known that after smoke has been produced it will rapidly 
cool to the surrounding temperatures [414]. This further indicates that the focus on the 
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study of Voisine et al. controls for conditions such as protein degradation during protein 
transfer and therefore is not necessary to account for in the prior calculations. 
 
7.7 Allergen Labelling of Products Produced in Part with Smoke from Tree Nut 
Wood 
 The Federal Food, Drug, and Cosmetic Act in the U.S. under section 201 (qq) 
defines major food allergens includes tree nuts and also stipulates labeling as defined in 
section 403 (w) [204]. Notably the requirement is that labeling is stipulated on the food 
ingredient containing protein derived from a major allergen, which requires both that tree 
nut protein be included in the wood and that tree nut protein transfer to the final product. 
It is not unreasonable to assume some tree nut is included in the wood, however here we 
have failed to demonstrate that transfer of protein in smoke is significant. Therefore, 
labeling products smoked with wood derived from trees that produce tree nuts is not 
necessary. 
 
7.8 Conclusions on the risks associated with Smoke derived from Tree Nut Wood 
 Use of wood from tree nut trees is not a significant risk to allergic consumers of 
smoked foods. There is evidence that a low level of protein transfer can occur through 
smoke, however wood proteins differ from tree nut allergens and precludes concerns of 
tree nut allergens transferring from the wood in smoke. Labeling is unnecessary because 
of the very low levels of expected protein transfer. 
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CHAPTER 8: SUMMARY AND CONCLUSIONS ON NOVEL SOURCES OF 
FOOD ALLERGENS 
 
Novel foods and novel sources of food allergens require investigation to evaluate 
present proteins and their associations with known allergens. Mass spectrometry has the 
capacity to evaluate novel sources of food allergens and can inform qualitative and 
quantitative assessments of risk. This set of works had the following aims:  
1. Explore novel foods, foods processed in novel ways, and novel means of exposure 
as novel sources of food allergens; 
2. Develop methodologies for incorporating mass spectrometry into allergen risk 
assessment; 
3. Evaluate how conventional risk assessment methodologies can be leveraged to 
determine the qualitative and quantitative allergic risks posed by novel sources of 
food allergens. 
 
 The first aim was accomplished using literature reviews and experimental 
evaluations using liquid chromatography-electrospray ionization-mass spectrometry to 
explore Acheta domesticus, the house cricket, and Tenebrio molitor, the yellow 
mealworm; extensively thermally processed walnut hulls and peanuts, as well as smoke 
from the wood of tree nut trees and E-cigarette liquids. While many foods are well-
characterized, there are many non-novel foods that are not well-characterized despite 
associations with food allergies. Novel foods and novel sources of food allergens are 
generally not well-characterized and therefore contain many unknowns such as the 
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identities of present proteins, the quantity of those proteins, and the associations those 
proteins with known allergens. To understand risks associated, the hazard must first be 
identified and characterized. 
 The second aim was accomplished during experimental investigation of subject 
novel sources of food allergens during the analysis of mass spectrometry data to annotate 
and predict the allergenic proteins present in both A. domesticus and T. molitor, 
determine theoretically viable IgE-binding lengths present in extensively thermally 
processed peanuts, and analysis of E-liquids in terms of both food allergen and 
respiratory risk assessments. Mass spectrometry is currently growing as a field of 
analysis particularly regarding data analysis. Unlike other methods of food allergen 
detection and quantification, such as ELISA that produces a single measure of allergen 
presence, mass spectrometry is far more open-ended regarding the amount of data that 
can be generated without clear boundaries regarding which data are meaningful. 
However, mass spectrometry also affords the opportunity for use of this greater amount 
of information generated to inform more complex questions in so far as the data analysis 
methodology is validated. Currently mass spectrometry is limited by a lack of clear data 
analysis workflows relative to the inherent integration of ELISA data, which forces mass 
spectrometry to act as secondary validation of ELISA as opposed to a direct alternative 
analytical technique. 
 The third aim was accomplished by incorporating assumptions into conventional 
risk assessment workflows to allow for the use of mass spectrometry data and inform 
risk. Assumptions are a critical point of risk assessment. A hazard that is impossible to 
encounter is no risk. Framing the circumstances that a hazard may become a risk is 
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therefore an important feature of risk assessment. In mass spectrometry, a critical 
assumption in data analysis is that individual peptide identifications indicate the presence 
of their progenitor protein and/or allergen. Incorporation of excessive assumptions into an 
analysis increases the likelihood that the resultant answer be regarded as insufficient, 
incorrect, or flawed. To ensure the future utility of mass spectrometry in a risk 
assessment workflow, a consensus among stakeholders is necessary on what conditions, 
circumstances, and assumptions are permissible. 
 Novel foods and ingredients will continue to be developed and discovered as will 
novel sources of food allergens. Stakeholders need to be sufficiently informed to make 
well-reasoned decisions as to which risks they are willing to undertake. Mass 
spectrometry will continue to improve and generate large amounts of data and therefore 
there is a need for further research into how mass spectrometry can be utilized in the 
workflow of allergen risk assessment. 
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APPENDIX A SUPPLEMENTARY FIGURES AND TABLES FROM CHAPTER 
2: PREDICTED ALLERGENS AND QUANTITIATIVE PROTEOMICS FROM 




Appendix A Figure 2.1.1 A. domesticus life stages 
 
Images of A. domesticus life stages in order of development from pinheads to adults. 
205 
Appendix A Table 2.1.1 Life stage replicate characteristics 
 









Pinhead 1 >50 215 1.06 5.64 
 2 >50 211 1.19 6.37 
 3 >50 202 1.17 6.26 
1 Week 1 50 208 1.15 6.13 
 2 50 207 1.32 7.05 
 3 50 216 1.01 5.39 
1/3 Grown 1 25 211 1.10 5.26 
 2 25 214 1.04 6.46 
 3 25 204 0.98 6.02 
2 Weeks 1 2 217 0.99 5.84 
 2 2 178 1.21 5.55 
 3 2 186 1.13 5.20 
1/2 Grown 1 2 234 0.88 4.72 
 2 2 373 1.11 5.94 
 3 2 327 1.34 7.17 
2/3 Grown 1 1 209 0.75 4.02 
 2 1 203 0.99 5.28 
 3 1 257 1.29 6.87 
Adult Male 1 1 376 1.23 6.56 
 2 1 382 0.93 4.97 
 3 1 416 1.45 7.74 
Adult Female 1 1 557 1.51 8.06 
 2 1 556 1.93 10.29 




Appendix A Figure 2.1.2 SDS-PAGE of extracts from A. domesticus life stages 
 
SDS-PAGE of 8 life stages of A. domesticus. Lanes were loaded with protein 
equivalent to 500 µg of wet tissue per life stage. Lanes were as follows: (L) molecular 
weight standards, (1) Pinhead, (2) 1 week, (3) 1/3 grown, (4) 2 weeks, (5) 1/2 grown, 
(6) 2/3 grown, (7) Adult male, (8) Adult female. Numbers are in order of development 
rather than lane loading order. 











# MS scans 926192 926192 926192 926192 
#MS/MS scans 425738 40737 14808 12807 
Peptide-Spectrum matches at FDR < 0.01 145671 20087 1955 290 
Peptides 4219 1161 287 71 
Peptide FDR 0.8% 0.8% 1.0% <0.1% 
Proteins 5446 609 66 8 
Protein Groups 481 340 46 8 
Protein FDR 6.5% 1.5% 4.3% <0.1% 





Appendix A Figure 2.1.3 Spectra of peptides with posttranslational modifications 


















































































































































































































































































































































































































































































































































































































































































































































Appendix A Figure 2.1.4 Phylogeny of the origin species of allergen predictions 
 
Phylogenetic tree of species produced with IcyTree whose allergenic sequences were 
significant matches to A. domesticus proteins. Branch length is arbitrary. Numbers to 
the right of each species represents the number of hits attributed to the species. 
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Appendix A Table 2.1.4 Enriched Gene Ontology (GO) terms for the top 10% most  
abundant proteins per life stage 
 
Pinhead             
GO ID GO name 
Go 







triphosphate binding MF 1.12E-03 6.84E-06 20 67 
GO:0051015 actin filament binding MF 1.12E-03 6.13E-06 7 4 
GO:0032555 
purine ribonucleotide 
binding MF 1.12E-03 6.84E-06 20 67 
GO:0003774 motor activity MF 5.96E-03 5.02E-05 6 4 
GO:0016459 myosin complex CC 5.96E-03 5.02E-05 6 4 
GO:0099513 polymeric cytoskeletal fiber CC 3.70E-02 3.64E-04 7 11 
GO:0006936 muscle contraction BP 4.78E-02 6.05E-04 3 0 
GO:0006996 organelle organization BP 4.78E-02 6.03E-04 12 39 
GO:0003924 GTPase activity MF 4.78E-02 5.38E-04 7 12 
GO:0005200 
structural constituent of 
cytoskeleton MF 4.78E-02 5.45E-04 6 8 
              
1 Week             
GO ID GO name 
Go 





GO:0003774 motor activity MF 1.09E-02 6.14E-05 6 4 
GO:0035639 
purine ribonucleoside 
triphosphate binding MF 1.09E-02 5.05E-05 19 68 
GO:0032555 
purine ribonucleotide 
binding MF 1.09E-02 5.05E-05 19 68 
GO:0016459 myosin complex CC 1.09E-02 6.14E-05 6 4 
GO:0051015 actin filament binding MF 2.07E-02 1.26E-04 6 5 
              
1/3 Grown             
GO ID GO name 
Go 





GO:0003774 motor activity MF 1.64E-02 6.14E-05 6 4 
GO:0016459 myosin complex CC 1.64E-02 6.14E-05 6 4 
GO:0051015 actin filament binding MF 2.98E-02 1.26E-04 6 5 
GO:0035639 
purine ribonucleoside 
triphosphate binding MF 3.33E-02 1.87E-04 18 69 
GO:0032555 
purine ribonucleotide 
binding MF 3.33E-02 1.87E-04 18 69 
GO:0099512 supramolecular fiber CC 4.15E-02 2.91E-04 8 14 
GO:0008152 metabolic process BP 4.53E-02 3.39E-04 13 279 
              
2 Weeks             
GO ID GO name 
Go 








monooxygenase activity MF 2.76E-03 5.17E-06 5 0 
GO:0042302 
structural constituent of 
cuticle MF 3.20E-03 7.49E-06 16 40 
GO:0044237 cellular metabolic process BP 5.68E-03 2.97E-05 7 228 
GO:0044238 primary metabolic process BP 6.50E-03 3.96E-05 6 210 
GO:0003774 motor activity MF 9.20E-03 6.78E-05 6 4 
GO:0016459 myosin complex CC 9.20E-03 6.78E-05 6 4 
GO:0051015 actin filament binding MF 1.64E-02 1.39E-04 6 5 
GO:0071704 
organic substance metabolic 
process BP 1.66E-02 1.48E-04 7 213 
              
1/2 Grown             
GO ID GO name 
Go 





GO:0003774 motor activity MF 1.64E-02 6.14E-05 6 4 
GO:0016459 myosin complex CC 1.64E-02 6.14E-05 6 4 
GO:0051015 actin filament binding MF 2.69E-02 1.26E-04 6 5 
GO:0044237 cellular metabolic process BP 3.36E-02 1.73E-04 8 227 
GO:0044238 primary metabolic process BP 3.78E-02 2.33E-04 7 209 
GO:0004503 
monophenol 
monooxygenase activity MF 3.78E-02 2.65E-04 4 1 
              
2/3 Grown             
GO ID GO name 
Go 





GO:0003774 motor activity MF 1.30E-02 3.66E-05 6 4 
GO:0016459 myosin complex CC 1.30E-02 3.66E-05 6 4 
GO:0042302 
structural constituent of 
cuticle MF 1.45E-02 4.76E-05 14 42 
GO:0051015 actin filament binding MF 2.01E-02 7.54E-05 6 5 
GO:0044237 cellular metabolic process BP 4.31E-02 1.82E-04 7 228 
GO:0044238 primary metabolic process BP 4.77E-02 2.41E-04 6 210 
              
Adult Male             
GO ID GO name 
Go 





GO:0003774 motor activity MF 1.39E-02 2.61E-05 6 4 
GO:0016459 myosin complex CC 1.39E-02 2.61E-05 6 4 
GO:0051015 actin filament binding MF 2.31E-02 5.40E-05 6 5 
GO:0008152 metabolic process BP 4.26E-02 2.19E-04 10 282 
              
Adult Female             
GO ID GO name 
Go 





GO:0006869 lipid transport BP 3.57E-07 1.67E-10 13 9 
GO:0005319 lipid transporter activity MF 5.37E-07 7.55E-10 12 8 
212 
GO:0009987 cellular process BP 3.67E-03 1.38E-05 9 306 
GO:0003774 motor activity MF 4.13E-03 2.32E-05 6 4 
GO:0016459 myosin complex CC 4.13E-03 2.32E-05 6 4 
GO:0051015 actin filament binding MF 7.34E-03 4.81E-05 6 5 
GO:0044238 primary metabolic process BP 3.07E-02 2.44E-04 5 211 
 
Go categories: MF, Molecular function; BP, Biological Process; CC, Cellular 
Component. Red and green highlighted GO IDs indicate over and underrepresented in 


















APPENDIX B ANNOTATIONS OF QUANTIFIED PROTEINS FROM ACHETA 
DOMESTICUS (XLSX, 380 KB) 
 
Annotations of 
quantified proteins from acheta domesticus.xlsx
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APPENDIX C SUPPLEMENTARY FIGURES AND TABLES FROM CHAPTER 
3: PROTEOMIC EVALUATION OF YELLOW MEALWORM, TENEBRIO 
MOLITOR, WITH EXPERIMENTAL GENETIC MODIFICATIONS  
 
 
Appendix C Table 3.1.1 Tribolium castaneum tropomyosin-2 exon 
structure utilized to manually curate T. molitor protein sequences 
 
TM# TM exons utilized per isoform 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1                 
2                 
3                 
4                 
5                 
6                 
7                 
8                 
9                 
10                 
11                 
12                 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix C Figure 3.1.1 Alignments and sequence coverage for arginine kinase and 
tropomyosins 
 
A. Arginine kinase 
 
XP_971800.2      MVDAAVLEKLEAGFKKLEASDSKSLLKKYLTRELFDKLKTKKTSFGSTLLDVIQSGLENH 60 
g5623t1          MVDAAVLEKLEAGFKKLEASDSKSLLKKYLTRELFDNLKTKKTSFGSTLLDVIQSGLENH 60 
                 ************************************:*********************** 
 
XP_971800.2      DSGIGIYAPDADSYSVFADLFDPIIEDYHGGFKKTDKHPPKDWGDVNAFGNLDPAGEFVV 120 
g5623t1          DSGIGIYAPDAEAYSVFSDLFDPIIEDYHGGFKKSDKHPPKNWGDTSVFGNLDPAGEYIV 120 
                 ***********::****:****************:******:***...*********::* 
 
XP_971800.2      STRVRCGRSLEGYPFNPCLTEEQYKEMEQKVSSTLSGLEGELKGTFYPLTGMSKEVQQKL 180 
g5623t1          STRVRCGRSLEGYPFNPCLTEEQYKEMEQKVSSTLSGLEGELKGTFYPLTGMSKEVQQKL 180 
                 ************************************************************ 
 
XP_971800.2      IDDHFLFKEGDRFLQAANACRFWPTGRGIFHNDAKTFLVWCNEEDHLRIISMQMGGDLGQ 240 
g5623t1          IDDHFLFKEGDRFLQAANACRFWPSGRGIFHNDAKTFLVWCNEEDHLRIISMQMGGDLGQ 240 
                 ************************:*********************************** 
 
XP_971800.2      VYRRLVTGVNDIEKRLPFSHSDRFGFLTFCPTNLGTTVRASVHIKVPKLAANKAKLDEVA 300 
g5623t1          VYRRLVTAVNDIEKRIPFSHSDRFGFLTFCPTNLGTTVRASVHIKVPKLSANKAKLDEVA 300 
                 *******.*******:*********************************:********** 
 
XP_971800.2      AKFNLQVRGTRGEHTEAEGGVYDISNKRRMGLTEFDAVKEMYDGISEIIKMEKEL 355 
g5623t1          GKFNLQVRGTRGEHTEAEGGVYDISNKRRMGLTEYDAVKEMYDGIAEIIKIEKEL 355 




g11661t1         MDAIKKKMQAMKLEKDNAQDKADAMEGQAKDANLRVEKLNEELRDLQKKLAQVEGDFSST 60 
XP_967128.1      MDAIKKKMQAMKLEKDNAQDKADAMEGQAKDANLRVEKLNEELRELQKKLSQVEGDLTTT 60 
                 ********************************************:*****:*****:::* 
 
g11661t1         KNNLEQANKDLEEKEKTLTNAESEMAALNRKVQLIEEDLERSEERLTTATTKLAEASQAA 120 
XP_967128.1      KNSLEQANKDLEEKEKTLTNAEAEMASLNRKVQTIEEDLERSEERLATATTKLAEASQAA 120 
                 **.*******************:***:****** ************:************* 
 
g11661t1         DESFRMCKVLENRSQQDEERMDQLTNQLKEARLLAEDADNKSDEVSRKLAFVEDELEVAE 180 
XP_967128.1      DESSRMCKVLENRSQQDEERMDQLTNQLKEARLLAEDADNKSDEVSRKLAFVEDELEVAE 180 
                 *** ******************************************************** 
 
g11661t1         DRVKGGDAKIMELEEELKVVGNSLKSLEVSEEKANQRVEEFKKQLKTLTVKLKEAEARAE 240 
XP_967128.1      DRVKGGDAKIMELEEELKVVGNSLKSLEVSEEKANQRVEEFKKQLKTLTVKLKEAEARAE 240 
                 ************************************************************ 
 
g11661t1         YAEKTVKKLQKEVDRLEDELGINKDRYKSLADEMDSTFAELAGY 284 
XP_967128.1      YAEKTVKKLQKEVDRLEDELGINKDRYKSLADEMDSTFAELAGY 284 
                 ******************************************** 
 
 
C. Tropomyosin-2 isoform 
ManualTM1.2.n       MDAIKKKMQAMKLEKDNALDRAIQNEQQAKDANLRGEKLEEEARTLQKKIQTIENELDQT 60 
217 
XP_008198924.1      MDAIKKKMQAMKLEKDNALDRAIFNEQQAKDANLRAEKLEEEARTLQKKIQTIENELDQT 60 
                    *********************** ***********.************************ 
 
ManualTM1.2.n       QEQLTQVNGKLEEKEKALQTAESEVAALNRRIQLLEEDLERSEERLATATAKLAEASAAA 120 
XP_008198924.1      QEQLTQVNGKLEEKEKALQTAESEVAALNRRIQLLEEDLERSEERLATATAKLAEASAAA 120 
                    ************************************************************ 
 
ManualTM1.2.n       DESERQRKVLENRSLADEERMDALENQLKEARFLAEEADKKYDEVARKLAMVEADLERAE 180 
XP_008198924.1      DESERQRKVLENRSLADEERMDALENQLKEARFLAEEADKKYDEVARKLAMVEADLERAE 180 
                    ************************************************************ 
 
ManualTM1.2.n       ERAETGESKIVELEEELRVVGNNLKSLEVSEEKANQREEEYKNQIKNLTTRLKEAEARAE 240 
XP_008198924.1      ERAEAGESKIVELEEELRVVGNNLKSLEVSEEKANQREEEYKNQIKNLTTRLKEAEARAE 240 
                    ****:******************************************************* 
 
ManualTM1.2.n       FAERSVQKLQKEVDRLEDELVAEKERYKEIGDDLDTAFVELIL 283 
XP_008198924.1      FAERSVQKLQKEVDRLEDELVAEKERYKEIGDDLDTAFVELIL 283 
                    ******************************************* 
 
Appendix C Figure 3.1.1 Alignments and sequence coverage for arginine kinase and 
tropomyosins 
 
Alignments of identified T. molitor (A) arginine kinase and (B) tropomyosin 1 predicted 
by Augustus and (C) a manually curated tropomyosin 2 isoform aligned to the top hits 
identified from Tribolium castaneum using Clustal Omega (12.4). Peptide coverage per 
protein is represented by red font. 
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# MS scans 154096 154096 154096 154096 
#MS/MS scans 208046 24772 19134 17486 
Peptide-Spectrum matches at FDR < 0.01 76377 1473 1334 760 
Peptides 5478 144 159 119 
Peptide FDR 0.7% 0.7% 0.6% <0.1% 
Proteins 1010 149 217 118 
Protein Groups 873 130 172 106 
Protein FDR 12.3% 59.3% 14.3% 66.7% 








Appendix C Figure 3.1.2 Spectra of peptides with posttranslational modifications 
























































































































































































































































































































































































































































































































































































































































































































































Appendix C Table 3.1.5 Enriched Gene Ontology (GO) terms of the top 10% most 
abundant proteins per sample against all proteins 
 
Wildtype       
GO ID Go Name 
Go 






structural constituent of 
cuticle MF 9.97E-06 3.17E-08 17 29 
GO:0005737 cytoplasm CC 7.94E-05 2.84E-07 8 284 
GO:0043231 
intracellular membrane-
bounded organelle CC 5.58E-04 3.11E-06 2 171 
GO:0019538 protein metabolic process BP 0.009885 7.08E-05 1 124 
GO:0031012 extracellular matrix CC 0.01602 1.27E-04 8 12 
GO:0044249 
cellular biosynthetic 
process BP 0.024143 2.02E-04 1 115 
 
Appendix C Figure 3.1.3 Phylogeny of the origin species of allergen predictions 
 
Phylogenetic tree of species produced with IcyTree whose allergenic sequences were 
significant matches to A. domesticus proteins. Branch length is arbitrary. Numbers to 
the right of each species represents the number of hits attributed to the species. 
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GO:0005488 binding MF 0.033049 2.89E-04 15 304 
GO:0016491 oxidoreductase activity MF 0.034324 3.41E-04 1 111 
GO:0044281 
small molecule metabolic 
process BP 0.034324 3.41E-04 1 111 
       
Genetically 
modified 1 
      
GO ID Go Name 
Go 





GO:0003824 catalytic activity MF 6.18E-06 9.83E-09 9 311 
GO:0042302 
structural constituent of 
cuticle MF 2.36E-05 7.50E-08 17 29 
GO:0005737 cytoplasm CC 8.35E-05 2.99E-07 9 283 
GO:0043231 
intracellular membrane-
bounded organelle CC 2.61E-04 1.14E-06 2 171 
GO:0019538 protein metabolic process BP 0.006375 4.56E-05 1 124 
GO:0031012 extracellular matrix CC 0.023341 1.86E-04 8 12 
GO:0044260 
cellular macromolecule 
metabolic process BP 0.041788 3.49E-04 1 105 
       
Genetically 
modified 2 
      
GO ID Go Name 
Go 





GO:0005737 cytoplasm CC 2.04E-05 5.53E-08 8 284 
GO:0003824 catalytic activity MF 2.04E-05 5.69E-08 10 310 
GO:0042302 
structural constituent of 
cuticle MF 2.09E-05 7.50E-08 17 29 
GO:0043231 
intracellular membrane-
bounded organelle CC 2.61E-04 1.14E-06 2 171 
GO:0019538 protein metabolic process BP 6.75E-03 4.56E-05 1 124 
GO:0031012 extracellular matrix CC 2.33E-02 1.86E-04 8 12 
GO:0044260 
cellular macromolecule 




process BP 4.76E-02 4.16E-04 2 120 
 
Go categories: MF, Molecular function; BP, Biological Process; CC, Cellular 
Component. Red and green highlighted GO IDs indicate over and underrepresented in 
test group, respectively. 
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Appendix C Table 3.1.6 Enriched Gene Ontology (GO) terms of the top 10% most 
abundant proteins per sample against robust proteins 
 
Wildtype       
GO ID Go Name 
Go 





GO:0003824 catalytic activity MF 1.55E-06 2.69E-09 5 241 
GO:0005737 cytoplasm CC 4.18E-05 1.45E-07 7 238 
GO:0042302 
structural constituent of 
cuticle MF 6.51E-05 2.54E-07 16 26 
GO:0043231 
intracellular membrane-
bounded organelle CC 0.005361 3.71E-05 2 129 
GO:0005488 binding MF 0.010576 7.78E-05 13 253 
GO:0044249 
cellular biosynthetic 
process BP 0.02062 1.61E-04 1 100 
GO:0019538 protein metabolic process BP 0.030571 2.78E-04 1 99 
GO:0044281 
small molecule metabolic 
process BP 0.030571 2.77E-04 1 95 
       
Genetically 
modified 1 
      
GO ID Go Name 
Go 





GO:0003824 catalytic activity MF 6.28E-06 2.09E-08 6 240 
GO:0005737 cytoplasm CC 6.28E-06 2.18E-08 6 239 
GO:0042302 
structural constituent of 
cuticle MF 6.51E-05 2.54E-07 16 26 
GO:0043231 
intracellular membrane-
bounded organelle CC 8.29E-04 5.38E-06 1 130 
GO:0005488 binding MF 0.00899 7.78E-05 13 253 
GO:1901576 
organic substance 
biosynthetic process BP 0.009744 9.28E-05 1 105 




process BP 0.01562 1.69E-04 0 82 
GO:0019538 protein metabolic process BP 0.023778 2.78E-04 1 99 
GO:0044281 
small molecule metabolic 
process BP 0.023778 2.77E-04 1 95 
       
Genetically 
modified 2 
      
GO ID Go Name 
Go 





GO:0003824 catalytic activity MF 8.03E-06 2.09E-08 6 240 
GO:0005737 cytoplasm CC 4.18E-05 1.45E-07 7 238 
GO:0042302 
structural constituent of 
cuticle MF 4.68E-04 1.82E-06 15 27 
GO:0043231 
intracellular membrane-
bounded organelle CC 0.005361 3.71E-05 2 129 
GO:0031012 extracellular matrix CC 0.01508 1.17E-04 8 10 
GO:0044249 
cellular biosynthetic 
process BP 0.019534 1.61E-04 1 100 
GO:0019538 protein metabolic process BP 0.029182 2.78E-04 1 99 
224 
GO:0044281 
small molecule metabolic 
process BP 0.029182 2.77E-04 1 95 
 
Go categories: MF, Molecular function; BP, Biological Process; CC, Cellular 
Component. Red and green highlighted GO IDs indicate over and underrepresented in 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix C Figure 3.1.5 Identity matrix of alignment of T. moltior tropomyosins 
with known allergenic tropomyosins 
 
T. moltior tropomyosins (g11661t1 and ManualTM1.2.n) were aligned with allergenic 
tropomyosins from shrimp (Penaeus modon, Pen m 1, Uniprot A1KYZ2), house dust 
mite (Dermatophagoides pteronyssinus, Der p 10, Uniprot O18416), and cockroach 
(Periplaneta americana, Per a 7.0102, Uniprot P0DSM7) using Clustal Omega 
(1.2.4). 
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APPENDIX D ANNOTATIONS OF QUANTIFIED PROTEINS FROM 
TENEBRIO MOLITOR (XLSX, 337 KB) 
Annotations of 
quantified proteins from tenebrio molitor.xlsx
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APPENDIX E SUPPLEMENTARY FIGURES AND TABLES FROM CHAPTER 
4: PERSISTENCE OF PEANUT ALLERGEN-DERIVED PEPTIDES 
THROUGHOUT EXCESSIVE DRY THERMAL PROCESSING 
 
Appendix E Table 4.1.1 Posttranslational modifications added to PTM search 
Name 
Monoisotopic 
mass Specificity Formula C H O 
Hydroxynonenal - Michael adduct 156.11500 CHKR C9H16O2 9 16 2 
Hydroxynonenal - 2-pentilpyrrole 120.09390 RK C9H12O0 9 12 0 
Hydroxynonenal - Dehydropentylfuran 
(CHRK) 
Hydroxynonenal - Shiff base (RK) 138.10450 CHKR C9H14O1 9 14 1 
Malondialdehyde - Dihydropyridine-
lysine 134.03680 K C8H6O2 8 6 2 
Malondialdehyde - Argpyrimidine 36.00000 R C3H0O0 3 0 0 
Malondialdehyde – N-propenal-Lysine 54.01056 K C3H2O1 3 2 1 
Acrolein - Michael Adduct 56.02621 CHK C3H4O1 3 4 1 
Acrolein - N-2 (4 hydroxy-tetrahydro-
pyrimidyl) Ornitine 56.02621 R C3H4O1 3 4 1 
Acrolein - Double Michael Adduct 112.05240 K C6H8O2 6 8 2 
Acrolein - Schiff Base 38.01565 K C3H2O0 3 2 0 
Acrolein - Formyl-dehydro-piperidyl-
lysine 94.04186 K C6H6O1 6 6 1 
Acrolein - Methylpyridine-lysine 77.03913 K C6H5O0 6 5 0 
Glyoxal-derived Hydroimidazolone 39.99491 R C2H0O1 2 0 1 
Methylglyoxal-derived Hydroimidazolone 
Imidazolonylornithine 54.01056 R C3H2O1 3 2 1 




Carboxymethyl Lysine (K) 
Glycollolysine (K) 58.00548 RK C2H2O2 2 2 2 
Triosone Hydroimisazolone 70.00548 R C3H2O2 3 2 2 
Methylglyoxal-derived Hemiaminal (RK) 
Carboxyethyllysine (K) 
Methylglyoxal-derived 
Dihydroxyimidazoline (R) 72.02113 RK C3H4O2 3 4 2 
Argpyrimidine 80.02621 R C5H4O1 5 4 1 
Triosone-derived Hemiaminal (RK) 
Triosone-derived Dihydroxyimidazoline 
(R) 88.01604 RK C3H4O3 3 4 3 
Triosidine-carbaldehyde 93.03404 K C6H5O1 6 5 1 
Pyrraline 108.02110 K C6H4O2 6 4 2 
3-Deoxy-pentosone Hydroimidazolone 114.03170 R C5H6O3 5 6 3 
Trihydroxy-triosidine 125.02390 K C6H5O3 6 5 3 
Dihydropyrimidine Ornithine 126.03170 R C6H6O3 6 6 3 
Pronyl-lysine 126.03170 K C6H6O3 6 6 3 
229 
 
Appendix E Table 4.1.2 Lists of peptides used for quantification of peanut allergens 
 







Ara h 1 NNPFYFPSR  X 1140.5352 
Isoforms IPSGFISYILNR  X 1378.7609 
1/2 SFNLDEGHALR X X 1257.6101 
 NTLEAAFNAEFNEIR X  1737.8322 
 GTGNLELVAVR X  1127.6299 
Ara h 2 C(+57.02)MC(+57.02)EALQQIMENQSDR  X 2011.822 
Isoforms NLPQQC(+57.02)GLR X X 1084.5448 
1/2 C(+57.02)C(+57.02)NELNEFENNQR X X 1725.6835 
 ANLRPC(+57.02)EQHLMQK X  1623.7974 
Ara h 6 C(+57.02)DLDVSGGR X X 977.4236 
Isoforms ELMNLPQQC(+57.02)NFR X X 1548.7177 
1/2 VNLKPC(+57.02)EQHIMQR X X 1651.8286 
Ara h 3 WLGLSAEYGNLYR  X 1540.7673 
Isoforms RPFYSNAPQEIFIQQGR X X 2050.0383 
4/5/10/ FNLAGNHEQEFLR X X 1573.7637 
13/17/20 SPDIYNPQAGSLK X  1388.6936 
Ara h 3 LNALTPDNR  X 1012.5302 
Isoforms GIPADVLINAFGLR  X 1454.8245 
1/11 EGQILLVPQNFAVGK X X 1611.8984 
 IESQGGITETWNSNHPELR X  2167.0293 
 FYLAGNPEEEHPETQQQQPQTR X  2626.2048 
Ara h 3 GGHITSLNTPNMAVLQYLQLGLDR  X 2610.3589 
Isoforms EAQEGNVFSGLALETLIGSFNVQR  X 2578.3027 
2/12 TSDNPIINTLAGELSLVR X X 1912.0265 
 GVMEIVVTGC(+57.02)R X  1219.6053 
 AGSDAFDWVAIK X  1278.6244 
Ara h 3 VLPVDVVANMYQVSR  X 1688.892 
Isoforms LPILADLQLSAER X X 1437.8191 
8/15 NIVMVEGGLDVVRPEPGSR X X 2023.052 
 FYIAGNTEDEHGEGGR X  1750.7546 





Dihydroxyimidazoline (R) 132.04230 RK C5H8O4 5 8 4 
Nε-(5,6-dihydroxy-2,3-dioxohexyl)-Lys 
Hexose Dehydrate 144.04230 K C6H8O4 6 8 4 
3-deoxyglucosone-derived 
Hydroimidazolone 





Hexose (K) 162.05280 RK C6H10O5 6 10 5 
Glucosone-derived Hemiaminal 178.04770 RK C6H10O6 6 10 6 
Alkyl Formyl Diglycosyl Pyrrole 270.07400 K C12H14O7 12 14 7 
Acetone aldol condensation 98.07320 KHR C6H10O1 6 10 1 
230 
Isoform ILSPEREEFDGR  X 1446.7102 
18 EIVQNLR X X 870.4923 
 IDSEGGFIETWNPK X  1591.7518 
 QEQEFLQYQHQHGGPR X  1980.9191 
Ara h 3 TVNELDLPILNR X X 1395.7721 
Isoform SQSEHFLYVAFK X X 1454.7194 
3/6/19 LGLSAEYGSIHR X X 1301.6727 
Ara h 3 NAMFVPHYTLNAH  X 1513.7136 
Isoform SSNPDIYNPQAGSLR X X 1617.7747 
7/16 VYDEELQEGHVLVVPQNFAVAAK X X 2554.3066 
 AQSENYEYLAFK X  1461.6776 
Ara h 3 GLLLPHYINAPR X X 1362.7771 
Isoform EGQILIVPQQFVVAK X X 1667.9609 
9/14 NDQFQC(+57.02)VGVSALR X X 1492.7092 
 
 
Appendix E Figure 4.1.1 Peanut kernel halves over thermal processing 
 
Peanut kernel halves roasted for times between 0 and 480 minutes at 176 °C (top) and 





Appendix E Figure 4.1.2 Extracts of peanuts heated at 176 °C and 260 °C 
 
Resultant defatted powders from peanut kernel halves roasted at 176 °C (top) and 260 °C 




Appendix E Figure 4.1.3 Extracts of peanuts heated at 176 °C and 260 °C 
 
Extracts produced from peanut kernel halves roasted at 176 °C (top) and 260 °C (bottom) 
for times between 0 and 480 minutes. 
 
 
Appendix E Figure 4.1.4 Peanut allergenic profile for peanuts heated at 176 °C 
 
The sum of peanut allergens Ara h 1, 2, 3, 6 per time point are graphed to the left Y-axis 
and the proportion of each allergen are graphed to the right Y-axis (N=5). For clarity, the 
peanut allergen profile is presented without CVs but is tabulated elsewhere. Sums of 
allergenic proteins that have different letters are significantly different via two-way 




Appendix E Figure 4.1.5 Persistence 
of peanut allergen peptides at 176 °C 
 
Unmodified peptides (circles) and 
post-translationally modified peptides 
(bars) per Ara h 1, 2, 3, and 6 scaled to 
each peptide’s maximum value 
observed over time. Data are 
represented as averages of 5 replicates 
without CV for clarity. Average %, 
pooled CV, and N of peptides per time 
point: 0 (85.3%, 21.1%, 358), 15 
(87.2%, 22.4%, 390), 30 (68.1%, 
33.1%, 364), 60 (54.3%, 56.3%, 312), 
120 (13.5%, 130.3%, 112), 240 (9.4%, 




Appendix E Figure 4.1.6 Negative control immunoblots 
 
Control Immunoblots probed using non-atopic unsensitized serum. Transferred 
immunoblots were loaded volumetrically relative to 30 µg of raw peanut (approximately 
1.7 µl) and dot blots were prepared with either 0.5 or 0.25 µl of extracts. Dot blot 
negative control was bovine serum albumin heated at 260 °C for 8 hours and extracted 
while positive control was directly applied Morinaga anti-peanut IgG. 
235 
APPENDIX F COMPLETE PEPTIDE LIST FOR ROASTED PEANUTS (XLSX, 
4853 KB) 
Complete peptide 
list for roasted peanuts.xlsx
236 
APPENDIX G SUPPLEMENTARY FIGURES AND TABLES FROM CHAPTER 
5: DETECTION OF FOOD ALLERGEN-DERIVED PEPTIDES FROM 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix G Figure 5.1.1 Annotated Peptide spectra 







Appendix G Figure 5.1.1 Annotated Peptide spectra 
 
 










In-solution digest of Peach, protein Q43607 
 
 





In-gel digestion of Coconut, protein Q43607 
 
 
In-gel digestion of Peach, protein Q43607 
 
Appendix G Figure 5.1.1 Annotated Peptide spectra 
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